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A B S T R A C T
Background
The ideal proportion of energy from fat in our food and its relation to body weight is not clear. In order to prevent overweight and obesity
in the general population, we need to understand the relationship between the proportion of energy from fat and resulting weight and
body fatness in the general population.
Objectives
To assess the e$ects of proportion of energy intake from fat on measures of body fatness (including body weight, waist circumference,
percentage body fat and body mass index) in people not aiming to lose weight, using all appropriate randomised controlled trials (RCTs)
of at least six months duration.
Search methods
We searched CENTRAL, MEDLINE, Embase, Clinicaltrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) to October
2019. We did not limit the search by language.
Selection criteria
Trials fulfilled the following criteria: 1) randomised intervention trial, 2) included adults aged at least 18 years, 3) randomised to a lower
fat versus higher fat diet, without the intention to reduce weight in any participants, 4) not multifactorial and 5) assessed a measure of
weight or body fatness aKer at least six months. We duplicated inclusion decisions and resolved disagreement by discussion or referral
to a third party.
Data collection and analysis
We extracted data on the population, intervention, control and outcome measures in duplicate. We extracted measures of body fatness
(body weight, BMI, percentage body fat and waist circumference) independently in duplicate at all available time points. We performed
random-e$ects meta-analyses, meta-regression, subgrouping, sensitivity, funnel plot analyses and GRADE assessment.
Main results
We included 37 RCTs (57,079 participants). There is consistent high-quality evidence from RCTs that reducing total fat intake results in
small reductions in body fatness; this was seen in almost all included studies and was highly resistant to sensitivity analyses (GRADE high-
consistency evidence, not downgraded). The e$ect of eating less fat (compared with higher fat intake) is a mean body weight reduction
of 1.4 kg (95% confidence interval (CI) -1.7 to -1.1 kg, in 53,875 participants from 26 RCTs, I2 = 75%). The heterogeneity was explained in
subgrouping and meta-regression. These suggested that greater weight loss results from greater fat reductions in people with lower fat
intake at baseline, and people with higher body mass index (BMI) at baseline. The size of the e$ect on weight does not alter over time and
is mirrored by reductions in BMI (MD -0.5 kg/m2, 95% CI -0.6 to -0.3, 46,539 participants in 14 trials, I2 = 21%), waist circumference (MD -0.5
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cm, 95% CI -0.7 to -0.2, 16,620 participants in 3 trials; I2 = 21%), and percentage body fat (MD -0.3% body fat, 95% CI -0.6 to 0.00, P = 0.05,
in 2350 participants in 2 trials; I2 = 0%).
There was no suggestion of harms associated with low fat diets that might mitigate any benefits on body fatness. The reduction in body
weight was reflected in small reductions in LDL (-0.13 mmol/L, 95% CI -0.21 to -0.05), and total cholesterol (-0.23 mmol/L, 95% CI -0.32
to -0.14), with little or no e$ect on HDL cholesterol (-0.02 mmol/L, 95% CI -0.03 to 0.00), triglycerides (0.01 mmol/L, 95% CI -0.05 to 0.07),
systolic (-0.75 mmHg, 95% CI -1.42 to -0.07) or diastolic blood pressure(-0.52 mmHg, 95% CI -0.95 to -0.09), all GRADE high-consistency
evidence or quality of life (0.04, 95% CI 0.01 to 0.07, on a scale of 0 to 10, GRADE low-consistency evidence).
Authors' conclusions
Trials where participants were randomised to a lower fat intake versus a higher fat intake, but with no intention to reduce weight, showed
a consistent, stable but small e$ect of low fat intake on body fatness: slightly lower weight, BMI, waist circumference and percentage body
fat compared with higher fat arms. Greater fat reduction, lower baseline fat intake and higher baseline BMI were all associated with greater
reductions in weight. There was no evidence of harm to serum lipids, blood pressure or quality of life, but rather of small benefits or no
e$ect.
P L A I N   L A N G U A G E   S U M M A R Y
Eect of cutting down the fat we eat on body weight
The ideal proportion of energy from fat in our food and its relation to body fatness is not clear. This review looked at the e$ect of cutting
down the proportion of energy from fat in our food on body fatness in adults who are not aiming to lose weight. Body fatness was measured
using body weight, body mass index, waist circumference and percent body fatness. The evidence is current to October 2019. The review
found that cutting down on the proportion of fat in our food leads to a small but noticeable decrease in body weight, body mass index,
percentage body fat and waist circumference. The e$ect did not change over time, but reducing fat intake to a greater extent results in
greater weight reduction. We assessed potential harms of reducing total fat, but found no evidence of harm on serum lipids, blood pressure
or quality of life.
Eects of total fat intake on body fatness in adults (Review)
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S U M M A R Y   O F   F I N D I N G S
 
Summary of findings 1.   Low dietary fat compared with usual fat for controlling body fatness
Low dietary fat compared with higher dietary fat for body fatness
Patient or population: adults from the general population including those who were healthy, with risk factors and with long-term conditions
Settings: any setting, including the community and institutions, for at least 6 months
Intervention: lower dietary total fat (intended that participants reduce dietary fat intake to ≤ 30% energy (≤ 30%E) from fat, and at least partially replace the energy lost
with carbohydrates (simple or complex), protein or fruit and vegetables)
Comparison: higher dietary total fat (intended that participants consume > 30% energy from total fats. The higher fat arm could be 'usual dietary intake', specifying a high-
er total fat intake, or one aiming to modify the type of fats consumed, such as increasing monounsaturated or polyunsaturated fats)
Methods: randomised controlled trials (RCTs)
Illustrative comparative risks* (95% CI)
Assumed risk Corresponding risk
Outcomes
Usual fat Low dietary fat
Relative ef-
fect
(95% CI)
No of partici-
pants
(studies)
Quality of the
evidence
(GRADE)
Comments
Body fatness (rep-
resented by body
weight, kg)
Follow-up: 6 to 96
months
Median weight change
-0.04 kg1
The mean body weight in the
low fat groups was
1.42 kg lower
(1.73 to 1.10 lower)
— 53,875
(26 RCTs, 33
comparisons)
Body fatness (repre-
sented by BMI, kg/
m2)
Follow-up: 6 to 96
months
Mean change in BMI
0.14 kg/m2
The mean BMI in the low fat
groups was 0.47 kg/m2 lower
(0.64 to 0.30 lower)
  46,604 (15
RCTs)
Body fatness (repre-
sented by waist cir-
cumference, cm)
Follow-up: 6 to 96
months
Mean change in waist
circumference -0.6 cm
Mean waist circumference in
low fat participants was 0.47
cm lower (0.73 to 0.22 lower)
  16,685 (4
RCTs)
Body fatness (repre-
sented by percentage
body fat)
Follow-up: 6 to 96
months
Mean change in per-
centage body fat 0.7%
Mean percentage of body fat in
low fat participants was 0.28%
lower (0.57 to 0 lower)
  2415 (3 RCTs)
⊕⊕⊕⊕
high 2,3,4,5,6,7
Reducing total fat intake
causes a small reduction in
body fatness (assessed with
body weight and other mea-
sures of body fatness). Not
downgraded
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Potential harms -
serum lipids, mmol/L
Means at baseline in
usual fat groups (in
mmol/L): Total choles-
terol 5.5; LDL choles-
terol 4.0; HDL choles-
terol 1.4, TG 1.3
Relative to control groups, to-
tal cholesterol in the low fat
arm was 0.23 mmol/L lower
(95% CI -3.2 to -0.14), LDL cho-
lesterol was 0.13 mmol/L low-
er (95% CI -0.21 to -0.05), HDL
cholesterol was 0.02 mmol/
L lower (95% CI -0.03 to 0.00),
and TG was 0.01 mmol/L high-
er (95% CI -0.05 to 0.07).
  Total chol:
9812 (22 RCTs)
LDL chol:
8137 (19 RCTs)
HDL chol:
8268 (20 RCTs)
TG: 8672 (18
RCTs)
⊕⊕⊕⊕
high 4,8,9,
10,11
We found no evidence that re-
ducing total fat intake harms
serum lipids. It leads to small
reductions in total and LDL
cholesterol, with little change
in HDL cholesterol or TG.
Potential harms -
blood pressure (BP),
mmHg
Mean change in usual
fat groups (in mmHg):
systolic BP -1.2; dias-
tolic BP -0.9
Relative to control groups,sys-
tolic BP in the low fat arm was
0.75 mmHg lower (95% CI
-1.42 to -0.07) and diastolic BP
was 0.52 mmHg lower (95% CI
-0.95 to -0.09).
  Systolic BP:
6078 (10 RCTs)
Diastolic BP:
6078 (10 RCTs)
⊕⊕⊕⊕
high 4,8,12, 13,
14
We found no evidence that re-
ducing total fat intake harms
BP. It leads to small reductions
in systolic and diastolic BP.
Potential harms -
quality of life (QoL)
Mean change in usual
fat group was 0.03
Relative to control groups,QoL
in the low fat arm was 0.04
higher (95% CI 0.01 to 0.07)
on a scale of 0 to 10, where 0 is
worst and 10 best QoL.
  40,130 (1 RCT) ⊕⊕ΟΟ
low 15,16,
17,18,19
We found no evidence that re-
ducing total fat intake harms
QoL. It may lead to small rises
in QoL.
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; RCT: randomised controlled trial
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1The median weight change in the control groups over the course of each study was -0.04 kg, ranging from -1.91 kg to 2.13 kg.
2 Risk of bias: While most studies were unblinded for participants and allocation concealment was oKen unclear (as randomisation was described poorly), RCT results in adults
were remarkably consistent in their direction. Sensitivity analyses removing studies not at low summary risk of bias did not lose the statistically significant relative weight
reduction in the low fat arm, and neither did running fixed-e$ect (rather than random-e$ects) meta-analysis or removing studies with attention bias favouring those in the low
fat arm, or those with other interventions alongside the fat reduction. Together this suggests that the risk of bias was low. Not downgraded.
3 Inconsistency: The direction of e$ects in these RCTs was remarkably consistent - in almost every study, participants eating lower total fat intakes were lower in weight
(on average) at the study end than participants eating a higher percentage of total fat. The only inconsistency (where heterogeneity arose) was in the size of this e$ect. The
heterogeneity was partly explained by the degree of reduction of fat intake, by the BMI of participants, and by the level of control group fat intake, which together explained 16%
of between-study variance (in meta-regression). The reduction in weight in those taking on lower fat diets was seen in very di$erent populations and from six months to several
years. It was also consistent when we excluded studies that gave additional support, time or encouragement to the low fat arms, and where we excluded studies that delivered
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additional dietary interventions (on top of the change in dietary fats). The results were consistent in direction, and much of the heterogeneity in the size of the e$ect was explained
by the selected factors. E$ects on body weight are supported by similar e$ects on BMI, waist circumference and percentage of body fat. Not downgraded.
4 Indirectness: All included RCTs directly compared (and randomised participants) to lower versus usual fat intake. Participants were directly relevant as they came from all parts
of the world, included men and women, and people who were healthy, with risk factors or with long-term conditions at baseline. The studies all addressed weight directly and
did not use proxy measures. Not downgraded.
5 Imprecision: Over 50,000 participants were included in RCTs of at least six months duration, and e$ect sizes were highly statistically significant in main analyses and subgroups.
There was little imprecision. If the true e$ect on weight was at either end of the 95% CI, we would interpret the e$ect in the same way. Not downgraded.
6 Publication bias: The funnel plot did not suggest publication bias. The consistent weight loss was despite the fact that none of the studies included intended to alter weight
in either arm, so that publication bias for this outcome is unlikely. Not downgraded.
7 Dose response: Subgrouping and meta-regression supported the presence of a dose-response gradient - greater reduction in total fat intake lead to greater weight loss. Not
upgraded.
8 Risk of bias: While most studies were unblinded for participants and allocation concealment was oKen unclear (as randomisation was described poorly), RCT results in adults
were remarkably consistent in their direction. Sensitivity analyses removing studies not at low summary risk of bias were not performed, but individual studies at low summary
risk of bias generally supported reductions in total and LDL cholesterol and little e$ect on HDL, TG, systolic and diastolic BP. This suggests low risk of bias. Not downgraded.
9 Inconsistency: While I2 > 0.5 for total and LDL cholesterol, the direction of e$ects in these RCTs was consistent - in almost every study participants eating lower total fat intakes
had lower total and LDL cholesterol (on average) at the study end than participants eating a higher percentage of total fat. The inconsistency (where heterogeneity arose) was in
the size of this e$ect. The results were consistent in direction. E$ects on total and LDL cholesterol support each other. Not downgraded.
10 Imprecision: E$ect sizes for total and LDL cholesterol were highly statistically significant. There was little imprecision. If the true e$ect on either total or LDL cholesterol was
at either end of the 95% CI, we would interpret the e$ect in the same way. Not downgraded.
11 Publication bias: The funnel plots were di$icult to interpret, but did not suggest publication bias. Not downgraded.
12 Inconsistency: I2 < 0.10 for systolic and diastolic BP. Not downgraded.
13 Imprecision: E$ect sizes for systolic and diastolic blood pressure were statistically significant, suggesting small non-clinically relevant reductions in BP. If the true e$ect on
either systolic or diastolic BP was at either end of the 95% CI we would interpret the e$ect in the same way. Not downgraded.
14 Publication bias: The funnel plots were di$icult to interpret, but suggested that studies with smaller reductions, or small rises in BP may be missing. If such studies were added
in, then the e$ect would move closer to zero. Not downgraded.
15 Indirectness: The single very large trial was in women from the USA. Downgraded once.
16 Risk of bias: The single very large trial was at low summary risk of bias. Not downgraded.
17 Inconsistency: Single trial only, no inconsistency but no evidence of consistency. Downgraded once.
18 Imprecision: The e$ect was statistically significant. Not downgraded.
19 Publication bias: Not possible to assess with a single study. Not downgraded.
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B A C K G R O U N D
Description of the condition
Optimal intakes of total fat were debated by the Joint Food
and Agriculture Organization of the United Nations (FAO)/World
Health Organization (WHO) expert consultation on fats and fatty
acids in human nutrition in 2008. In light of the rising levels of
overweight and obesity, particularly in low- and middle-income
countries undergoing rapid nutrition transition, this consultation
agreed that any e$ect of total fat intake on body weight was pivotal
in making global recommendations on total fat intake. Overweight
and obesity are associated with increased risk of many cancers,
coronary heart disease and stroke (Manson 1990; Song 2004; WCRF/
AICR 2009).
How the intervention might work
A previous systematic review that aimed to assess e$ects of lower
fat intake on body weight did not find any eligible randomised
controlled trials (RCTs) (Kelly 2006), but we were aware of RCTs
that had randomised participants to lower fat versus higher fat
diets, and measured weight or BMI, not as the primary outcome of
intervention, but as a process measure or intermediate outcome
(Hooper 2012a; Hooper 2015a). Additionally, meta-regression
within a systematic review assessing RCTs on the e$ects of step I
and II diets (diets designed by the National Heart, Lung and Blood
Institute national cholesterol education programme to reduce
the risk of cardiovascular disease in the general population and
those at increased cardiovascular risk, respectively), found a strong
relationship between total fat intake and body weight (Yu-Poth
1999). This review, however, included studies that were as short as
three weeks in duration and studies in which weight loss was a goal
of the intervention, which may have overstated any relationship
because the advice was to lower both fat and energy intake. It also
excluded many trials of reduction in total fat intake that did not fit
the step I or II criteria.
More recent reviews that have explored the long-term e$ects of
low fat diets either did not explore weight or body fatness as an
outcome (Schwingshackl 2013), or looked at low fat intake as part of
a wider health promotion intervention (Ni 2010). Other systematic
reviews have explored the relationship between fat intake and body
fatness but were either limited to the e$ect of low fat dairy versus
high fat dairy consumption (Benatar 2013), or investigated it as part
of overall dietary patterns (Ambrosini 2014), or diet quality (Aljadani
2015).
Why it is important to do this review
The WHO Nutrition Guidance Expert Advisory Group (NUGAG)
subgroup on diet and health (www.who.int/nutrition/topics/
advisory_group/nugag_dietandhealth_topics/en/) was requested
by WHO to assess the relationship between total fat intake
and body weight. This was to aid the WHO's understanding of
this relationship and enable updating of WHO's guidelines on
total fat intake. The expert advisory group aimed to generate a
recommendation on the population impact of total fat intake in
the development of obesity. The NUGAG group agreed to exclude
studies of populations recruited specifically for weight loss and
interventions intended to result in weight loss. These studies
are potentially confounded by the implicit objective of reducing
calorie intake to produce weight loss and might therefore lead to
an overemphasis on studies carried out in highly selected obese
populations in North America and Europe, which may have limited
transferability to non-obese populations or those in developing
countries or in countries in transition.
To fulfil the requirements for the new guideline, a systematic review
was needed of all available evidence of the longer-term e$ects
of total fat intake on body fatness, in studies not intending to
cause weight loss. The WHO therefore commissioned a systematic
review and meta-analysis to assess the relationship between total
fat intake and indicators of body fatness (including obesity, waist
circumference and body mass index) using all appropriate RCTs and
cohort studies in adults and children (Hooper 2012b), which was
updated in 2015 (Hooper 2015a). This update of the review focusses
on RCTs in adults, and a companion review assesses e$ects in
children (Naude 2018).
O B J E C T I V E S
To assess the e$ects of proportion of energy intake from fat on
measures of weight and body fatness (including body weight, waist
circumference, body mass index and percentage of body fat) in
adults not aiming to lose weight, using all appropriate RCTs with a
duration of at least six months.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We aimed to include randomised controlled trials (RCTs) in adults
aged at least 18 years. They needed to assess e$ects of reduced fat
intake compared with higher fat intake with no intention to reduce
weight (in any participants in either or both arms). Trials needed to
have a minimum duration of six months, be unconfounded by non-
nutritional interventions and assess a measure of body fatness at
least six months aKer the intervention was initiated.
Randomisation of individuals was accepted, or of larger groups
where there were at least six of these groups (clusters) randomised.
We excluded studies where allocation was not truly randomised
(e.g. divisions based on days of the week or first letter of the
family name were excluded) or where allocation was not stated
as randomised (and no further information was available from the
authors). We excluded cross-over studies (as previous weight gain
or weight loss is likely to a$ect future weight trends) unless the first
half of the cross-over could be used independently.
We included full-text studies, those published as abstracts only, and
unpublished data. We did not include cohort studies in this update.
Types of participants
We accepted studies of adults (≥ 18 years, no upper age limit)
at any risk of cardiovascular disease (with or without existing
cardiovascular disease). Participants could be of either sex, but
we excluded those who were acutely ill (including with immunity
problems such as HIV or post-transplant), pregnant or lactating.
We excluded intervention studies where participants were chosen
for raised weight or body mass index (as most appeared to aim to
reduce body weight within interventions, even when this was not
explicitly stated in the intervention goals).
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Types of interventions
We considered all randomised controlled trials (RCTs) of
interventions stating an intention to reduce dietary fat, when
compared with a higher (usual or modified fat) intake.
We considered a low fat intake to be one that aimed to reduce fat
intake to ≤ 30% energy (≤ 30%E) from fat, and at least partially
replace the energy lost with carbohydrates (simple or complex),
protein or fruit and vegetables. We considered a higher fat diet to be
one that aimed to include > 30% energy from total fats. The higher
fat arm could be "usual dietary intake", specifying a higher total fat
intake, or one aiming to modify the type of fats consumed (such as
increasing mono-unsaturated or poly-unsaturated fats).
As we were interested in the e$ects of fat intake on body weight
and fatness in everyday dietary intake (rather than in people aiming
to reduce their body weight in weight-reducing diets), we excluded
studies aiming to reduce the weight of some or all participants, as
well as those that included only participants who had recently lost
weight, or recruited participants according to a raised body weight
or BMI. We excluded multifactorial interventions other than diet
or supplementation (unless the e$ects of diet or supplementation
could be separated, such as in a 2 x 2 trial where the additional
intervention was consistent between the intervention and control
groups). We excluded Atkins-type diets aiming to increase protein
and fat intake, as well as studies where fat was reduced by means
of a fat substitute (like Olestra). We excluded enteral and parenteral
feeds, as well as formula weight-reducing diets.
Examples
The following are some examples of the types of studies we would
include or exclude based on their intervention and comparison
groups. We included studies that reduced fats and encouraged
physical activity in one arm and compared this with encouraging
physical activity in the control. We excluded studies that reduced
fats and encouraged physical activity in one arm and compared
this with no intervention in the control. We included studies that
reduced fats and encouraged fruit and vegetables in one arm and
compared this with no intervention in the control.
We included all trials that intended to reduce dietary fat to ≤
30%E in one arm compared to higher fat intake (> 30%E from
fat) in another arm regardless of the degree of di$erence between
fat intake in the two arms (dose). We explored the e$ects of the
di$erence in %E from fat between control and intervention groups,
as well as the e$ects of fat intake in the control groups and dietary
fat goals in the intervention groups, in subgrouping and meta-
regression.
Types of outcome measures
Primary outcomes
The main outcome was body fatness assessed using a variety of
measures. These included body weight, body mass index, waist
circumference, skinfold thickness and percentage fat. Studies had
to assess or report at least one of these measures, or a change
in these measures, to be included in the review. Measures of
body fatness needed to be assessed at least six months aKer the
intervention was initiated, and data at trial end, or from the latest
available time during the trial, were used.
Secondary outcomes
Secondary outcomes included other classic cardiovascular risk
factors (systolic or diastolic blood pressure; serum total, low
density lipoprotein (LDL) or high density lipoprotein (HDL)
cholesterol, and triglyceride) and quality of life measures (including
informal outcomes such as feelings of health and time o$ work).
They were included in the review to assess any possible harms of
reducing total fat on quality of life or cardiovascular risk factors.
Tertiary outcomes
Tertiary outcomes were process outcomes and included changes
in saturated and total fat intakes, as well as other macronutrients,
sugars and alcohol.
This is not a systematic review of the e$ects of reduced fat on these
secondary or tertiary outcomes, but we collated the outcomes from
included studies in order to understand whether any e$ects on
weight might be compromised by negative e$ects on secondary or
tertiary outcomes.
Search methods for identification of studies
Electronic searches
The searches for this review were last run in November 2014 as
part of a broader review (Hooper 2015a). As the review has now
been split and the previous search strategy was unsuitable, a new
strategy was run on 18 October 2019, from database inception, in
the following databases:
• CENTRAL (Issue 10 of 12, 2019, Cochrane Library)
• Epub Ahead of Print, In-Process & Other Non-Indexed Citations,
MEDLINE Daily and MEDLINE (Ovid, 1946 to October 17, 2019)
• Embase (Ovid, 1980 to 2019 week 41)
Two clinical trials registers were also searched on 18 October 2019;
Clinicaltrials.gov (https://clinicaltrials.gov/) and WHO International
Clinical Trials Registry Platform (ICTRP, https://apps.who.int/
trialsearch/). The searches are described in Appendix 1. The
RCT filter for MEDLINE is the Cochrane sensitivity and precision-
maximising RCT filter (Lefebvre 2011), and for Embase, terms
as recommended in the Cochrane Handbook have been applied
(Lefebvre 2011).
The results were de-duplicated against each other. As we were
updating another Cochrane review relating to dietary fat (Hooper
2015b) at the same time, results of the searches for both reviews
were combined and de-duplicated before assessment of titles and
abstracts.
The search to 2014 is described in Hooper 2015a, and previous
searches (to June 2010) in Hooper 2012b.
Searching other resources
We searched for recent and additional publications of all our
included studies, using trials registry entries (for outcome data and
publication lists), searching on trials registry numbers, and tracking
key authors, to ensure the best and most complete information was
available for all our included studies. We also checked reference
lists of included studies and looked for retraction statements and
errata.
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Data collection and analysis
Selection of studies
Titles and abstracts identified by searches were loaded into
Covidence soKware, and all authors took part in assessment of
titles and abstracts. We only rejected articles on initial screen if
the review author could determine from the title and abstract
that the article was not a relevant RCT. We rejected articles if
they were not reporting a RCT; the trial did not address a low fat
intake; the trial was exclusively in children (less than 18 years old),
pregnant women or the critically ill; participants were chosen for
being overweight or obese; there was an intention to reduce weight
in some or all participants; the trial was of less than six months
duration; or the intervention was multifactorial.
When a title/abstract could not be rejected with certainty, we
obtained the full text of the article for further evaluation.
Data extraction and management
We extracted data concerning participants, interventions and
outcomes, and trial quality characteristics onto a form designed
for the review. We extracted data on potential e$ect modifiers
(including duration of intervention, control group fat intake, sex,
year of first publication, di$erence in % energy from fat between
the intervention and control groups, type of intervention (food or
advice provided), the dietary fat goals set for each arm, baseline
BMI and health at baseline). Where provided, we collected data
on risk factors for cardiovascular disease (secondary and tertiary
outcomes).
All trial outcomes were continuous and, where possible, we
extracted change data (change in the outcome from baseline
to outcome assessment) with relevant data on variance for
intervention and control arms (along with numbers of participants
at that time point). Where change data were not available, we
extracted data at study end (or other relevant time point) along
with variance and numbers of participants for each arm. LH,
OFJ and AA assessed inclusion of full-text studies independently
in duplicate, and discussed disagreements until agreement was
reached (including the third member of the team where needed).
Assessment of risk of bias in included studies
We carried out 'Risk of bias' assessment independently in duplicate
as part of data extraction. We assessed trial risk of bias using the
Cochrane 'Risk of bias' tool (Higgins 2011b). For included RCTs, in
addition to the tool's domains, we assessed whether:
1. trials were free of di$erences in diet (between intervention and
control arms) other than dietary fat intake;
2. there was any systematic di$erence in attention or care or time
given between the intervention and control groups; and
3. there was evidence that the two arms achieved statistically
significant di$erences in total fat intake (compliance).
These issues were chosen as we felt that these factors may also
a$ect di$erences in weight between arms. We used the category
'other bias' to note any further issues of methodological concern.
Funding was not formally a part of our assessment of bias in RCTs
as it is not a core part of the Cochrane 'Risk of bias' tool, but was
reported in the Characteristics of included studies.
We assessed each trial for summary risk of bias. Summary risk
of bias was considered low in trials with low risk of selection
bias (low risk from random sequence generation and allocation
concealment) and low risk of detection bias. Summary risk of bias
was considered moderate to high in all other included trials.
Measures of treatment eect
The e$ect measure of choice for continuous outcomes (all review
outcomes were continuous outcomes) was the mean di$erence
(MD) with its 95% confidence interval.
Unit of analysis issues
We did not include any cluster-randomised or cross-over trials in
this review.
Where there was more than one relevant intervention arm but only
one control arm we pooled the relevant intervention arms to create
a single pairwise comparison (where the intervention arms were
equivalently appropriate for this review) as described in Higgins
2011a. We excluded intervention arms that were not appropriate
for this review, or less appropriate than another arm. When two
arms were appropriate for di$erent subgroups. then we used the
control group once with each intervention arm, but we did not pool
the subgroups overall.
When weight or BMI were assessed at more than one time point,
we used the data from the latest time point available in general
analyses, but we extracted data for all time points for use in
subgrouping by study duration.
Dealing with missing data
Where included studies used methods to infer missing data (such as
carrying the latest weight data forward), then we used these data in
analyses. Where this was not done we used the data as presented.
Assessment of heterogeneity
We examined heterogeneity using the I2 statistic and considered
heterogeneity important where the I2 was above 50% (Higgins 2003;
Higgins 2011a).
Assessment of reporting biases
We drew funnel plots to examine the possibility of publication bias
for measures of body fatness with at least 10 included comparisons
(Egger 1997). We also compared findings of fixed- and random-
e$ects meta-analysis since the two methods weight small trials
di$erently, and di$erent e$ect sizes suggest potential small study
bias (Page 2019).
Data synthesis
All trial outcomes were continuous and, where possible, we
extracted change data (change in the outcome from baseline
to outcome assessment) with relevant data on variance for
intervention and control arms (along with numbers of participants
at that time point). Where change data were not available, we
extracted data at study end (or other relevant time point) along
with variance and numbers of participants for each arm. We did
not use end data where the di$erence between the intervention
and control groups at baseline was greater than the change in that
measure between baseline and endpoint in both arms (instead we
used change data in forest plots, but without standard deviations
Eects of total fat intake on body fatness in adults (Review)
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(SDs), so the data did not add to the meta-analyses but provided
comparative information).
We combined data by the inverse variance method in random-
e$ects meta-analysis (RevMan 2014) to assess mean di$erences
with 95% confidence intervals between lower and higher fat intake
arms.
Summary of findings
We created a 'Summary of findings' table assessing the e$ects of
low dietary fat compared with usual fat for body fatness (combining
data on body weight, BMI, waist circumference and percentage
body fat, which all assess body fatness) in adults using RCT data,
reflecting GRADE assessment of quality of our findings.
Subgroup analysis and investigation of heterogeneity
We classified all dietary interventions as lower fat versus higher fat.
Prespecified subgroups for body weight, to explore the stability of
findings in di$erent study subgroups, included:
• duration of intervention (6 to < 12 months, 12 to < 24 months, 24
to < 60 months, and 60+ months);
• control group total fat intake (> 35%E from fat, > 30%E to 35%E
from fat, > 25%E to 30%E from fat). Control group fat intake is
equivalent to baseline fat intake;
• year of first publication of results (1960s, 1970s, 1980s, 1990s,
2000s, 2010s);
• sex (studies of women only, of men only, of men and women
mixed);
• di$erence in %E from fat between control and reduced fat
groups (up to 5%E from fat, 5%E to < 10%E from fat, 10%E to <
15%E from fat, 15+%E from fat, or unknown di$erence);
• type of intervention (dietary advice, advice plus supplements
and diet provided);
• total fat goal in the intervention arm (10%E to < 15%E from fat,
15%E to < 20%E from fat, 20%E to < 25%E from fat, 25%E to <
30%E from fat, 30%E from fat, and no specific goal stated);
• achieving fat goals (achieved 30%E from fat or less, did not
achieve this);
• mean BMI at baseline (< 25, 25 to < 30, 30+);
• state of health at baseline (not recruited on the basis of risk
factors or disease, recruited on the basis of risk factors such
as lipids, hormonal levels etc., recruited on the basis of having
or having had diseases such as diabetes, myocardial infarction,
cancer, polyps);
• assessed energy reduction in the intervention compared with
the control group during the intervention period (E intake the
same or greater in the low fat group, E intake 1 to 100 kcal/d
lower in the low fat group, 101 to 200 kcal/d lower in the low fat
group, > 200 Kcal/d lower in the low fat group).
For subgrouping factors that appeared to suggest significant
di$erences in e$ect size between subgroups, we explored the
e$ects using meta-regression on weight. We performed random-
e$ects meta-regression (Berkley 1995) using the STATA command
metareg (Sharp 1998; Sterne 2001; Sterne 2009).
Sensitivity analysis
We carried out sensitivity analyses for primary outcomes, assessing
the e$ect of:
• running fixed-e$ect meta-analyses (rather than random-e$ects)
(Higgins 2011a);
• excluding studies not at low summary risk of bias
• excluding the largest study (WHI 2006);
• excluding studies that were not free of systematic di$erences in
care (or unclear);
• excluding studies that were not free of dietary di$erences other
than fat (or unclear)
R E S U L T S
Description of studies
Results of the search
For this update, the electronic searches identified 15,314 possible
titles and abstracts (including trials registry entries) for assessment
for this review and the sister review being updated (Hooper
2015a). Of these, 14,784 were rejected on title and abstract
screening, and 530 were collected in full text for further assessment.
Seventy-three full-text publications were included or assessed
as pending, and these were grouped into seven new included
RCTs (AUSMED 2018; CORDIOPREV 2016; Ma 2016; ODMDC 2017;
RISCK 2010; WHT Full-scale; Yadav 2016 including 3584 randomised
participants), three ongoing RCTs, six RCTs awaiting further
assessment (as existing details were not su$icient to ensure
inclusion), and 18 new publications for eight already included RCTs.
One previously included trial was excluded (Sondergaard 2003)
during reassessment as it was felt on reflection that it was highly
unlikely either arm aimed at < 30% E from fat. Combining with the
30 RCTs already included means that this review includes 37 RCTs,
three ongoing RCTs and a further six RCTs are awaiting assessment
(Figure 1).
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Figure 1.   Study flow diagram
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Figure 1.   (Continued)
 
We included all 37 RCTs in forest plots. Twenty-nine RCTs provided
full information on at least one body fatness outcome and so were
included in meta-analytic pooling. Eight RCTs only provided partial
data so are displayed in forest plots (Analysis 1.2; Analysis 1.3;
Analysis 1.4; Analysis 2.7) but not included in meta-analysis. They
are displayed to allow us to assess whether these results support
or detract from meta-analytic findings (AUSMED 2018; beFIT 1997;
Black 1994; MeDiet 2006; NDHS Open 1st L&M 1968; NDHS Open 2nd
L&M 1968; Rivellese 1994).
Included studies
Of the 37 RCTs (including up to 57,079 participants - exact numbers
depending on time point in study and endpoint used), 24 were
from North America, 10 from Europe, two from Australia or New
Zealand, and one from China. The duration of the trials varied from
six months to more than eight years. In four trials, the participants
were all men, in 16 all women and in 17 both sexes (one of
which reported outcomes by sex). Mean ages and states of health
(low, moderate or high risk of cardiovascular disease or breast
cancer, where low risk are people without specific risk factors,
moderate risk people have risk factors, and those at high risk have
experienced CVD or cancer) varied. See Characteristics of included
studies for detailed characteristics of the RCTs.
When discussing the 37 RCTs, De Bont 1981 and DEER 1998 are
referred to and counted as single studies, although individual arms
appear in analyses (data were presented by body weight at baseline
for De Bont 1981, and by sex and exercise prescription for DEER
1998). This is because this was how the data were presented
in the original papers for these trials and the di$erent arms
occasionally appear in di$erent subgroups (making subgrouping
more e$ective). However, Sarkkinen Low & Mod 1993 and
Sarkkinen Low Fat 1993 had four distinct dietary arms that worked
as two intervention/control pairs, so are presented as separate
trials.
As well as the addition of the seven new trials, new publications
were located for some already included trials. These allowed
updating of three already included trials and addition of new
outcome data (WHEL 2007; WHI 2006; WHTFSMP 2003).
Excluded studies
During this update, we added seven new trials to the list of excluded
studies (Cocinar para su salud 2016; DIRECT 2009; Drummond 1998;
Eckard 2013; HIPERCOL 2018; Nutri-EPA 2017; Troyer 2010). They
were excluded for an inappropriate intervention or control (Cocinar
para su salud 2016; Drummond 1998; HIPERCOL 2018; Troyer 2010;
Nutri-EPA 2017) or because the study aimed to reduce weight in
some or all participants (DIRECT 2009; Eckard 2013).
Risk of bias in included studies
To understand the risk of bias in the individual included RCTs in a
visual way, see Figure 2. Risk of bias is reported by included arms
(so Sarkkinen Low & Mod 1993 and Sarkkinen Low Fat 1993 are
reported separately), so are discussed as 38 RCT arms.
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Figure 2.   'Risk of bias' summary: review authors' judgements about each methodological quality item for each
included adult and child RCT comparison.
R
an
do
m
 s
eq
ue
nc
e 
ge
ne
ra
tio
n 
(s
el
ec
tio
n 
bi
as
)
A
llo
ca
tio
n 
co
nc
ea
lm
en
t (
se
le
ct
io
n 
bi
as
)
B
lin
di
ng
 o
f 
pa
rt
ic
ip
an
ts
 a
nd
 p
er
so
nn
el
 (
pe
rf
or
m
an
ce
 b
ia
s)
: A
ll 
ou
tc
om
es
B
lin
di
ng
 o
f 
ou
tc
om
e 
as
se
ss
m
en
t (
de
te
ct
io
n 
bi
as
):
In
co
m
pl
et
e 
ou
tc
om
e 
da
ta
 (
at
tr
iti
on
 b
ia
s)
: A
ll 
ou
tc
om
es
Se
le
ct
iv
e 
re
po
rt
in
g 
(r
ep
or
tin
g 
bi
as
)
O
th
er
 b
ia
s
Fr
ee
 o
f 
sy
st
em
at
ic
 d
if
fe
re
nc
e 
in
 c
ar
e?
Fr
ee
 o
f 
di
et
ar
y 
di
ff
er
en
ce
s 
ot
he
r 
th
an
 f
at
?
C
om
pl
ia
nc
e 
pr
ob
le
m
s
Anderson 1990 + ? - - - ? + - + -
AUSMED 2018 + ? - ? - - + + - +
BDIT Pilot Studies 1996 ? ? - + + ? + - + +
beFIT 1997 + ? - ? ? - + - + ?
Black 1994 + ? - + - ? + - + +
Bloemberg 1991 + ? - ? + ? + - + +
Boyd 1988 ? ? - + - ? + - + +
BRIDGES 2001 + + - ? - ? + - - ?
Canadian DBCP 1997 + + - ? + ? + - + +
CORDIOPREV 2016 + + - + + ? + + ? +
De Bont 1981 ? ? - ? - ? + + + +
DEER 1998 + ? - ? + ? + - + +
Diet and Hormone Study 2003 + ? - - - ? + - - +
Ma 2016 + + - + + - + - - -
MeDiet 2006 ? ? - ? + ? + - - -
Moy 2001 + ? - ? + ? + - ? +
MSFAT 1995 + + - ? - ? + + + +
NDHS Open 1st L&M 1968 + + + + - ? + + + ?
NDHS Open 2nd L&M 1968 + + - ? - ? + + + ?
Nordevang 1990 ? ? - ? - ? + - + +
Nutrition & Breast Health + + - - - ? + - + +
ODMDC 2017 + + - + + + + + + +
Pilkington 1960 ? ? - ? ? ? + + + ?
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Figure 2.   (Continued)
ODMDC 2017 + + - + + + + + + +
Pilkington 1960 ? ? - ? ? ? + + + ?
Polyp Prevention 1996 + + - ? + ? + - - +
RISCK 2010 + ? - ? - - + + + +
Rivellese 1994 + ? - - - ? + + - ?
Sarkkinen Low & Mod 1993 + ? - - + ? + + + -
Sarkkinen Low Fat 1993 + ? - - - ? + + + +
Simon 1997 + ? - ? - ? + - + +
Strychar 2009 ? ? - ? - ? + + + ?
Swinburn 2001 + + - ? - ? + - + +
WHEL 2007 + ? - ? + + + - - ?
WHI 2006 + + - + + + + - - +
WHTFSMP 2003 + ? - ? + - + - - +
WHT Full-scale ? ? - - ? + - - + +
WHT Vanguard 1991 ? ? - - + + + - + +
WINS 1993 + + - ? + ? + - + +
Yadav 2016 + ? - ? - + + - - +
 
Allocation
Twenty-nine RCT arms had low risk of bias from random sequence
generation (as they provided some information on the method
of randomisation, suggesting true randomisation was performed
in some way); the remainder were at unclear risk. Thirteen RCT
arms were at low risk of selection bias (arising from low risk from
allocation concealment and randomisation), and the remaining
RCTs were at unclear risk.
Blinding
There was a high risk of performance bias due to lack of blinding
of participants (which is usual in dietary trials) in 36 included
RCTs, and low risk in one of the National Diet and Heart Studies
(NDHS Open 1st L&M 1968), which provided trial shops that blinded
purchases of usual or low fat products. The risk of detection bias
was low in eight trials, high in eight trials, and unclear in the
remainder.
Summary risk of bias was low in five included trials (CORDIOPREV
2016; Ma 2016; NDHS Open 1st L&M 1968; ODMDC 2017; WHI 2006) -
trials with low risk of selection bias (low risk from random sequence
generation and allocation concealment) and low risk of detection
bias.
Incomplete outcome data
For RCTs, we assessed those studies that lost more than 10% of
participants per year as at high risk of attrition bias; others were
at low risk of attrition bias. Sixteen RCT arms were at low risk of
attrition bias, 19 were at high risk of attrition bias and three were
unclear.
Selective reporting
Most RCTs were at unclear risk of reporting bias (due to the paucity
of accessible and prospective trial registrations and protocols, so
that we could not assess reporting bias), but six RCT arms were at
low risk and five at high risk of bias.
Other potential sources of bias
We considered all RCTs to be at low risk of other types of bias,
except for WHT Full-scale which was terminated early, before many
participants had outcomes measured, and is poorly reported.
Thirteen RCT arms had low risk of systematic di$erences in level
of care between the intervention and control groups, while 25
had high risk of such di$erences in care. Di$erences in attention,
training, time from health professionals, number of health checks
and/or group support could potentially alter feelings of self e$icacy
and increase contact with healthcare professionals o$ering various
types of support, and alter participants' ability to look aKer
themselves and maintain a healthy weight.
Some dietary interventions to reduce fat also had specific goals
around fruit, vegetables, fibre, alcohol etc., which raises the
possibility that any changes in weight may result from these
alterations, not from change in fat intake. Eleven RCT arms were at
high risk of e$ects from dietary di$erences other than fat; two were
unclear and the remaining 25 RCTs were at low risk of e$ects from
other dietary advice.
We assessed studies to be at low risk of compliance problems if
there was a statistically significant di$erence in total fat intake
during the intervention period (as late as possible during the
intervention). We found that 25 trial arms were at low risk, four at
high risk and 9 at unclear risk of compliance problems.
Eects of interventions
See: Summary of findings 1 Low dietary fat compared with usual
fat for controlling body fatness
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The 'Summary of findings' table assessing the e$ects of lower
dietary fat compared with higher dietary fat intake for body weight,
and including the GRADE assessment, is presented (Summary of
findings 1).
Eects of reducing dietary fat on weight and body fatness in
adults
Body fatness
Body fatness was measured in this review with body weight, BMI,
waist circumference and percentage body fatness. E$ects on each
of these specific measures are reported below. Combining data on
all of these measures, we found that eating a lower proportion of
energy as fat results in slightly lower body fatness than eating the
usual proportion of fat (GRADE assessment: high-quality evidence,
not downgraded).
Weight
Eating a lower proportion of energy as fat results in lower body
weight (or lower weight gain, or greater weight reduction) than
eating the usual proportion of fat (MD -1.4 kg, 95% confidence
interval (CI) -1.7 to -1.1, I2 = 75%, 53,875 participants, 33 estimable
comparisons from 26 RCTs, Analysis 1.1, high-quality evidence). The
e$ect was small and consistent; the best estimate of e$ect was a
reduction in weight in the lower fat arm consistently across 30 of
the 33 comparisons.
Sensitivity analyses. We ran sensitivity analyses to assess e$ects
of lower fat intake on body weight when analyses were run using
di$erent assumptions. E$ects using fixed-e$ect meta-analysis (-0.9
kg, 95% CI -1.1 to -0.8, Analysis 2.1), including only trials at low
summary risk of bias (-1.4 kg, 95% CI -1.7 to -1.1, Analysis 2.2),
excluding the largest trial, WHI 2006 (-1.5 kg, 95% CI -1.9 to -1.2,
Analysis 2.3), excluding trials with more time or attention to the
intervention group (-0.9 kg, 95% CI -1.2 to -0.6, Analysis 2.4),
excluding trials with dietary di$erences additional to fat di$erences
(-1.6 kg, 95% CI -2.1 to -1.2, Analysis 2.5) or excluding studies with
potential compliance problems (-1.6 kg, -1.9 to -1.2, Analysis 2.6) all
suggested lower weight in study populations eating lower fat diets.
Small study bias and missing data. The funnel plot suggested
that one or two small studies showing weight gain in the lower
fat arm may be missing (Figure 3). The e$ect of adding any such
missing studies back into the meta-analysis would be a small
reduction in amount of weight loss in lower fat arms. All of the
nine comparisons without an estimable e$ect size, due to lack of
variance data or large baseline di$erences, were consistent with
greater weight reduction in the reduced fat arms (Analysis 2.7). As
the e$ect in fixed-e$ect analysis, which gives less weight to small
studies (-0.9 kg, 95% CI -1.1 to -0.8, Analysis 2.1), is smaller than the
e$ect in random-e$ects meta-analysis (-1.4 kg, 95% CI -1.7 to -1.1,
Analysis 1.1), which gives more weight to smaller studies, there is a
suggestion of small study bias in the overall e$ect size. The weight
reduction with reduced fat intake is still present, but may be closer
to -0.9 kg (Analysis 2.1) than -1.4 kg.
 
Figure 3.   Funnel plot of comparison: 1 Fat reduction versus usual fat diet, outcome: 1.1 Weight, kg.
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Subgrouping. Heterogeneity was high (I2 = 75%) but only in the
degree of weight loss - lower weight in the lower fat arm was
remarkably consistent across the included trials. Subgrouping may
be able to explain why e$ects di$er in di$erent trials. We used
prespecified subgroups to examine the influence of potential e$ect
modifiers of fat intake on body weight. There were significant
di$erences between e$ects in subgroups of di$erent duration,
suggesting that greatest e$ects on body weight may occur 12 to
24 months from first reducing fat intake, but without any clear
progression and with weight reduction in all subgroups (Analysis
3.1). Subgrouping by baseline total fat intake suggested greatest
weight reduction in study populations with lower fat intakes at
baseline (25 to 30%E from fat), but again, with weight reductions in
all subgroups and no clear progression (Analysis 3.2). There were no
statistically significant di$erences between studies first published
in di$erent decades, and no suggestion of trend (Analysis 3.3), or
between e$ects in men and women (Analysis 3.4). In trials with a
greater di$erence in fat intake between arms, there appeared to be
a greater relative weight reduction in study populations taking the
lower fat diet, suggesting a dose e$ect, with statistically significant
di$erences between subgroups (Analysis 3.5). Similarly, weight
reduction was greater when the lower fat arm achieved total fat
intake of 30%E or less (Analysis 3.6). E$ects di$ered by intervention
type, with greatest weight reduction resulting from dietary advice,
less from advice plus supplementary foods, and least (MD -0.61 kg,
95% CI -0.84 to -0.39, Analysis 3.7) when all foods were provided.
E$ects also di$ered by subgroup of the fat goal in the lower fat
arm, but did not suggest a dose response (Analysis 3.8). There
was no statistically significant di$erence between subgroups with
di$erent mean baseline BMI, but there was a suggestion of greater
weight loss with higher baseline BMI (Analysis 3.9), but people
recruited for having a long-term condition, or risk factors for such
a condition appeared to lose more weight than those who were
healthy at baseline (Analysis 3.10). In trials where lower fat arm
participants were assessed as eating fewer calories, weight loss
appeared higher, as expected (Analysis 3.11). Weight loss occurred
in all subgroups, but the degree of weight loss appeared higher
when study populations reduced their fat intake to a greater extent,
to 30%E energy or less, with lower fat intake at baseline, in people
who were heavier at baseline, and those with long-term conditions
or risk factors for such conditions.
Meta-regression. In light of the subgrouping results, we ran a
multiple regression model on dose, BMI, baseline health and
control group (baseline) fat intake, all at once. As we included only
33 comparisons (and as a rule of thumb it is appropriate to include
an additional factor for every 10 comparisons), we then omitted the
factor with the highest P value (health condition, P = 0.44) and re-
ran the meta-regression with the final three factors. This suggested
statistically significant relationships with all three factors: dose (the
fat di$erence between intervention and control, suggesting that
greater fat reduction results in greater weight reduction in the lower
fat arm, coe$icient -0.20 kg/1% energy from total fat reduction,
95% CI -0.34 to -0.06, P = 0.007); the baseline fat intake (assessed
in the control arm, greater weight reduction in people with lower
fat intake at baseline, coe$icient 0.17 kg/1% energy from fat in the
control group, 95% CI 0.04 to 0.29, P = 0.010); and BMI (greater
weight reduction in those with higher BMI at baseline, coe$icient
-0.2 kg for each 1 kg/m2 rise in BMI, 95% CI -0.39 to -0.004, P = 0.046).
Together these factors explained 16% of variance between studies.
GRADE: GRADE assessment suggested that the evidence that
reducing total dietary fat results in a small decrease in body weight
was of high quality (Summary of findings 1).
Body mass index (BMI), waist circumference and other measures
of body fatness
Fewer studies reported BMI than weight, but the e$ect of a
lower proportion of energy from fat on BMI appeared similar to
that on weight (MD -0.5 kg/m2, 95% CI -0.6 to -0.3, I2 = 60%,
46,539 participants, 15 comparisons, Analysis 1.2). A point estimate
suggesting lower BMI in the lower fat arms was consistent across
13 of the 15 comparisons, including one trial that could not
be included in meta-analysis due to a lack of data on variance
(AUSMED 2018, which reported -0.1 kg/m2 in the intervention group
compared to 0 kg/m2 in the control, in 65 participants but without
any variance data). As BMI reflects very similar information to body
weight, and there were fewer studies than for weight, we did not
attempt sensitivity analyses and subgrouping for BMI.
Data on waist circumference suggested that waist circumference
in those on low fat diets was significantly lower than in those
on usual fat diets (MD -0.5 cm, 95% CI -0.7 to -0.2, I2 = 21%,
16,620 participants in 3 trials, Analysis 1.3), although this was not
supported in the trial that did not provide variance data so could
not be included in meta-analysis (AUSMED 2018, which reported a
mean reduction of 0.4 cm in the lower fat group, and a reduction
of 1.1 cm in the control group). Data on percentage of body fat
suggested lower percentage of body fat in those eating less dietary
fat, but was only marginally significant (MD -0.3% body fat, 95% CI
-0.6 to 0, P = 0.05, I2 = 0%, 2350 participants in 2 trials, Analysis 1.4),
though data were more limited on this outcome, from only 3 trials,
one of which did not provide variance data (AUSMED 2018, which
reported a mean reduction of 0.4% in the lower fat group compared
to a reduction of 0.6% in the control).
In summary, other indicators of body fatness support data
suggesting lower body weight in those consuming lower fat intakes.
Secondary outcomes - lipids and blood pressure
There was no suggestion of harms associated with low fat diets that
might mitigate any benefits on body fatness.
E$ects of lower fat compared with higher fat diets suggested that
the lower fat diets were associated with lower total cholesterol (MD
-0.23 mmol/L, 95% CI -0.32 to -0.14, I2 = 72%, 9812 participants in
22 trials, Analysis 1.5) and low-density lipoprotein (LDL) cholesterol
(MD -0.13 mmol/L, 95% CI -0.21 to -0.05, I2 = 57%, 8072 participants
in 18 trials, Analysis 1.6), without important e$ects on high-density
lipoprotein (HDL, MD -0.02 mmol/L, 95% CI -0.03 to 0.00, I2 = 23%,
8268 participants in 19 RCTs, Analysis 1.7), triglycerides (MD 0.01
mmol/L, 95% CI -0.05 to 0.07, I2 = 50%, 8607 participants in 17 trials,
Analysis 1.8) or total cholesterol/HDL ratio (MD -0.05, 95% CI -0.14
to 0.04, I2 = 44%, 3639 participants in 5 trials, Analysis 1.9).
There were small clinically insignificant beneficial e$ects of a lower
fat diet on systolic (-0.75 mmHg, 95% CI -1.42 to -0.07, I2 = 9%,
6013 participants in nine comparisons, Analysis 1.10) and diastolic
(-0.52 mmHg, 95% CI -0.95 to -0.09, I2 = 7%, 6012 participants in nine
comparisons, Analysis 1.11) blood pressure (these were reported in
relatively few studies).
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Secondary outcomes - e#ects of reducing fat intake on quality of
life measures
Quality of life outcomes were rarely measured or reported. Quality
of life was assessed in WHI 2006 and suggested very small
improvements in Global Quality of Life in those in the lower fat arm
compared to higher fat (MD 0.04, 95% CI 0.01 to 0.07, on a scale of
0 to 10, where 0 is worst and 10 best, in 40,130 participants at trial
close, Analysis 1.12). No other relevant data were located.
Tertiary outcomes - e#ects of reducing fat intake on intakes of
energy, protein, carbohydrate, sugars and alcohol
Indications were that, during the studies, energy intake was usually
lower in the low fat group than in the control or usual fat groups.
Sugar intake was not measured oKen but, where reported, sugar
intake appeared higher in low fat arms (except in MeDiet 2006, see
Table 1). Carbohydrate intakes appeared almost universally higher
in low fat arms than in usual fat arms, and protein intakes were
sometimes higher and sometimes similar. There was no consistent
pattern in alcohol intake.
D I S C U S S I O N
Summary of main results
Randomised controlled trials (RCTs) of the e$ects on body fatness
of reducing total fat intake (without any intention to reduce body
weight) show a small but highly consistent reduction in weight in
the lower fat arm compared with the higher fat arm. There is some
heterogeneity between studies in the size of this e$ect, but not
in its presence, and the e$ect was highly resistant to sensitivity
analyses. The heterogeneity was partially explained in subgrouping
and meta-regression. The degree of weight loss appeared higher
when study populations reduced their fat intake to a greater extent,
to 30%E energy or less, in those who were heavier at baseline, and
in those with lower fat intake at baseline.
The small reduction in body weight with lower dietary fat intake
(MD -1.4 kg, 95% CI -1.7 to -1.1, I2 = 75%, over 53,875 participants
in 33 estimable comparisons from 26 RCTs) was also reflected in
a reduction in BMI (MD -0.5 kg/m2, 95% CI -0.6 to -0.3, I2 = 60%,
46,604 participants, 15 comparisons), waist circumference (MD -0.5
cm, 95% CI -0.7 to -0.2, I2 = 21%) and percentage body fat (MD -0.3%
body fat, 95% CI -0.6 to 0, I2 = 0%, P = 0.05, in 2415 participants) in
the studies that reported these data. There were no suggestions of
harm that might mitigate any benefits on weight, and there was a
suggestion of small benefits to serum lipids resulting from lower fat
diets.
Overall completeness and applicability of evidence
We have searched very carefully and used a set of comprehensive
search strategies to find the full set of RCTs assessing the e$ect of
reducing total fat intake on measures of body fatness. We did this
by searching for trials that reduced total fat in one arm and not in
the other, regardless of the primary aims or outcomes mentioned
in the title or abstracts. Indeed, the included RCTs rarely had weight
as a key outcome. There was some evidence of small study bias,
with small studies suggesting that smaller weight loss in the low
fat arms was missing, so that if such studies were added back the
weight reduction in the lower fat arms would be slightly smaller, but
still reflect reduced weight in the lower fat arms.
The studies are highly applicable to the question, allowing us to
draw conclusions on the e$ect of altering the percentage of energy
from total fat on body fatness.
Quality of the evidence
Summary risk of bias was low in five of the 37 included trials;
these were trials with low risk of selection bias (low risk from
random sequence generation and allocation concealment) and low
risk of detection bias. However, limiting analyses to trials at low
summary risk of bias also resulted in lower weight in the lower
fat arms. Similarly, excluding trials with more time or attention
to the intervention group (attention bias), excluding trials with
dietary di$erences additional to fat di$erences (in case e$ects were
being driven by other dietary interventions) and excluding studies
with potential compliance problems all suggested lower weight
in participants eating lower fat diets. This resilience suggests that
e$ects are not simply due to bias; the higher validity trials reflect
the main message, that eating a lower proportion of energy from
fat results in slightly lower body fatness.
The funnel plot suggests that one or two small studies showing
weight gain in the lower fat arm may be missing. Additionally,
the e$ect in fixed-e$ect analysis, which gives less weight to small
studies (-0.9 kg, 95% CI -1.1 to -0.8, Analysis 2.1), is smaller than
the e$ect in random-e$ects meta-analysis (-1.4 kg, 95% CI -1.7 to
-1.1, Analysis 1.1), which gives more weight to smaller studies. Both
suggest the presence of small study bias when assessing e$ects
of lower total fat intake on body weight. The e$ect of adding any
such missing studies back into the meta-analysis would be a small
reduction in amount of weight loss in lower fat arms. The weight
reduction with reduced fat intake is still present, but may be closer
to -0.9 kg (Analysis 2.1) than -1.4 kg.
Almost all studies included in this review su$er from performance
bias; it is very di$icult to blind participants to how much fat they are
eating (the exception was one 'shop-based' trial where participants
bought potentially fatty foods from a trial shop, and these foods
were modified according to intervention group (NDHS Open 1st
L&M 1968). Potential problems with participants knowing whether
they are in the intervention or control group is that, if they know
they are reducing their dietary fat, they may bother less with other
healthy lifestyle practices (such as smoking cessation or physical
activity), which could in turn impact on body fatness (in opposite
ways).
Potential biases in the review process
When compiling the included studies, we tried to locate RCTs that
investigated the e$ects of reducing total dietary fat for at least
six months. There was a high degree of heterogeneity among
trials from di$erent sources, including the type and number of
participants, the duration and nature of interventions, control
methods and follow-up. However, our sensitivity analyses and
subgrouping to examine the e$ect of many potential e$ect
modifiers did not a$ect the statistical significance of the suggested
e$ect; the lower weight in those eating lower fat is remarkably
robust to subgroup and sensitivity analyses.
Our review included only published studies (we did not seek
unpublished data), which could bias the results due to the lack of
publication of negative or inconclusive studies. However, we did
include and assess studies that measured body fatness but without
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su$icient detail to include in meta-analysis, and almost all these
trials also suggested lower weight or body fatness in the lower fat
arms.
Our decision to exclude trials that explicitly or implicitly aimed to
reduce weight may have led to missing some trials or restricting
the number of included studies, especially excluding studies where
there was no energy restriction, no explicit aim of weight loss,
or encouraging of weight loss for some and not all participants.
However, this decision makes the e$ect we found on weight and
other measures of body fatness more reliable in people eating
normal diets and avoids the potential confounding e$ects of
dieting and unconscious energy restriction or other diet changes.
The restriction of inclusion to RCTs with a minimum of six months
duration led to missing some potentially relevant shorter trials.
However, it is essential to draw the line at some point, and longer
trials and follow-up ensure that the data are relevant to long-term
fatness, which a$ects long-term health.
A limitation of the review was that we did not assess the causal
pathway between restriction of energy from fat and weight and so
the mechanism of the e$ect is not clear. It is likely that restricting
energy from fat also reduces energy intake slightly (see Table 1 and
Analysis 3.11), which leads to lower body weight. Further evidence
that energy intake is important in mediating the e$ect of lowering
fat intake on body weight is suggested by a higher relative weight
loss in the low fat arms with greater energy reduction.
Most (23 of 37) included RCTs were published before the year 2000
- this is primarily because most recent studies have focused on
weight reduction so were ineligible for this review. However, there
was no suggestion when subgrouping by decade of publication that
e$ects have altered over time.
We assessed e$ects of reducing total fat on quality of life and
cardiovascular risk factors (lipids and blood pressure) at the
request of WHO to check that, if we found positive e$ects on body
fatness, they were not counteracted by harms to other outcomes.
This was not a formal systematic review of e$ects of total fat
on lipids, blood pressure or quality of life (as studies were only
included if they assessed at least one measure of body fatness),
but our results did not suggest any harms from reducing total fat.
However, other potential harms (such as reductions in fat-soluble
vitamin status, or gastric symptoms) were not assessed - though we
are not aware of any harms such as these reported in our included
trials.
Agreements and disagreements with other studies or
reviews
The conclusions of this updated review have not altered in overall
import from earlier versions of this review (Hooper 2012b; Hooper
2015a). Yu-Poth 1999 found that dietary trials (excluding trials that
also assessed exercise interventions) of the National Cholesterol
Education Program's Step I and Step II dietary intervention
programmes resulted in weight reductions (compared with control
groups) of just under 3 kg, and that this was related to the degree
of total fat reduction. Their regression suggested that for every 1%
decrease in energy as total fat, there was a 0.28 kg decrease in body
weight, while our meta-regression found that for every 1% decrease
in energy as total fat there was a slightly smaller 0.20 kg decrease in
weight (95% CI -0.34 to -0.06, P = 0.007). The slightly smaller e$ect
size in this review may be due to our excluding shorter duration
studies and studies that aimed to reduce weight in the intervention
arm.
The single trial that set out to assess the e$ect of reducing total fat
intake on body weight, by feeding participants carefully controlled
levels of dietary fat and carbohydrate over 6 months (ODMDC 2017),
found that body weight in participants eating 20% of energy from
fat was 0.6 kg lower than participants eating 30% or 40% of energy
from fat. This high-quality trial confirmed our findings of lower
weight with lower fat intake, but the e$ect size was smaller than our
suggested e$ect size. This may have been because the intervention
was only for six months; weight e$ects may have been greater if the
feeding had continued over a longer time period.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
Attempts should be made to reduce total fat intake in populations
where mean total fat intake is 30% or more of energy, in order to
support maintenance of healthy weights. For populations where
the mean total fat intake is below 30% of energy, then interventions
to restrict increases in total fat intake to over 30% of energy may
help to avoid obesity.
Implications for research
High-quality trials are needed to investigate the e$ect on body
weight of reducing fat intake in developing or transitional countries
with total fat intakes greater than 30% of energy, and of preventing
total fat intake rising above 30% of energy in countries with total fat
intakes of 25% to 30% of energy. None of the ongoing trials found
are being carried out in developing or transitional countries.
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C H A R A C T E R I S T I C S   O F   S T U D I E S
Characteristics of included studies [ordered by study ID]
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants Moderately hypercholesterolaemic, non-obese Caucasian men and women aged 30 to 50 (USA)
CVD risk: moderate
Control: randomised 62, analysed 51
Intervention: randomised 56, analysed 47
Mean years in trial: control 0.91, intervention 0.92
% male: control 61, intervention 66
Age: mean control 40.3 (SD 5.4), intervention 40.7 (SD 5.2) (all 30 to 50)
Baseline BMI: not reported
Interventions Reduced fat diet vs usual diet
Control aims: no diet intervention
Intervention aims: 25%E from fats, 20%E from protein, 55%E from CHO, < 200 mg cholesterol/day
(also an intervention arm with similar aims plus increased fibre intake)
Control methods: no intervention
Intervention methods: seminars and individual eating patterns taught, 10 weeks teaching and 40
weeks maintenance
Weight goals: participants were directed to maintain initial body weight throughout the study.
Total fat intake (at 1 year): low fat 30 (SD 7.5), control 31 (SD 5.7) %E
Saturated fat intake (at 1 year): low fat 9 (SD 2.7), control 10 (SD 2.9) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: diet composition, lipids
Available outcomes: weight, total, LDL and HDL cholesterol
Notes AHA phase II diet (low fat) compared to control group here; a further arm was not used, the low fat plus
high fibre arm.
This trial was called "Kentucky Low Fat" in previous versions of this review.
Risk of bias
Bias Authors' judgement Support for judgement
Anderson 1990 
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Random sequence genera-
tion (selection bias)
Low risk "matched on age, gender & cholesterol level, randomly assigned to interven-
tion group using systematic random procedure"
Allocation concealment
(selection bias)
Unclear risk Randomisation method not clearly described
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants knew allocation.
Blinding of outcome as-
sessment (detection bias)
High risk Researchers knew allocation.
Incomplete outcome data
(attrition bias)
All outcomes
High risk 20 of 118 (17%) lost over 1 year (> 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk See 'Control methods' and 'Intervention methods' in the 'Interventions' sec-
tion above
Free of dietary differences
other than fat?
Low risk (The high fibre arm has not been used in the data set). See 'Control aims' and
'Intervention aims' in the 'Interventions' section above
Compliance problems High risk No significant difference in total fat intake
Anderson 1990  (Continued)
 
 
Study characteristics
Methods RCT
AUStralian MEDiterranean diet trial for secondary prevention of heart disease (AusMed)
Summary risk of bias: moderate to high
Participants Adults within one year of acute MI (Australia)
CVD risk: high
Control (Med diet): 37 randomised, 27 analysed at 1 year
Intervention (low fat): 36 randomised, 21 analysed
Mean years in trial: control 1.0, intervention 1.0
% male: control 79%, intervention 87%
Age, years: mean control 61.8 (SD 9.2), intervention 61.8 (SD 9.5)
Baseline BMI: mean control 30.8 (SE 0.9), intervention 29.0 (SE 0.9)
Interventions Low fat vs Med diet
Control (Med diet): 35-40%E total fat (of which ≥ 50% MUFA), 15-20%E protein, 40-45%E CHO
AUSMED 2018 
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Intervention (Low fat diet): < 30%E total fat, < 7%E SFA, 45-65% CHO, 15-25% protein, ≤ 5%E alcohol
Control methods: Client-centred counselling and goal-setting with dietitian. Received 2-week model
meal plan, MedDiet resource kit, recipe book, shopping list, weekly food intake checklist, label info.
Hamper of foods provided at baseline and 3 months including olive oil, nuts, tinned fish and legumes,
Greek yogurt. Consultation frequency and data time points were consistent across both arms.
Intervention methods: Client-centred counselling and goal-setting with dietitian. Received resources
on low fat cooking, label reading, Supermarket vouchers provided at the 3 face-to-face appointments.
Weight goals: both diets provided ad libitum with no specific recommendations on energy restriction
Total fat intake (at 6 mo): low fat 30.3 (SD 7.2), control 38.7 (SD 7.9) %E
Saturated fat intake(at 6 mo): low fat 10.3 (SD 3.5), control 9.5 (SD 2.4) %E
Style: diet advice with supplementary foods
Setting: community
Outcomes Stated trial outcomes: primary cardiac endpoints at 12 months, secondary lipids, inflammatory mark-
ers, coagulation factors, dietary adherence, body composition and anthropometry, BP, activity, QoL
(SF36), adipokine markers, adhesion molecule markers
Available outcomes: weight, BMI, waist circumference, percentage body fat, lipids, BP (however weight,
BMI, waist circumference, body fat, LDL, TG & BP data were too different at baseline to use these data in
meta-analysis).
Notes Funding: La Trobe University.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomised using a computer-generated stratification (by age and sex)
Allocation concealment
(selection bias)
Unclear risk Unclear, randomisation performed by statistician
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants were aware of their dietary allocation.
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear who assessed anthropometry or whether they were blinded
Incomplete outcome data
(attrition bias)
All outcomes
High risk 21 of 36 (58%) in low fat intervention, and 27 of 37 (73%) in Med diet were as-
sessed at 12 months (> 10% dropouts per year)
Selective reporting (re-
porting bias)
High risk Trials registry entry in 2016, recruitment started in 2014, recruitment ended in
2018. Some data, such as QoL do not appear to be published yet.
Other bias Low risk None noted
Free of systematic differ-
ence in care?
Low risk Consultation frequency and data time points were consistent across both
arms.
AUSMED 2018  (Continued)
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Free of dietary differences
other than fat?
High risk No, variety of other differences, including advice on fruit and vegetables, fish,
legumes etc.
Compliance problems Low risk Statistically significant difference in fat intake at 6 months
AUSMED 2018  (Continued)
 
 
Study characteristics
Methods RCT
Breast Dysplasia Intervention Trial (BDIT)
Summary risk of bias: moderate to high
Participants Women with mammographic dysplasia (Canada)
CVD risk: low
Control: 147 randomised, 78 analysed
Intervention: 148 randomised, 76 analysed
Mean years in trial: control 7.5, intervention 6.8
% male: 0
Age: mean control 45, intervention 44 (all > 30)
Baseline BMI: mean intervention 24.3 (SD 3.8), control 24.3 (SD 3.6)
Interventions Reduced fat intake vs usual diet
Control aims: healthy diet advice, no alteration in dietary fat advised, aim to maintain weight
Intervention aims: total fat 15%E, replace fat by complex CHO, aim to maintain weight
Control methods: seen for advice once every 4 months for 12 months
Intervention methods: seen for advice once a month for 12 months
Weight goal: low fat group - "isocaloric exchange of complex carbohydrate for fat. We tried to maintain
an isocaloric diet to avoid weight loss...". Not discussed for control group
Total fat intake (at 9.2 years): low fat 31.7 (SD 7.3) %E, control 35.3 (SD 5.6) %E
Saturated fat intake (at 9.2 years): low fat 10.6 (SD 4.6) %E, control 12.3 (SD 4.6) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: dietary fat, serum cholesterol
Available outcomes: weight, BMI, total and HDL cholesterol
Notes Weight data available for 1 year, 2 years and 9 years. Unclear whether participants were still in the trial
by 9 years, so 2-year data used in main analysis
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "randomly allocated"
BDIT Pilot Studies 1996 
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Allocation concealment
(selection bias)
Unclear risk Randomisation not described, though randomisation occurred after baseline
assessment
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants not blinded
Blinding of outcome as-
sessment (detection bias)
Low risk Outcome assessors blinded to intervention
Incomplete outcome data
(attrition bias)
All outcomes
Low risk 141 of 295 (48%) lost over 8 years (< 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk Women in intervention group seen more frequently. See 'Control methods'
and 'Intervention methods' in the 'Interventions' section above
Free of dietary differences
other than fat?
Low risk See 'Control aims' and 'Intervention aims' in the 'Interventions' section above
Compliance problems Low risk Significant difference in total fat intake
BDIT Pilot Studies 1996  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants Women and men with mild hypercholesterolaemia (USA)
CVD risk: moderate
Control: unclear how many randomised, 192 analysed
Intervention: unclear how many randomised, 217 analysed
Mean years in trial: unclear (max duration 0.5 years)
% male: 52 (not divided by intervention group)
Age: mean 43.2 (not divided by intervention group) (all > 30)
Baseline BMI (not reported by intervention): women with hypercholesterolaemia (n = 84) mean 25.9 (SD
4.9), women with combined hyperlipidaemia (n = 94) mean 29.2 (SD 6.1), men with hypercholestero-
laemia (n = 123) mean 26.6 (SD 3.3), men with combined hyperlipidaemia (n = 108) mean 27.5 (SD 3.2)
Interventions Reduced and modified fat vs usual diet
Control aims: asked to delay dietary changes (provided intervention after the randomised trial)
Intervention aims: total fat < 30%E, SFA < 7%E, dietary cholesterol < 200 mg/d
Control methods: usual intake
Intervention methods: 8 weekly classes with nutrition info and behaviour modification with spouses,
plus individual appointments at 3 and 6 months
beFIT 1997 
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Weight goals: intervention group "assigned food group pattern for their calorie needs", no information
for control group
Total fat intake (at 6 months): intervention 25.2 (SD unclear) %E, control unclear - no significant differ-
ence from baseline 34 (SD unclear) %E
Saturated fat intake (at 6 months): intervention 7.6% (SD unclear) %E, control unclear - no significant
difference from baseline 12 (SD unclear) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: lipids
Available outcomes: weight, total, LDL and HDL cholesterol, TG (but variance data only provided for the
randomised comparison for LDL cholesterol)
Notes Weight: control 'no change', intervention -2.7 kg at 6 months
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Stratified random sampling scheme
Allocation concealment
(selection bias)
Unclear risk Allocation method not clearly described
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants knew their allocation.
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear whether outcome assessors were blinded
Incomplete outcome data
(attrition bias)
All outcomes
Unclear risk Unclear what proportion lost over trial as unclear how many recruited
Selective reporting (re-
porting bias)
High risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk Intensive intervention for intervention group, but no intervention during the 6
months of the randomised part of the study for the control group. See 'Control
methods' and 'Intervention methods' in the 'Interventions' section above
Free of dietary differences
other than fat?
Low risk See 'Control aims' and 'Intervention aims' in the 'Interventions' section above
Compliance problems Unclear risk Unclear (as data not provided for control group), though there appears to be a
big difference in total fat intake at 6 months
beFIT 1997  (Continued)
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Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants People with non-melanoma skin cancer (USA)
CVD risk: low
Control: randomised 67, analysed 58
Intervention: randomised 66, analysed 38
Mean years in trial: 1.9
% male: control 67%, intervention 54%
Age: mean control 52.3 (SD 13.2), intervention 50.6 (SD 9.7)
Baseline BMI: data not provided
Interventions Reduced fat vs usual diet
Control aims: no dietary advice
Intervention aims: total fat 20%E, protein 15%E, CHO 65%E
Control methods: no dietary change, 4 monthly clinic visits
Intervention methods: 8 weekly classes, with behavioural techniques, plus 4 monthly clinic visits
Weight goals: "to maintain body weight .... patients were instructed to increase their intake of carbohy-
drate, particularly complex carbohydrate"
Total fat intake ("during study" months 4 to 24): low fat 20.7 (SD 5.5), control 37.8 (SD 4.1) %E
Saturated fat intake ("during study" months 4 to 24): low fat 6.6 (SD 1.8), control 12.8 (SD 2.0) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: incidence of actinic keratosis and non-melanoma skin cancer
Available outcomes: none (weight data provided, but no variance info)
Notes At 2 years: control -1.5 kg, n = 50?, intervention: -1 kg, n = 51?
This trial was named "Veterans Dermatology" in previous versions of this review.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "list of randomly generated numbers"
Allocation concealment
(selection bias)
Unclear risk Allocation method not clearly described
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants were aware of assignment.
Blinding of outcome as-
sessment (detection bias)
Low risk Physician blinding: adequate
Black 1994 
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Incomplete outcome data
(attrition bias)
All outcomes
High risk 37 of 133 (28%) lost over 2 years (> 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk All had 4 monthly clinic visits; the intervention group had 8 behavioural tech-
nique classes that the control group did not have.
Free of dietary differences
other than fat?
Low risk See 'Control aims' and 'Intervention aims' in the 'Interventions' section above
Compliance problems Low risk Big and statistically significant difference in total fat intake between arms
Black 1994  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants Men with untreated raised total cholesterol (the Netherlands)
CVD risk: moderate
Control: randomised 41, analysed 40
Intervention: randomised 39, analysed 39
Mean years in trial: control 0.5, randomised 0.5
% male: 100%
Age: mean control 47.5 (SD 8.0), intervention 47.2 (SD 8.3)
Baseline BMI: mean control 26.3 (SD 2.3), intervention 26.0 (SD 2.6)
Interventions Reduced and modified fat vs usual diet
Control aims: usual diet
Intervention aims: 30%E from fat, PUFA/SFA 1.0, dietary cholesterol 20 mg
Control methods: no advice provided
Intervention methods: individual advice provided face-to-face, followed by 2 phone calls and 5 mailings
of information on healthy foods
Weight goals: weight and calories not mentioned
Total fat intake (change to 6 months): intervention -5.0 (SD 6.5) (33.5 overall), control -1.5 (SD 5.9) (36.8
overall) %E
Saturated fat intake (change to 6 months): intervention -4.3 (SD 3.9), control -0.7 (SD 2.9) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: lipids
Bloemberg 1991 
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Available outcomes: weight, total and HDL cholesterol
Notes —
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "randomised" and stratified by age and BMI (each dichotomised)
Allocation concealment
(selection bias)
Unclear risk No method stated (as above)
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants not blinded
Blinding of outcome as-
sessment (detection bias)
Unclear risk Laboratory sta$ blinded, but unclear re weight
Incomplete outcome data
(attrition bias)
All outcomes
Low risk 1 of 80 (< 1%) lost over 0.5 years (< 10% per year)
Selective reporting (re-
porting bias)
Unclear risk No protocol or trials registration found
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk Much more time spent on those in the intervention group
Free of dietary differences
other than fat?
Low risk Dietary focus on fats alone
Compliance problems Low risk Significant difference in total fat intake, supported by borderline total choles-
terol difference
Bloemberg 1991  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants Women with severe cyclical mastopathy for at least 5 years (Canada)
CVD risk: low
Control: randomised 10, analysed 9
Intervention: randomised 11, analysed 10
Mean years in trial: control 0.45, intervention 0.45
% male: 0%
Age: mean control 36, intervention 38 (variances unclear)
Boyd 1988 
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Baseline BMI: no data provided
Interventions Reduced fat vs usual diet
Control aims: given principles of healthy diet, not counselled to alter fat content
Intervention aims: total fat 15%E, CHO 65%E
Control methods: seen every 2 months to monitor symptoms, nutrition and biochemistry
Intervention methods: seen monthly to monitor symptoms, nutrition and biochemistry, teaching mate-
rials included food guide, recipes, product information and advice on eating out
Weight goals: the intervention goals included the isocaloric replacement of complex carbohydrate for
fat (no mention for control group)
Total fat intake (at 6 months): low fat 22.8 (SD unclear), control 33.4 (SD unclear) %E
Saturated fat intake (at 6 months): low fat 8.8 (SD unclear), control 12.3 (SD unclear) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: mastopathy symptoms, plasma hormone and lipids
Available outcomes: weight, total cholesterol (but variance data not provided)
Notes Total cholesterol rose by 0.09 mmol/L in control group (from 4.5 to 4.59) and fell by 0.15 mmol/L in in-
tervention group (4.84 to 4.69). Weight changed in the intervention group (mean fall of 2.1 kg over 6
months, no variance provided), but change, or otherwise, in control group not mentioned.
This trial was called "Mastopathy Diet" in previous versions of this review.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "randomly allocated"
Allocation concealment
(selection bias)
Unclear risk Allocation method not clearly described
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants were not blinded.
Blinding of outcome as-
sessment (detection bias)
Low risk Those assessing physical outcomes were blinded; those assessing symptoms
were not.
Incomplete outcome data
(attrition bias)
All outcomes
High risk 2 of 21 (10%) lost over 0.5 years (> 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Boyd 1988  (Continued)
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Free of systematic differ-
ence in care?
High risk Minor differences in follow-up frequency. See 'Control methods' and 'Interven-
tion methods' in the 'Interventions' section above
Free of dietary differences
other than fat?
Low risk See 'Control aims' and 'Intervention aims' in the 'Interventions' section above
Compliance problems Low risk While variance not provided there was a very big difference in total fat intake.
Boyd 1988  (Continued)
 
 
Study characteristics
Methods RCT
Breast Research Initiative for Determining Effective Strategies for Coping with Breast Cancer (BRIDGES)
Summary risk of bias: moderate to high
Participants Women diagnosed with stage I or II breast cancer over the past 2 years (USA)
CVD risk: low
Control: randomised unclear (at least 56), analysed 46
Intervention: randomised unclear (at least 50), analysed 48
Mean years in trial: unclear (1 year max follow-up)
% male: 0
Age: mean control unclear (71% postmenopausal), intervention unclear (56% postmenopausal) (all 20
to 65)
Baseline BMI: not reported
Interventions Reduced fat vs usual diet
Control aims: no formal intervention
Intervention diet aims: total fat 20%E, high fibre, plant-based micronutrients
Intervention stress: separate parallel arm, stress reduction programme (data not used here)
Control methods: no formal intervention
Intervention methods: nutrition intervention programme, 15 sessions (42 hours) over 15 weeks, group-
based, dietitian-led, 2 individual sessions using social cognitive theory and patient centred counselling
to increase self efficacy and confidence
Weight goals: "reduction in body mass was not a primary goal of NEP. (NEP was neither designed nor
presented to participants as a weight loss or weight control program)." The control group was present-
ed as "individual choice".
Total fat intake (at 12 months): low fat 29.9 (SD unclear), control 33.6 (SD unclear) %E
Saturated fat intake: unclear
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: diet and BMI
Available outcomes: weight
Notes —
BRIDGES 2001 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "randomised", stratified by medical centre, cancer stage and age; randomised
number/envelope method by project coordinator
Allocation concealment
(selection bias)
Low risk The project coordinator had contact with those from the University of Massa-
chusetts, but not those from the other 3 centres, and allocation could not be
altered later.
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants not blinded
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear whether researchers were blinded
Incomplete outcome data
(attrition bias)
All outcomes
High risk Unclear how many recruited, so unclear how many were lost to follow-up (at
least 12 of 106 (11%) over 1 year, so > 10%/year
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk High-intensity programme for intervention group, nothing for control group.
See 'Control methods' and 'Intervention methods' in the 'Interventions' sec-
tion above
Free of dietary differences
other than fat?
High risk Intervention also focused on fibre and plant-based micronutrients. See 'Con-
trol aims' and 'Intervention aims' in the 'Interventions' section above
Compliance problems Unclear risk Unclear if difference in total fat intake between arms was statistically signifi-
cant as no variance provided
BRIDGES 2001  (Continued)
 
 
Study characteristics
Methods RCT
Canadian Diet and Breast Cancer Prevention (Canadian DBCP)
Summary risk of bias: moderate to high
Participants Women with mammographic densities > 50% breast area (Canada)
CVD risk: low
Control: randomised 448+, analysed 401
Intervention: randomised 448+, analysed 388
Mean years in trial: control 2.0, randomised 2.0 (note, papers suggested a 10-year follow-up overall)
% male: 0%
Age: mean control 45.9 (SD unclear), intervention 46.5 (SD unclear)
Canadian DBCP 1997 
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Baseline BMI: mean control 23.6, intervention 23.4, no variance reported
Interventions Reduced fat vs usual diet
Control aims: usual diet
Intervention aims: total fat 15%E, protein 20%E, CHO 65%E, isocaloric diet
Control methods: encouraged to continue usual diet, interviewed by dietitian every 4 months during
first year, then every 3 months in the second year
Intervention methods: dietary prescription using food exchange (fat calories replaced by CHO), met
with dietitian monthly during first year, then every 3 months. Scales, recipes, shopping guide provided
Weight goals: "calories derived from fat were replaced by isocaloric exchange with carbohydrate"
Total fat intake (at 2 years): intervention 21.3 (SD 6.2), control 31.8 (SD 6.7) %E
Saturated fat intake (at 2 years): intervention 7.1 (SD 2.5), control 11.5 (SD 3.3) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: incidence of breast cancer
Available outcomes: weight
Notes Weight data available for 1 and 2 years, 2-year data used in main analysis
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomly allocated by telephone to Dept. of Biostatistics at Ontario Cancer
Institute, stratified by centre
Allocation concealment
(selection bias)
Low risk As above
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants knew what arm they were in.
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear who measured or whether blinded
Incomplete outcome data
(attrition bias)
All outcomes
Low risk At least 107 of at least 896 (12%) lost over 2 years (< 10% per year)
Selective reporting (re-
porting bias)
Unclear risk No protocol found
Other bias Low risk None reported
Free of systematic differ-
ence in care?
High risk Minor difference in attention for participants in intervention and control in first
year
Canadian DBCP 1997  (Continued)
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Free of dietary differences
other than fat?
Low risk Focus on dietary fat
Compliance problems Low risk Significant difference in self-reported total fat intake at 2 years, no reported
lipids to confirm
Canadian DBCP 1997  (Continued)
 
 
Study characteristics
Methods RCT
CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (CORDIOPREV study)
Summary risk of bias: low
Participants People with CHD and with high CVD risk (Spain)
CVD risk: high
Control (Mediterranean diet): 502 randomised, no. analysed varied between publications
Intervention: 500 randomised, no. analysed varied between publications
Mean years in trial: aim 7.5 years follow-up published for some outcomes
% male: control 84%, intervention 83%
Age, years: mean control 59.7 (SE 0.4), intervention 59.5 (SE 0.4)
Baseline BMI: mean control 31.0 (SE 0.1), intervention 31.2 (SE 0.2)
Interventions Low fat vs Mediterranean diet
Control: Mediterranean diet, 35+%E fat (< 10%E SFA, 22%E MUFA, 6%E PUFA), 15%E protein, up to
50%E CHO, cholesterol < 300mg/d
Intervention: Low fat, < 30%E fat (< 10%E SFA, 12-14%E MUFA, 6-8%E PUFA), 15%E protein, up to 55+
%E CHO, cholesterol < 300mg/d
Med diet methods: personalised dietetic interviews and support at start and 6-monthly, quarterly
group education including talks, meal plans, recipes, shopping lists etc, some baskets of appropriate
foods provided occasionally. Olive oil provided free for whole family.
Low fat methods: personalised dietetic interviews and support at start and 6-monthly, quarterly group
education including talks, meal plans, recipes, shopping lists etc, some baskets of appropriate foods
provided occasionally.
Weight goals: no energy restriction (in either arm)
Total fat intake (at 5 years): low fat 31.7 (SD 6.0), control 41.0 (SD 6.3) %E
Saturated fat intake (at 5 years): low fat 7.1 (SD 2.0), control 8.0 (SD 2.1) %E
Style: diet advice plus supplementary foods
Setting: community
Outcomes Stated trial outcomes: primary cardiovascular events, secondary intermittent claudication, LDL, lipid
ratios, metabolic responses to CHO (glucose and insulin), BP, malignancy, cognition, CVD progression
all at 7 years
CORDIOPREV 2016 
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Available outcomes: weight, BMI, waist circumference, dietary intake, lipids (LDL and some HDL data
too different at baseline to use in meta-analysis)
Notes Note: 7-year completion is due in 2020, current published data are from 2 or 5-year follow-up. Also, cau-
tion, total cholesterol data in Gomez-Delgado 2015 is surprising as the change in total cholesterol was
not mirrored in changes in LDL, HDL or TGs.
Funding: CORDIOPREV was supported by Fundacion Patrimonio Comunal Olivarero. Additional fund-
ing was received from CITOLIVA, CEAS, Junta de Andalucia (Consejeria de Salud, Consejeria de Agricul-
tura y Pesca, Consejeria de Innovacion, Ciencia y Empresa), Diputaciones de Jaen y Cordoba, Centro
de Excelencia en Investigacion sobre Aceite de Oliva y Salud and Ministerio de Medio Ambiente, Medio
Rural y Marino, and the Spanish Government.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation was stratified by sex, age and previous MI.
Allocation concealment
(selection bias)
Low risk Randomisation was carried out by a third party (Andalusian School of Public
Health).
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants were aware of their dietary allocation.
Blinding of outcome as-
sessment (detection bias)
Low risk Dietitians were the only members of the intervention team who knew dietary
assignments.
Incomplete outcome data
(attrition bias)
All outcomes
Low risk Dropout levels appeared acceptable, for example, of non-diabetics, 21 of 246
(9%) Med diet and 41 of 216 (19%) Low fat dropped out by 5 years, < 10%/year.
Selective reporting (re-
porting bias)
Unclear risk Unclear, trials registry (registered 2009, trial due to complete in 2020) out-
comes are all 7-year assessments, and trial has not reached 7 years yet.
Other bias Low risk None noted
Free of systematic differ-
ence in care?
Low risk Yes, time and intervention type appear similar between the two groups with
the possible exception that olive oil was provided to control group partici-
pants.
Free of dietary differences
other than fat?
Unclear risk Unclear, stated they were assessing dietary patterns, but differences other
than fat and CHO levels were not clarified
Compliance problems Low risk 5-year difference in self-reported total fat was statistically significant.
CORDIOPREV 2016  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
De Bont 1981 
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Participants Women with type 2 diabetes (UK)
CVD risk: moderate
Control: randomised unclear (total in control and intervention 148), analysed 65 (for obese and non-
obese)
Intervention: randomised unclear, analysed 71 (for obese and non-obese)
Mean years in trial: control 0.5, randomised 0.5
% male: 0%
Age: mean control 54 (SD 8), intervention 56 (SD 7), (all 35 to 64) (for obese and non-obese)
Baseline BMI: non-obese chosen for BMI < 28, obese mean not reported
Interventions Reduced and modified fat vs usual diet
Control aims: usual diet but with CHO ≤ 40%E
Intervention aims: 30%E from fat, focus on reducing meat fat, dairy foods and substituting margarines
to improve the SFA/PUFA ratio; CHO increased to maintain energy intake
Control methods: 3 home visits from a nutritionist over the 6 months of the trial
Intervention methods: 3 home visits from a nutritionist over the 6 months of the trial
Weight goals: to maintain the required total energy intake, the proportion of carbohydrates in these di-
ets was increased.
Total fat intake (change to 6 months): intervention -10.1 (SD 10.8) (overall 31.1), control -1.0 (SD 10.5)
(overall 41.8) %E (for obese and non-obese)
Saturated fat intake (change to 6 months): intervention -8.1 (SD 5.8), control -1.1 (SD 5.7) %E (for obese
and non-obese)
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: diet, weight, lipids
Available outcomes: weight, total and HDL cholesterol, triglycerides
Notes Outcome data separated by those obese (BMI ≥ 28) or not obese at baseline
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "randomly allocated"
Allocation concealment
(selection bias)
Unclear risk No information provided
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants not blinded
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear whether outcome assessors blinded
Incomplete outcome data
(attrition bias)
High risk 12 of 148 (8%) lost over 0.5 years (> 10% per year)
De Bont 1981  (Continued)
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All outcomes
Selective reporting (re-
porting bias)
Unclear risk No protocol found
Other bias Low risk None noted
Free of systematic differ-
ence in care?
Low risk Follow-up similar
Free of dietary differences
other than fat?
Low risk Diet focused on fat
Compliance problems Low risk Statistically significant difference in total cholesterol and in fat intake between
arms
De Bont 1981  (Continued)
 
 
Study characteristics
Methods RCT
Diet and Exercise for Elevated Risk (DEER)
Summary risk of bias: moderate to high
Participants Men and postmenopausal women with raised LDL and low HDL cholesterol (USA)
CVD risk: moderate
Control:
• Men with exercise: randomised 50, analysed 47
• Women with exercise: randomised 44, analysed 43
• Men, no exercise: randomised 47, analysed 46
• Women, no exercise: randomised 47, analysed 46
Intervention:
• Men with exercise: randomised 51, analysed 48
• Women with exercise: randomised 43, analysed 43
• Men, no exercise: randomised 49, analysed 49
• Women, no exercise: randomised 46, analysed 45
Mean years in trial: control 1.0, intervention 1.0
% male: 100% in male arms, 0% in female arms
Age: mean 47.8 (SD 8.9) for all men (exercise and non-exercise arms)
Age: mean 56.9 (SD 5.1) for all women (exercise and non-exercise arms)
Baseline BMI:
• Men with exercise: intervention 26.6 (SD 2.6), control 26.9 (SD 2.6)
• Women with exercise: intervention 26.4 (SD 3.5), control 25.9 (SD 2.4)
• Men, no exercise: intervention 26.9 (SD 3.1), control 26.7 (SD 3.2)
• Women, no exercise: intervention 26.6 (SD 2.8), control 26.0 (SD 3.9)
Interventions Reduced fat vs usual diet
Control aims: usual diet (and exercise intervention)
DEER 1998 
Eects of total fat intake on body fatness in adults (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
61
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Intervention aims: NCEP step 2 diet: < 30%E from fat, < 7%E from SFA, < 200 mg/d cholesterol (and ex-
ercise intervention)
Control methods: no advice provided
Intervention methods: individual advice provided face-to-face, followed by 8 1-hour group sessions
during first 12 weeks, then monthly contact with dietitians by mail, phone, individual or group appoint-
ment
Weight goals: "weight loss was not emphasised"
Total fat intake (change to 12 months):
• Men with exercise: intervention -8.2 (SD 5.9) (22.2 overall), control -0.5 (SD 5.7) (29.9 overall) %E
• Women with exercise: intervention -8.0 (SD 5.8) (20.4 overall), control 0.3 (SD 6.9) (28.7 overall) %E
• Men, no exercise: intervention -8.0 (SD 8.1) (22.4 overall), control -0.7 (SD 5.9) (29.7 overall) %E
• Women, no exercise: intervention -5.7 (SD 7.4) (overall 22.7), control -0.2 (SD 6.7) (overall 28.2) %E
Saturated fat intake (change to 12 months):
• Men with exercise: intervention -3.9 (SD 2.6), control -0.1 (SD 2.6) %E
• Women with exercise: intervention -3.0 (SD 2.3), control 0.2 (SD 3.1) %E
• Men, no exercise: intervention -3.4 (SD 3.2), control 0.0 (SD 2.4) %E
• Women, no exercise: intervention -2.4 (SD 2.8), control 0.2 (SD 2.8) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: dietary intake and lipids
Available outcomes: weight, total, LDL and HDL cholesterol, triglycerides, systolic and diastolic BP
Notes Factorial trial with regards to exercise and reported by sex
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Assignments by computer, modified Efron procedure, balanced by HDL and
LDL
Allocation concealment
(selection bias)
Unclear risk Not described
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants aware of randomisation group
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear
Incomplete outcome data
(attrition bias)
All outcomes
Low risk 10 of 377 (3%) lost over 1 year (< 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Trials registry entry dated 1999, study completed in 1996
DEER 1998  (Continued)
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Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk Very different levels of attention and review
Free of dietary differences
other than fat?
Low risk Dietary focus on fat
Compliance problems Low risk Reported a statistically significant reduction in total fat in low fat compared to
control arms, supported by the statistically significant reduction in LDL in low
fat compared to control arms
DEER 1998  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants Healthy premenopausal women aged 20 to 40 years (USA)
CVD risk: low
Control: randomised 107, analysed 96
Intervention: randomised 106, analysed 81
Mean years in trial: control 0.95, intervention 0.88
% male: 0%
Age: control mean 33.3, intervention 33.5 (SDs not given)
Baseline BMI: mean control 23.8 (SD 3.5), intervention 23.7 (SD 4.2)
Interventions Reduced fat vs usual diet
Control aims: usual diet
Intervention aims: < 20%E from fat, 25 to 30 g/d fibre, > 8 servings/d fruit and vegetables, CHO 60% to
65%E, protein 15% to 20%E
Control methods: received a pamphlet on healthy eating (minimal intervention)
Intervention methods: classroom nutrition education (18 group classes) plus 2 individual counselling
sessions over 12 months covering knowledge and behavioural skills; appropriate foods served at inter-
vention sessions
Weight goals: "not encouraged to reduce total caloric intake and weight was monitored to maintain
within 2 kg of baseline weight"
Total fat intake (at 12 cycles/months): intervention 22.2 (SD 7.2), control 30.7 (SD 7.5) %E
Saturated fat intake (at 12 cycles/months): intervention 14.9 (SD 6.7), control 23.9 (SD 13.2) g/d
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: hormonal responses
Available outcomes: weight, BMI, dietary intake, hormones, menstrual cycle length
Diet and Hormone Study 2003 
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Notes No answer to requests for data on deaths or health events. Weight and BMI data provided at 4 and 12
cycles
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "randomly assigned by reference to a random number table"
Allocation concealment
(selection bias)
Unclear risk Not described
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants knew allocation.
Blinding of outcome as-
sessment (detection bias)
High risk Researchers knew allocation.
Incomplete outcome data
(attrition bias)
All outcomes
High risk 36 of 213 (17%) lost over 1 year (> 10% per year). Reasons not stated, greater
losses in intervention group
Selective reporting (re-
porting bias)
Unclear risk No protocol found
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk Very different levels of attention and review
Free of dietary differences
other than fat?
High risk Intervention group also asked to increase fibre, fruit and vegetables substan-
tially
Compliance problems Low risk Statistically significant difference between arms in total fat intake
Diet and Hormone Study 2003  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: low
Participants Adults with uncontrolled persistent asthma (USA)
CVD risk: low
Control (usual diet): 44 randomised, 44 analysed (ITT analysis, 5 dropouts)
Intervention (DASH diet): 46 randomised, 46 analysed (ITT analysis, 3 dropouts)
Mean years in trial: control 0.5, intervention 0.5
% male: control 39%, intervention 28%
Age, years: mean control 51.4 (SD 12.9), intervention 52.2 (SD 11.9)
Ma 2016 
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Baseline BMI: mean overall 27.9 (SD 4.8)
Interventions Low fat (DASH) vs usual diet
Control: usual diet
Intervention: DASH diet, 27%E from fat, 9-12 servings/d fruit & vegetables, 2-3 servings/d low fat dairy
products, reducing SFA, limiting sodium, increase whole grains, nuts, seeds, legumes plus decreased
sugar intake, moderate alcohol intake
Control methods: standard care
Intervention methods: intensive intervention over first 3 months (8 group and 3 individual sessions
each 45-60 min), then counselling phone calls monthly for 20-30 min over next 3 months
Weight goals: fat intake estimated from caloric needs for weight maintenance
Total fat intake (change to 6 months): low fat -5.3 (SE 4.8), control -4.7 (SE 4.7) g/d
Saturated fat intake: unclear
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: primary Juniper asthma control questionnaire, secondary lung function, asthma
specific QoL, asthma symptom-free days, asthma-related healthcare utilisation, diet adherence, psy-
chosocial predictors of dietary change, comorbidities, generic health-related QoL
Available outcomes: weight, BMI, BP, lipids (waist circumference measured but not reported by inter-
vention arm)
Notes Funding: National Heart Lung and Blood Institute, and Palo Alto Medical Foundation Research Institute
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Web-based random allocation system
Allocation concealment
(selection bias)
Low risk Randomisation performed by designated personnel without the ability to in-
fluence its execution
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants knew their assignments as they needed to follow the dietary ad-
vice.
Blinding of outcome as-
sessment (detection bias)
Low risk "blinding of outcome assessment and adjudication, data and safety monitor-
ing, and data analysis will be enforced".
Incomplete outcome data
(attrition bias)
All outcomes
Low risk ITT analysis (although 8 of 90 dropped out over 6 months, > 10% per year, all
were analysed)
Selective reporting (re-
porting bias)
High risk Trials registration 2012, start date 2013, trial end 2014. Most prespecified out-
comes appeared to be reported, though not QoL.
Other bias Low risk None noted
Ma 2016  (Continued)
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Free of systematic differ-
ence in care?
High risk Very different level of support and time with investigators in the two arms
Free of dietary differences
other than fat?
High risk DASH included fruit and vegetable, sodium, alcohol etc. advice as well as fat
intake
Compliance problems High risk No significant difference in fat intake between arms
Ma 2016  (Continued)
 
 
Study characteristics
Methods RCT
MeDiet Project
Summary risk of bias: moderate to high
Participants Healthy postmenopausal women with above median serum testosterone (Italy)
CVD risk: low
Control: randomised 57, analysed at 6 months 55
Intervention: randomised 58, analysed at 6 months 51
Mean years in trial: control 4.38, intervention 4.28
% male: 0
Age: mean unclear (age range 48 to 69)
Baseline BMI: not reported
Interventions Reduced and modified fat vs usual diet
Control aims: advised to increase fruit and vegetable intake
Intervention aims: taught Sicilian diet including reduced total, saturated and omega-6 fats, increased
blue fish (high in omega 3), increased whole cereals, legumes, seeds, fruit and vegetables
Control methods: advice
Intervention methods: taught Sicilian diet and cooking by professional chefs, with a weekly cooking
course including social dinners
Weight goals: not mentioned
Total fat intake (at 6 months): low and mod fat 30.9 (SD 11.4), control 34.0 (SD 11.8) %E
Saturated fat intake (at 6 months): low and mod fat 8.4 (SD 3.0), control 11.2 (SD 5.0) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: breast cancer, weight, lipids, well-being
Available outcomes: weight
Notes Weight data provided at 6 months (fall of 0.6 kg in control group, fall of 1.3 kg in intervention group),
but without variance information
Risk of bias
MeDiet 2006 
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "individually randomised"
Allocation concealment
(selection bias)
Unclear risk Allocation method not clearly described
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants were aware of assignment
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear
Incomplete outcome data
(attrition bias)
All outcomes
Low risk 9 of 115 (8%) lost over 4 years (< 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk Intensive cookery course with social element compared with brief advice. See
'Control methods' and 'Intervention methods' in the 'Interventions' section
above
Free of dietary differences
other than fat?
High risk Both groups encouraged to increase fruit and vegetables, but intervention
group also encouraged to increase fish, pulses, seeds and whole grains
Compliance problems High risk No significant difference in total fat between arms
MeDiet 2006  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants Middle-aged siblings of people with early CHD, with at least one CVD risk factor (USA)
CVD risk: moderate
Control: randomised 132, analysed 118
Intervention: randomised 135, analysed 117
Mean years in trial: 1.9
% male: control 49%, intervention 55%
Age: control mean 45.7 (SD 7), intervention 46.2 (SD 7)
Baseline BMI: control mean 29.5 (SD 7), intervention 28.5 (SD 5)
Interventions Reduced fat intake vs usual diet
Control: physician management (physicians informed on risk factor management)
Intervention: nurse management, aim total fat 40 g/d or less
Moy 2001 
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Control methods: physician management with risk factor management at 0, 1 and 2 years
Intervention methods: nurse management, appointments 6- to 8-weekly for 2 years
Weight goals: not mentioned
Total fat intake (at 2 years): low fat 34.1 (SD unclear), control 38.0 (SD unclear) %E
Saturated fat intake (at 2 years): low fat 11.5 (SD unclear), control 14.4 (SD unclear) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: dietary intake
Available outcomes: BMI, HDL and LDL cholesterol, TG
Notes —
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomly assigned via computerised schema after all eligible siblings from a
family had been screened
Allocation concealment
(selection bias)
Unclear risk Allocation method not clearly described
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants knew their allocation
Blinding of outcome as-
sessment (detection bias)
Unclear risk Trialists clear about allocation, though unclear whether outcome assessors
knew allocation
Incomplete outcome data
(attrition bias)
All outcomes
Low risk 32 of 267 (12%) lost over 2 years (< 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk Differences in frequency of follow-up, but unclear what differences in care oc-
curred between the physician and nurse-led care. See 'Control methods' and
'Intervention methods' in the 'Interventions' section above
Free of dietary differences
other than fat?
Unclear risk See 'Control aims' and 'Intervention aims' in the 'Interventions' section above
Compliance problems Low risk Total fat intake not clearly statistically significantly different, though lower in
intervention arm, however LDL was statistically significantly lower in interven-
tion.
Moy 2001  (Continued)
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Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants Healthy people aged 20 to 55 (Netherlands)
CVD risk: low
Control: randomised unclear (120?), analysed 103
Intervention: randomised unclear (120?), analysed 117
Mean years in trial: control 0.46, intervention 0.49
% male: control 50%, intervention 50%
Age: mean control men 35.6 (SD 10), control women 36.0 (SD 11), intervention men 35.5 (SD 11), inter-
vention women 36.0 (SD 12) (all 19 to 55)
Baseline BMI: mean control men 24.9 (SD 2.2), control women 25 (SD 2), intervention men 24.9 (SD 2.3),
intervention women 24.7 (SD 2)
Interventions Reduced fat vs usual diet
Control aims: advised to use products from trial shop ad lib. (usual fat products provided)
Intervention aims: advised to use products from trial shop ad lib. (low fat products provided)
Control methods: participants obtained foods in a study shop at least once a week
Intervention methods: participants obtained foods in a study shop at least once a week
Weight goals: ad libitum diet
Total fat intake (at 6 months): low fat 34.7 (SD unclear), control 42.7 (SD unclear) %E
Saturated fat intake (at 6 months): low fat 14.2 (SD unclear), control 18.2 (SD unclear) %E
Style: food provided
Setting: community
Outcomes Stated trial outcomes: weight, vitamin and fatty acid intake, anti-oxidative capacity
Available outcomes: weight (for subgroup), weight and lipids provided for larger group, but without
variance data
Notes Change from baseline to 6 months for whole group (control 103, intervention 117):
Weight, kg: 1.1, 0.4
Total cholesterol, mmol/L: 0.07, -0.09
HDL cholesterol, mmol/L: -0.03, -0.06
LDL cholesterol, mmol/L: 0.15, 0.16
TG, mmol/L: 0.04, -0.04
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "stratified randomisation (according to sex, age, QI index and eating behav-
iour) by coordinating centre", a statistician at Unilever Research, SAS soft-
ware, and allocation could not be altered later
MSFAT 1995 
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Allocation concealment
(selection bias)
Low risk "stratified randomisation (according to sex, age, QI index and eating behav-
iour) by coordinating centre", a statistician at Unilever Research, SAS soft-
ware, and allocation could not be altered later
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants aware of allocation.
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear for weight; sta$ analysing biochemistry were not blinded
Incomplete outcome data
(attrition bias)
All outcomes
High risk 20 of 240 (8%) lost over 0.5 years (> 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk Not noted
Free of systematic differ-
ence in care?
Low risk Both groups used study shop. See 'Control methods' and 'Intervention meth-
ods' in the 'Interventions' section above
Free of dietary differences
other than fat?
Low risk See 'Control aims' and 'Intervention aims' in the 'Interventions' section above
Compliance problems Low risk Big difference between total fat in the two arms, though no variance provided
MSFAT 1995  (Continued)
 
 
Study characteristics
Methods RCT
National Diet-Heart Study (NDHS)
Summary risk of bias: low
Participants Free-living men (USA)
CVD risk: low
Control: randomised 382, analysed 348
Intervention B: randomised 385, analysed 332
Intervention X: randomised 54, analysed 46
Mean years in trial: control 1.0, B 0.9, X 0.9
% male: 100
Age: unclear (all 45 to 54)
Baseline BMI: not reported
Interventions Reduced and modified fat diet vs usual diet
Control aims: total fat 40%E, SFA 16%E to 18%E, dietary cholesterol 650 to 750 mg/d, P/S 0.4
Intervention B: total fat 30%E, SFA < 9%E, dietary cholesterol 350 to 450 mg/d, PUFA 15%E, P/S 1.5
Intervention X: total fat 30%E, SFA < 9%E, dietary cholesterol 350 to 450 mg/d, PUFA 15%E, P/S 1.5
NDHS Open 1st L&M 1968 
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Control methods: dietary advice to reduce saturated fat and cholesterol (plus 10 follow-up visits with
nutritionist), purchase of 'usual fat' items from a trial shop
Intervention B methods: dietary advice to reduce saturated fat and cholesterol (plus 10 follow-up visits
with nutritionist), plus purchase of appropriately reduced and modified fat items from a trial shop
Intervention X methods: dietary advice but no trial shop
Weight goals: weight and calories not mentioned
Total fat intake (through study): B 29.7 (SD unclear) %E, X 31.7 (SD unclear), control 34.9 (SD unclear)
%E
Saturated fat intake (through study): B 7.1 (SD unclear) %E, X 8.9 (SD unclear), control 11.6 (SD unclear)
%E
Style: B diet provided, X - diet advice
Setting: community
Outcomes Stated trial outcomes: lipid levels and dietary assessment
Available outcomes: total cholesterol (some weight and BP data presented but no variance info)
Notes At 52 weeks, weight change in the control was not presented, weight change in B was -2.4 kg. Average
weight change over the first year (mean of weights at weeks 6, 12, 20, 28, 36 and 44 weeks) was -2.45 kg
(-5.4lb) for the low fat group (B) and -1.95 kg (-4.3lb) for the control group (D)
At 52 weeks, diastolic BP change from baseline was -2.2 kg in control, -1.9 in B and -5.8 in X
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Stratified randomisation by the statistical centre
Allocation concealment
(selection bias)
Low risk Stratified randomisation by the statistical centre
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
Low risk Intervention B: all reduced saturated fat and purchased blinded foods from a
trial shop, double-blind
Intervention X: no trial shop, so participants not blinded, though those
analysing blood samples etc. were
Blinding of outcome as-
sessment (detection bias)
Low risk Outcome assessors blinded for all outcomes for intervention B, and for lipids
etc for intervention X
Incomplete outcome data
(attrition bias)
All outcomes
High risk 87 of 821 (11%) lost over 1 year (> 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
Low risk Yes for intervention B (as both intervention and control received dietary advice
and purchased food from trial shop). No for intervention X (as it did not include
NDHS Open 1st L&M 1968  (Continued)
Eects of total fat intake on body fatness in adults (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
71
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
a trial shop as in the control group). See 'Control methods' and 'Intervention
methods' in the 'Interventions' section above
Free of dietary differences
other than fat?
Low risk See 'Control aims' and 'Intervention aims' in the 'Interventions' section above
Compliance problems Unclear risk Differences in total fat intake, but no variance provided
NDHS Open 1st L&M 1968  (Continued)
 
 
Study characteristics
Methods RCT
National Diet-Heart Study (NDHS)
Summary risk of bias: moderate to high
Participants Free-living men who had participated in NDHS 1st studies (USA)
CVD risk: low
Control: randomised 304, analysed 215
Intervention BC (this study had a range of interventions, we were interested in BC for the systematic re-
view): randomised 194, analysed 179
Mean years in trial: control 0.6, intervention BC 0.6
% male: 100
Age: unclear (all 45 to 54)
Baseline BMI: not reported
Interventions Reduced and modified fat vs usual diet
Control aims: total fat 40%E, SFA 16%E to 18%E, dietary cholesterol 650 to 750 mg/d, P/S 0.4, X - advice
to continue usual diet
Intervention aims: BC total fat 30%E to 40%E, SFA reduced, dietary cholesterol 350 to 450 mg/d, in-
creased PUFA, P/S 1.5 to 2.0
Control methods: dietary advice to reduce saturated fat and cholesterol (plus 10 follow-up visits with
nutritionist), purchase of 'usual fat' items from a trial shop
Intervention BC methods: dietary advice to reduce saturated fat and cholesterol (plus 10 follow-up vis-
its with nutritionist), plus purchase of appropriately reduced and modified fat items from a trial shop
Weight goals: weight and calories not mentioned
Total fat intake (through study): BC 32.5 (SD unclear) %E, control 35.5 (SD unclear) %E
Saturated fat intake (through study): BC 7.4 (SD unclear) %E, control 12.0 (SD unclear) %E
Style: food provided
Setting: community
Outcomes Stated trial outcomes: lipid levels and dietary assessment
Available outcomes: weight
Notes Weight data provided for the BC intervention group -1.8 kg (-4 lb over 6 months), and -0.9 kg (-2 lb). No
info provided for the control group (D)
NDHS Open 2nd L&M 1968 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Stratified randomisation by the statistical centre
Allocation concealment
(selection bias)
Low risk Stratified randomisation by the statistical centre
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Some participants continued with advice to reduce saturated fat and pur-
chased blinded foods from a trial shop, but half of the participants were in-
structed in their own purchase of appropriate foods from normal shops to
compile their own dietary regimen.
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear
Incomplete outcome data
(attrition bias)
All outcomes
High risk 104 of 498 (21%) lost over 0.6 years (> 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
Low risk Trial shop used by both groups, plus dietary advice. See 'Control methods' and
'Intervention methods' in the 'Interventions' section above
Free of dietary differences
other than fat?
Low risk See 'Control aims' and 'Intervention aims' in the 'Interventions' section above
Compliance problems Unclear risk Unclear as no variance provided for total fat intakes
NDHS Open 2nd L&M 1968  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants Women who had had surgery for breast cancer (Sweden)
CVD risk: low
Control: randomised 121, analysed 63
Intervention: randomised 119, analysed 106
Mean years in trial: control 1.9, randomised 1.5
% male: 0%
Age: mean 58 (not described by randomisation group)
Baseline BMI: intervention 6 BMI < 20, 81 BMI 20 to 24.9, 34 BMI ≥ 25; control 9 BMI < 20, 74 BMI 20 to
24.9, 36 BMI ≥ 25
Interventions Reduced fat vs usual diet
Nordevang 1990 
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Control aims: usual diet
Intervention aims: 20%E to 25%E from fat, increase energy from CHO to replace lost energy
Control methods: no advice provided, only seen at baseline and 2 years
Intervention methods: 4 to 6 sessions during the first 2 months, group meetings every 6 to 8 weeks,
evening classes in low fat cooking, 3 monthly counselling during the first year, then at 18 months
Weight goals: "The total energy and/or protein intake was to be held constant".
Total fat intake (at 2 years): intervention -12.9 (SD unclear) (24 overall), control -3.1 (SD unclear) (34.1
overall) %E
Saturated fat intake (change to 2 years): intervention -6.8 (SD unclear), control -1.9 (SD unclear) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: dietary intake
Available outcomes: weight, BMI
Notes No exact variance or P values reported for weight and BMI outcomes, so have estimated variance from
P < 0.05 for the difference between the 2 arms for weight. As P > 0.05 for BMI no variance could be esti-
mated
This trial was named "Swedish Breast Cancer" in previous versions of this review.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "randomly assigned"
Allocation concealment
(selection bias)
Unclear risk No details provided
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants not blinded
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear for those assessing outcomes
Incomplete outcome data
(attrition bias)
All outcomes
High risk Outcome data ignored for those who dropped out (48% of the intervention
group), > 10%/year
Selective reporting (re-
porting bias)
Unclear risk No protocol found
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk Different levels of time and follow-up in the 2 groups
Nordevang 1990  (Continued)
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Free of dietary differences
other than fat?
Low risk Focus on fat
Compliance problems Low risk Very big difference between groups, though no variance reported
Nordevang 1990  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants Premenopausal women at increased risk of breast cancer (USA)
CVD risk: low
Control: randomised 53, analysed 50
Intervention: randomised 69, analysed 47
Mean years in trial: control 1.0, intervention 0.8
% male: control 0%, intervention 0%
Age: mean 38 (SD 7) - not provided by study arm (all 21 to 50)
Baseline BMI: not reported
Interventions Reduced fat vs usual diet
Control aims: followed usual diet, given daily food guide pyramid (half of this group randomised to 9
portions/d of fruit and vegetables advice)
Intervention aims: total fat 15%E (half of this group randomised to 9 portions/d of fruit and vegetables
advice)
Control methods: no dietary counselling (offered this at the end of study), but those given fruit and veg-
etables advice had support as below
Intervention methods: met dietitian every 2 weeks until compliant, monthly group meetings, coun-
selling on home diets, restaurants, parties, social support, eating at work, exchange booklets, cook-
book
Weight goals: "goals were derived such that baseline energy intake would be maintained while meeting
study goals".
Total fat intake (at 12 months): low fat 15.7 (SD 5.1) %E, control 32.7 (SD 6.1) %E
Saturated fat intake (at 12 months): low fat 7.2 (SD unclear) %E, control 11.6 (SD unclear) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: body weight, dietary compliance
Available outcomes: weight, total, LDL and HDL cholesterol, TG, BMI (but variance data not provided for
any but weight)
Notes Change from baseline to 12 months for the control (n = 23), control plus fruit and vegetables (n = 25),
low fat (n = 24), low fat plus fruit and vegetables (n = 23):
• Total cholesterol mg/dL: 9, 2, -8, 0
• TG mg/dL: -7, 1, 5, 8
• HDL cholesterol mg/dL: 0, 0, -4, 0
Nutrition & Breast Health 
Eects of total fat intake on body fatness in adults (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
75
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
• LDL cholesterol mg/dL: 11, 2, -6, -2
• BMI kg/m2: 0, 4, -13, 0
For weight, end data only are provided (no change data) although the intervention group was consider-
ably heavier at baseline (149 lb and 154 lb) than control groups (both 143 lb)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk The statistician made envelopes ahead of time; dietitians handed out en-
velopes at first visit.
Allocation concealment
(selection bias)
Low risk Allocation could not be altered once made.
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants were aware of allocation.
Blinding of outcome as-
sessment (detection bias)
High risk Researchers were not blinded.
Incomplete outcome data
(attrition bias)
All outcomes
High risk 15 of 122 (12%) lost over 1 year (> 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk High levels of intervention for those on low fat or high fruit and vegetable di-
ets. See 'Control methods' and 'Intervention methods' in the 'Interventions'
section above
Free of dietary differences
other than fat?
Low risk Randomisation to fruit and vegetable intervention was independent of low fat
allocation
Compliance problems Low risk Significant difference in total fat between arms
Nutrition & Breast Health  (Continued)
 
 
Study characteristics
Methods RCT with 3 arms
Optimal Dietary Macronutrient Distribution in China (ODMDC)
Summary risk of bias: low
Participants Healthy young adults (China)
CVD risk: low
Control:
ODMDC 2017 
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• High fat low CHO: 101 randomised, 101 analysed
• Mod fat mod CHO: 105 randomised, 105 analysed
Intervention:
• low fat high CHO: 101 randomised, 101 analysed
Mean years in trial: control 0.5, intervention 0.5
% male: control high fat: 52%, control mod fat: 48%, intervention low fat 50%
Age, mean (SD), years: control high fat 23.7 (4.3), control mod fat 23.2 (3.9), intervention low fat 23.4
(3.6), range 18-35
Baseline BMI, mean (SD): control high fat 21.9 (25), control mod fat 21.8 (2.6), intervention low fat 21.7
(2.5)
Interventions Low fat vs moderate fat vs high fat
Control:
• High fat low CHO: isocaloric diet with 2100 kcal/d for men, 1700 kcal/d for women, 40%E fat, 46%E
CHO, 14%E protein, 14 g/d fibre, 300 mg/d cholesterol
• Mod fat mod CHO: isocaloric diet with 2100 kcal/d for men, 1700 kcal/d for women, 30%E fat, 56%E
CHO, 14%E protein, 14 g/d fibre, 300 mg/d cholesterol
Intervention:
• Low fat high CHO: isocaloric diet with 2100 kcal/d for men, 1700 kcal/d for women, 20%E fat, 66%E
CHO, 14%E protein, 14 g/d fibre, 300 mg/d cholesterol
Control & intervention methods: all food provided, encouraged to maintain usual fruit intake and usual
levels of physical activity. Diets composed by replacing white rice and wheat flour with soybean oil.
Weight goals: "isocaloric"
Total fat intake (during intervention):
• by menu analysis: high fat 40%E, mod fat 31%E, low fat 20%E
• by chemical analysis: high fat 38%E, mod fat 28%E, low fat 18%E
Saturated fat intake: unclear
Style: all food provided
Outcomes Stated trial outcomes: primary weight change, secondary waist circumference, blood pressure, lipids,
glucose, insulin, glycated protein, adiponectin, leptin
Available outcomes: weight change, waist circumference, blood pressure, lipids, glucose, insulin, gly-
cated protein, adiponectin, leptin
Notes We used both the high fat (40%E) and moderate fat (30%E) arms as higher fat arms, and the low fat
(20%E) arm as the lower fat arm.
Funding: National Basic Research Program of China (2015CB553604)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated random number list, stratified by centre, age, sex and
BMI
ODMDC 2017  (Continued)
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Allocation concealment
(selection bias)
Low risk Randomised by data manager and after run-in period
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants not informed of allocations, but would have been aware of these
from foods provided
Blinding of outcome as-
sessment (detection bias)
Low risk Clinical sta$ and lab personnel who carried out measurements were masked
to allocation.
Incomplete outcome data
(attrition bias)
All outcomes
Low risk All participants were included in the ITT analysis (however 28 of 101 (high fat),
22 of 105 (mod fat), and 16 of 101 (low fat) dropped out during the 6 months of
the trial).
Selective reporting (re-
porting bias)
Low risk Trials register posted Feb 2015, trial completed in Oct 2015. All primary and
secondary outcomes fully reported
Other bias Low risk None noted
Free of systematic differ-
ence in care?
Low risk Yes, same process and contact schedule in all arms
Free of dietary differences
other than fat?
Low risk Yes, fat/CHO swaps
Compliance problems Low risk All food provided and diet diaries used to assess compliance
ODMDC 2017  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants Men with angina or who have had a MI (UK)
CVD risk: high
Reduced fat: randomised unclear, analysed 12
Modified fat: randomised unclear, analysed 23
Mean years in trial:reduced fat 1.1, modified fat 1.1
% male: reduced fat 100%, modified fat 100%
Age: not stated
Baseline BMI: not reported
Interventions Reduced fat vs modified fat diet
Reduced fat aims: total fat 20 g/d, advice to avoid dairy fats except skimmed milk plus 1 egg or 21 g
cheese/d. Lean meat and fish each allowed once/d, other non-fatty foods allowed in unlimited quanti-
ties
Modified fat aims: fat aims not stated, dairy produce avoided except skimmed milk, 90 mL/d soya oil
provided, lean meat originally prohibited but allowed after 6 months along with 113 g/wk of 'relatively
unsaturated margarine'. Fish and vegetables allowed freely
Reduced fat methods: unclear; "dietary histories taken before and during treatment"
Pilkington 1960 
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Modified fat methods: unclear; "dietary histories taken before and during treatment"
Weight goals: non-fatty foods not restricted, no weight goals mentioned
Total fat intake (during treatment): low fat 15.8 (SD unclear) %E, mod fat 36 (SD unclear) %E
Saturated fat intake: unclear
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: lipids
Available outcomes: weight, total and LDL cholesterol
Notes —
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "randomised"
Allocation concealment
(selection bias)
Unclear risk No details provided
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants not blinded
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear whether outcome assessors blinded
Incomplete outcome data
(attrition bias)
All outcomes
Unclear risk Unclear exactly how many were randomised, but paper suggested that all ran-
domised participants were analysed
Selective reporting (re-
porting bias)
Unclear risk No protocol or trials registry found
Other bias Low risk None noted
Free of systematic differ-
ence in care?
Low risk Appeared to be similar levels of assessment and support in both arms
Free of dietary differences
other than fat?
Low risk Dietary focus entirely on fat
Compliance problems Unclear risk A large difference in self-reported fat intake per day was reported, which is al-
most certainly statistically significant, though no measure of variance was re-
ported, however, the lower fat diet resulted in higher total and LDL choles-
terol, so unclear
Pilkington 1960  (Continued)
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Study characteristics
Methods RCT
Polyp Prevention Trial
Summary risk of bias: moderate to high
Participants People with at least one adenomatous polyp of the large bowel removed (USA)
CVD risk: low
Control: 1042 randomised, 943 analysed
Intervention: 1037 randomised, 943 analysed
Mean years in trial: control 3.05, intervention 3.05
% male: control 64%, intervention 66%
Age: mean control 61.5, intervention 61.4 (all at least 35)
Baseline BMI: mean control 27.5 (SE 0.12), intervention 27.6 (SE 0.13)
Interventions Low fat vs usual diet
Control: general dietary guidelines
Intervention: total fat 20%E, 18 g fibre/1000 kcal, 5 to 8 servings fruit and vegetables daily
Control methods: leaflet, no additional information or behaviour modification
Intervention methods: > 50 hours of counselling over 4 years, included skill building, behaviour modifi-
cation, self-monitoring and nutritional materials
Weight goals: "weight loss is permitted but not encouraged....counselled to replace fat intake with in-
creased intake of fruit, vegetable and grain products rather than reduce total calorie intake."
Total fat intake (at 4 years): low fat 23.8 (SD 6.0), control 33.9 (SD 5.9) %E
Saturated fat intake: unclear
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: recurrence of polyps, prostate cancer
Available outcomes: weight, total cholesterol
Notes Weight data reported at 1, 2, 3 and 4 years. 3-year data used in main analysis
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "randomly assigned" by computer randomisation centre, stratified according
to centre
Allocation concealment
(selection bias)
Low risk Phone call to computer randomisation centre, stratified according to centre
Blinding of participants
and personnel (perfor-
mance bias)
High risk Participants not blinded
Polyp Prevention 1996 
Eects of total fat intake on body fatness in adults (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
80
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
All outcomes
Blinding of outcome as-
sessment (detection bias)
Unclear risk Outcome assessors blinded for main trial outcomes, but not clear for body
weight
Incomplete outcome data
(attrition bias)
All outcomes
Low risk 193 of 2079 (9%) lost over 3 years (< 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen, clinical trial register set up 10 years after publication of
baseline data
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk 50 hours behaviour modification in intervention group, not in control. See
'Control methods' and 'Intervention methods' in the 'Interventions' section
above
Free of dietary differences
other than fat?
High risk Fibre, fruit and vegetable goals in intervention group
Compliance problems Low risk Significant difference in total fat intake at 4 years; not backed up by different
total cholesterol
Polyp Prevention 1996  (Continued)
 
 
Study characteristics
Methods 2 × 2 parallel RCT (5 arms)
Reading, Imperial, Surrey, Cambridge, and Kings (RISCK) study
Summary risk of bias: moderate to high
Participants People at increased risk of developing metabolic syndrome ≥ 4 (UK)
CVD risk: low
Control: HM/HGI 145 randomised, 111 analysed; HM/LGI 144 randomised, 116 analysed
Intervention: LF/HGI 145 randomised, 116 analysed; LF/LGI 149 randomised, 121 analysed
Mean years in trial: control 0.5 (SD x), intervention 0.5 (SD x)
% male: 42% overall
Age: mean age given overall by gender: Male = 52 ± 10; Female = 51 ± 9
Baseline BMI: overall mean BMI given as male or female: Male = 28.3 ± 3.8; Female = 28.6 ± 5.3
Interventions Low fat vs usual diet (low fat and high GI, low fat and low GI vs high MUFA and high GI, high MUFA and
high GI) - additional arm not used (high sat fatty acid and high GI).
Low fat (intervention arm): 28% fat, either 45% or 55% CHO, 12% MUFA, 10% SFA
Higher fat (control arm): 38% fat, 45% or 55% CHO, 20% MUFA, 10% SFA
Control methods: Provision of key sources of fat (including spreads, cooking oils and margarine) and
carbohydrates (including bread, pasta, rice and cereals) in the diet with additional dietary information,
RISCK 2010 
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tailored to the study group, given in writing and reinforced at individual study visits. Higher fat (38%
fat, 20% MUFA, 10% SFA)
Intervention methods: Provision of key sources of fat (including spreads, cooking oils and margarine)
and carbohydrates (including bread, pasta, rice and cereals) in the diet with additional dietary infor-
mation, tailored to the study group, given in writing and reinforced at individual study visits. Lower fat
(28% fat, 12% MUFA, 10% SFA)
Weight goals: Participants were advised that dietary advice was for weight maintenance.
Total fat intake (at 6 months); change % of energy; mean (95% CI):
• LF/HGI: -10.4 (-12.2, -8.6) vs HM/HGI: -2.3 (-4.1, -0.5)
• LF/LGI: -11.8 (-13.5, -10.1) vs HG/LGI: -2.2 (-3.9, -0.4)
Saturated fat intake (at 6 months); change % of energy; mean (95%CI):
• LF/HGI: -7.3 (-8.3, -6.4) vs HM/HGI: -7.0 (-7.9, -6.0)
• LF/LGI: -8.2 (-9.1, -7.3) vs HG/LGI: -6.9 (-7.8, -6.0)
Style: dietary advice and supplement
Setting: community
Outcomes Stated trial outcomes: Primary: Change in insulin sensitivity from measures of glucose and insulin dur-
ing an intravenous glucose tolerance test
Secondary: Fasting lipid profile, vascular reactivity and endothelial function, haemostatic factors,
markers of the inflammatory response, leptin and adiponectin, urinary microalbumin to creatinine ra-
tio, plasma fatty acid composition, DNA for nutrient-gene interactions.
Available outcomes: weight, total cholesterol, triglyceride, LDL and HDL cholesterol, BP, total energy,
total fat % energy, SFA % energy, PUFA % energy, MUFA % energy, CHO % energy, sugars % energy,
protein g/d
Notes Funding: UK Food Standards Agency (project NO2031). Foods were supplied by Unilever Food and
Health Research Institute (Unilever R&D, Vlaardingen, Netherlands), Cereal Partners UK (Welwyn Gar-
den City, Hertfordshire, United Kingdom), Grampian (Ban$, United Kingdom), Weetabix Ltd (Kettering,
United Kingdom), and Sainsbury’s Supermarkets Ltd (London, United Kingdom).
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-based minimisation procedure to balance assignment by age, sex,
waist, and HDL cholesterol
Allocation concealment
(selection bias)
Unclear risk No details
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants and the nutritionist advising on the dietary changes were not
blinded to the treatment.
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear whether those who measured adiposity were blinded to intervention
Incomplete outcome data
(attrition bias)
All outcomes
High risk Flow of participants through the study was shown with the CONSORT diagram,
171 out of 720 lost to follow-up over 6 months (reason given - discontinued), >
10%/year
RISCK 2010  (Continued)
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Selective reporting (re-
porting bias)
High risk Study was registered retrospectively in 2005, but weight not mentioned as an
outcome, though reported.
Other bias Low risk None noted
Free of systematic differ-
ence in care?
Low risk Appeared to be similar levels of assessment and support in both arms
Free of dietary differences
other than fat?
Low risk Focus on fat
Compliance problems Low risk Significant difference in total fat intake between arms
RISCK 2010  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants Adults with primary hyperlipoproteinaemia (Italy)
CVD risk: moderate
Intervention reduced fat: 33 randomised, 27 analysed
Intervention modified fat: 30 randomised, 17 analysed
Mean years in trial: reduced fat 0.4, modified fat 0.4
% male: reduced fat 82%, modified fat 63%
Age, years: reduced fat 47.4 mean (SD 10.3), modified fat 48.6 (SD 8.1)
Baseline BMI: reduced fat 24.4 mean (SD 2.9), modified fat 25.2 (SD 2.7)
Interventions Reduced fat vs modified fat diet
Reduced fat aims: total fat 25%E, SFA 8%E, MUFA 15%, PUFA 2%, dietary cholesterol < 300 mg/d, CHO
58%, protein 17%E, soluble fibre 41 g/d
Modified fat aims: total fat 38%E, SFA < 10%E, MUFA 20%E, PUFA 10%E, dietary cholesterol < 300 mg/d,
CHO 47%E, protein 15%E, soluble fibre 19 g/d
Reduced fat methods: seen monthly by dietitian and doctor; feedback based on 7-day food diary each
time
Modified fat methods: seen monthly by dietitian and doctor; feedback based on 7-day food diary each
time
Weight goals: neither weight or energy intake goals mentioned for either group
Total fat intake (at 5 to 6 months): low fat 27 (SD unclear), mod fat 36 (SD unclear) %E
Saturated fat intake (at 5 to 6 months): low fat 6 (SD unclear) %E, mod fat 7 (SD unclear) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: metabolic effects
Available outcomes: weight, total, LDL and HDL cholesterol, TG
Rivellese 1994 
Eects of total fat intake on body fatness in adults (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
83
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Notes Weight data were presented without variance info. Participants in the low fat arm lost 1.8 kg over the 6
months; the modified fat diet arm lost 1.6 kg.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Following 3 or 6 weeks compliance with control diet run-in, stratified block
randomisation with tables of random numbers
Allocation concealment
(selection bias)
Unclear risk Allocation method not clearly described
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk No blinding
Blinding of outcome as-
sessment (detection bias)
High risk No blinding
Incomplete outcome data
(attrition bias)
All outcomes
High risk 19 of 63 (30%) lost over 0.4 years (> 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
Low risk Identical follow-up. See 'Control methods' and 'Intervention methods' in the
'Interventions' section above
Free of dietary differences
other than fat?
High risk Some differences in soluble fibre intake
Compliance problems Unclear risk Big difference in total fat intake, but no variance to verify
Rivellese 1994  (Continued)
 
 
Study characteristics
Methods RCT (4 arms have been used here as 2 RCTs)
Summary risk of bias: moderate to high
Participants Free-living people aged 30 to 60 with serum total cholesterol levels 6.5 to 8.0 mmol/L (Finland)
CVD risk: moderate
Control (monoene-enriched): randomised 41, analysed 41
Intervention AHA: randomised 41, analysed 41
Mean years in trial: for all 4 groups 0.5
% male: control 46, AHA 46
Age: mean control 46.4, AHA 47.3 (all 30 to 60)
Baseline BMI: mean control 26.6 (SD 3.8), intervention 26.2 (SD 4.0)
Sarkkinen Low & Mod 1993 
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Interventions Reduced and modified fat vs modified fat diet
Control aims mono: total fat 38%E, SFA < 14%E, MUFA 18%E, PUFA < 6%E, rapeseed oil, rapeseed
spread and skimmed milk provided
Intervention aims AHA: total fat 30%E, SFA < 10%E, MUFA 10%E, PUFA 10%E, sunflower oil, sunflower
spread and skimmed milk provided
Control and intervention methods: given written dietary instructions and a diet plan with checking and
reinforcement for 3 visits, then at 2, 6, 12, 18 and 26 weeks
Weight goals: dietary written instructions were designed for 5 energy levels (1800, 2000, 2400, 2800 and
3200) based on individual diet and activity assessment
Total fat intake (weeks 14 to 28): low and mod fat 34 (SD 4), control 35 (SD 5) %E
Saturated fat intake (weeks 14 to 28): low and mod fat 11 (SD 2), control 11 (SD 2) %E
Style: dietary advice and supplement (food)
Setting: community
Outcomes Stated trial outcomes: lipids and blood pressure
Available outcomes: BMI, total, LDL and HDL cholesterol, TG, BP
Notes This trial was named "Kuopio Low and Modified fat" in previous versions of this review.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "randomisation stratified for men and women, singles and couples, random
number tables".
Allocation concealment
(selection bias)
Unclear risk Allocation method not clearly described
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants knew allocation.
Blinding of outcome as-
sessment (detection bias)
High risk Researchers knew allocation.
Incomplete outcome data
(attrition bias)
All outcomes
Low risk 0 of 82 (0%) lost over 0.5 years (< 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
Low risk Similar intensity and duration in both groups. See 'Control methods' and 'In-
tervention methods' in the 'Interventions' section above
Free of dietary differences
other than fat?
Low risk See 'Control aims' and 'Intervention aims' in the 'Interventions' section above
Sarkkinen Low & Mod 1993  (Continued)
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Compliance problems High risk Appeared very little difference in total fat intake between arms
Sarkkinen Low & Mod 1993  (Continued)
 
 
Study characteristics
Methods RCT (4 arms have been used here as 2 RCTs)
Summary risk of bias: moderate to high
Participants Free-living people aged 30 to 60 with serum total cholesterol levels 6.5 to 8.0 mmol/L (Finland)
CVD risk: moderate
Control (high saturated fat): randomised 37, analysed 12
Intervention low fat: randomised 40, analysed 40
Mean years in trial: for both groups 0.5
% male: control 46, low fat 48
Age: mean control 43.2, low fat 45.8 (all 30 to 60)
Baseline BMI: mean control 25.6 (SD 4.2), intervention 26.5 (SD 3.4)
Interventions Reduced fat vs usual diet (low fat vs control)
Control aims: advised total fat 38%E, SFA < 18%E, MUFA 15%E, PUFA < 5%E, rapeseed oil, butter and
semi-skimmed milk provided
Intervention aims low fat: total fat 28-30%E, SFA < 14%E, MUFA 10%E, PUFA 4%E, butter and rapeseed
spread and skimmed milk provided
Control and intervention methods: given written dietary instructions and a diet plan with checking and
reinforcement for 3 visits, then at 2, 6, 12, 18 and 26 weeks
Weight goals: dietary written instructions were designed for 5 energy levels (1800, 2000, 2400, 2800 and
3200) based on individual diet and activity assessment
Total fat intake (weeks 14 to 28): low fat 31 (SD 5), control 36 (SD 5) %E
Saturated fat intake (weeks 14 to 28): low fat 12 (SD 2), control 15 (SD 2) %E
Style: dietary advice and supplement (food)
Setting: community
Outcomes Stated trial outcomes: lipids and blood pressure
Available outcomes: BMI, total, LDL and HDL cholesterol, TG, BP
Notes This trial was named "Kuopio Low Fat" in previous versions of this review.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "randomisation stratified for men and women, singles and couples, random
number tables".
Allocation concealment
(selection bias)
Unclear risk Allocation method not clearly described
Sarkkinen Low Fat 1993 
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Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants knew allocation.
Blinding of outcome as-
sessment (detection bias)
High risk Researchers knew allocation.
Incomplete outcome data
(attrition bias)
All outcomes
High risk 25 of 77 (32%) lost over 0.5 years (> 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
Low risk Similar intensity and duration in both groups. See 'Control methods' and 'In-
tervention methods' in the 'Interventions' section above
Free of dietary differences
other than fat?
Low risk See 'Control aims' and 'Intervention aims' in the 'Interventions' section above
Compliance problems Low risk Statistically significant difference in total fat intake between arms
Sarkkinen Low Fat 1993  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants Women with a high risk of breast cancer (USA)
CVD risk: low
Control: randomised 96, analysed 38
Intervention: randomised 98, analysed 34
Mean years in trial: control 1.8, intervention 1.7
% male: 0
Age: mean control 46, intervention 46
Baseline BMI: mean intervention 25.2 (SE 0.8), control 28.1 (SE 0.8)
Interventions Reduced fat vs usual diet
Control aims: usual diet
Intervention aims: total fat 15%E
Control methods: continued usual diet
Intervention methods: biweekly individual dietetic appointments over 3 months followed by month-
ly individual or group appointments, including education, goal-setting, evaluation, feedback and self-
monitoring
Weight goals: weight and calorie goals not discussed
Total fat intake (at 12 months): low fat 18.0 (SD 5.6), control 33.8 (SD 7.4) %E
Simon 1997 
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Saturated fat intake (at 12 months): low fat 6.0 (SD unclear), control 11.3 (SD unclear) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: intervention feasibility
Available outcomes: weight, total, LDL and HDL cholesterol, TG
Notes —
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Stratified by age and randomised (block size 2)
Allocation concealment
(selection bias)
Unclear risk Allocation method not clearly described
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants knew their allocation.
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear whether physicians knew allocations
Incomplete outcome data
(attrition bias)
All outcomes
High risk 122 of 194 (63%) lost over 2 years (> 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk Very different contact time with dietitian, but medical appointments same in
both groups. See 'Control methods' and 'Intervention methods' in the 'Inter-
ventions' section above
Free of dietary differences
other than fat?
Low risk See 'Control aims' and 'Intervention aims' in the 'Interventions' section above
Compliance problems Low risk Big and statistically significant difference between arms in total fat intake
Simon 1997  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants People with well controlled type I diabetes mellitus (Canada)
Strychar 2009 
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CVD risk: moderate
Intervention reduced fat: 18 randomised, 15 analysed
Intervention modified fat: 17 randomised, 15 analysed
Mean years in trial: reduced fat 0.46, modified fat 0.47
% male: reduced fat unclear, modified fat unclear
Age, years: 37.9 (8.1 SD) (not specified by study arm)
Baseline BMI: mean reduced fat 24.3 (SD 2.6), modified fat 24.3 (SD 2.7)
Interventions Reduced fat vs modified fat diet
Reduced fat aims: total fat 27%E to 30%E, SFA ≤ 10%E, MUFA 10%, CHO 54% to 57%
Modified fat aims: total fat 37%E to 40%E, SFA ≤ 10%E, MUFA 20%E, CHO 43%E to 46%E
Reduced fat methods: after initial dietary advice, monitored weekly by phone by a dietitian (24-hour
food recall). Glycaemia, insulin doses, CHO at meals, hypoglycaemic attacks all self-monitored daily
and reported weekly.
Modified fat methods: after initial dietary advice, monitored weekly by phone by a dietitian (24-hour
food recall). Glycaemia, insulin doses, CHO at meals, hypoglycaemic attacks all self-monitored daily
and reported weekly.
Total fat intake (at 6 months): not stated
Saturated fat intake (at 6 months): not stated
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: triglycerides and other CVD risk factors
Available outcomes: weight; BMI; total, LDL and HDL cholesterol; TG; systolic and diastolic blood pres-
sure
Notes —
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "randomly assigned"
Allocation concealment
(selection bias)
Unclear risk No details provided
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk No details provided, but participants had to make decisions about what they
ate.
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear
Incomplete outcome data
(attrition bias)
All outcomes
High risk 5 of 35 (14%) lost over 0.5 years (> 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Strychar 2009  (Continued)
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Other bias Low risk None noted
Free of systematic differ-
ence in care?
Low risk Similar intervention in both groups
Free of dietary differences
other than fat?
Low risk Focus on fat and CHO intake
Compliance problems Unclear risk Unclear total fat intake
Strychar 2009  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants People with impaired glucose intolerance or high normal blood glucose (New Zealand)
CVD risk: moderate
Control: unclear how many randomised (176 between both groups), 51 analysed
Intervention: unclear how many randomised (176 between both groups), 48 analysed
Mean years in trial: 4.1 over whole trial
% male: control 80%, intervention 68%
Age: mean control 52.0 (SE 0.8), intervention 52.5 (SE 0.8)
Baseline BMI: mean control 29.1 (SE 0.6), intervention 29.3 (SE 0.6)
Interventions Reduced fat vs usual diet
Control aims: usual diet
Intervention aims: reduced fat diet (no specific goal stated)
Control methods: usual intake
Intervention methods: monthly meetings to follow a 1-year structured programme aimed at reducing
fat in the diet; included education, personal goal-setting, self-monitoring
Weight goals: weight and calories not mentioned; diet was "aimed solely at reducing the total amount
of fat in their diet".
Total fat intake (at 1 year): low fat 26.1 (SD 7.7), cont 33.6 (SD 7.8) %E
Saturated fat intake (at 1 year): low fat 10.0 (SD 4.2), cont 13.4 (SD 4.7) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: lipids, glucose, blood pressure
Available outcomes: weight, total, LDL and HDL cholesterol, TG, BP
Notes This trial was named "Auckland Low Fat" in previous versions of this review.
Risk of bias
Bias Authors' judgement Support for judgement
Swinburn 2001 
Eects of total fat intake on body fatness in adults (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
90
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Random sequence genera-
tion (selection bias)
Low risk Paper states "individually assigned by simple randomization using an un-
marked envelope system"
Allocation concealment
(selection bias)
Low risk Unmarked opaque envelopes were opened by the person recruiting; unable to
alter allocation later.
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants were not blinded.
Blinding of outcome as-
sessment (detection bias)
Unclear risk Outcome assessors were blinded.
Incomplete outcome data
(attrition bias)
All outcomes
High risk 77 of 176 recruited lost to follow-up, 44% over 5 years (> 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk See 'Control methods' and 'Intervention methods' in the 'Interventions' sec-
tion above
Free of dietary differences
other than fat?
Low risk See 'Control aims' and 'Intervention aims' in the 'Interventions' section above
Compliance problems Low risk Statistically significant difference in total fat intake between arms
Swinburn 2001  (Continued)
 
 
Study characteristics
Methods RCT
Women's Healthy Eating and Living (WHEL) study
Summary risk of bias: moderate to high
Participants Women with previously treated early breast cancer (USA)
CVD risk: low
Control: randomised 1561, analysed 1313
Intervention: randomised 1546, analysed 1308
Mean years in trial: unclear, 11 years max, around 11 years mean?
% male: 0
Age: control mean 53.0 (SD 9.0), intervention mean 53.3 (SD 8.9)
Baseline BMI: control mean 27.2 (SD 6.1), intervention mean 27.2 (SD 6.1)
Interventions Reduced fat intake vs usual diet
Control: aim 30%E from fat
Intervention: aim 15%E to 20%E from fat, 5 vegetables/d, 3 fruit/d, 16 oz vegetable juice and 30 g/d fi-
bre
WHEL 2007 
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Control methods: given print materials only
Intervention methods: telephone counselling programme (31 calls by study end), cooking classes (12
offered in first year, 4 attended on average) and monthly newsletters (48 by study end), all focused on
self-efficacy, self-monitoring and barriers, retaining motivation
Weight goal: intervention goal was to achieve the change in dietary pattern without weight reduction;
weight and calories not mentioned in the control group
Total fat intake (at 72 months): low fat 28.9 (SD 9.0), control 32.4 (SD 8.0) %E
Saturated fat intake (at 72 months): low fat 7.2 (SD unclear), control 8.9 (SD unclear) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: mortality, invasive breast cancer
Available outcomes: weight, total, LDL and HDL cholesterol, TG
Notes Weight measured and reported at 1, 2, 3, 4 and 6 years, and 3-year data used in main analysis
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation via computer program
Allocation concealment
(selection bias)
Unclear risk Unclear
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants aware of allocation
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear whether those assessing weight were blinded to allocation
Incomplete outcome data
(attrition bias)
All outcomes
Low risk 486 of 3107 (16%) lost over 11 years (< 10% per year)
Selective reporting (re-
porting bias)
Low risk NCT entry 2005, study completion date 2007. Breast cancer recurrence and
mortality noted as outcomes and published
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk High-intensity intervention compared with leaflets. See 'Control methods' and
'Intervention methods' in the 'Interventions' section above
Free of dietary differences
other than fat?
High risk Fruit and vegetable intervention in low fat arm, not in control
Compliance problems Unclear risk Total fat intake lower in intervention group than control; not statistically sig-
nificant and not backed by significant differences in total or LDL cholesterol
WHEL 2007  (Continued)
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Study characteristics
Methods RCT
Women's Health Initiative (WHI)
Summary risk of bias: low
Participants Postmenopausal women aged 50 to 79 (USA)
CVD risk: mixed, mostly low but some participants had CVD at baseline
Control: randomised 29,294, analysed 25,056
Intervention: randomised 19,541, analysed 16,297
Mean years in trial: control 8.1, intervention 8.1
% male: 0
Age: mean intervention 62.3 (SD 6.9), control 62.3 (SD 6.9)
Baseline BMI: mean intervention 29.1 (SD 5.9), control 29.1 (SD 5.9)
Interventions Reduced fat vs usual diet
Control: diet-related education materials
Intervention: low fat diet (20%E from fat) with increased fruit and vegetables
Control methods: given copy of 'Dietary Guidelines for Americans'
Intervention methods: 18 group sessions with trained and certified nutritionists in the first year, quar-
terly maintenance sessions thereafter, focusing on diet and behaviour modification
Weight goals: "the intervention did not include total energy reduction or weight-loss goals".
Total fat intake (at 6 years): intervention 28.8 (SD 8.4) %E, control 37.0 (SD 7.3) %E
Saturated fat intake (at 6 years): intervention 9.5 (SD 3.2) %E, control 12.4 (SD 3.1) %E
Style: dietary advice
Setting: community
Outcomes Stated trial outcomes: breast cancer, mortality, other cancers, cardiovascular events, diabetes
Available outcomes: weight, BMI, waist circumference, body fat %, total, LDL and HDL cholesterol, TG,
systolic and diastolic BP, quality of life
Notes Weight data available at 1 year, 3 years, 6 years and 7.5 years. Latest (7.5 year) data used for main analy-
sis for weight, BMI and waist circumference
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated permuted block algorithm stratified by clinical centre
and age
Allocation concealment
(selection bias)
Low risk Allocations developed by the WHI Clinical Coordinating Center
Blinding of participants
and personnel (perfor-
mance bias)
High risk Participants aware of allocation
WHI 2006 
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All outcomes
Blinding of outcome as-
sessment (detection bias)
Low risk Trained clinic sta$, who were responsible for anthropometric assessments and
administration of FFQs, were blinded to treatment assignments to the extent
practical. The dietary intervention sta$ did not conduct clinical assessments,
and clinic sta$ were not permitted to participate in any intervention activities;
participants were instructed not to discuss nutrition activities with clinic sta$.
Incomplete outcome data
(attrition bias)
All outcomes
Low risk 7482 of 48,835 (15%) lost over 8 years (< 10% per year)
Selective reporting (re-
porting bias)
Low risk Weight and secondary outcomes reported as in protocol
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk Intervention participants received 18 group sessions with behavioural modifi-
cation plus quarterly maintenance sessions thereafter. See 'Control methods'
and 'Intervention methods' in the 'Interventions' section above
Free of dietary differences
other than fat?
High risk Also fruit and vegetable intervention. See 'Control aims' and 'Intervention
aims' in the 'Interventions' section above
Compliance problems Low risk Statistically significant difference in total fat intake
WHI 2006  (Continued)
 
 
Study characteristics
Methods RCT, 2 parallel arms
Women's Health Trial (WHT) - full-scale trial
Summary risk of bias: moderate to high
Participants Women at increased risk of breast cancer (USA)
CVD risk: low
Control: randomised unclear, analysed 318 (1761 recruited overall in the full-scale phase between con-
trol & intervention arms, 40% randomised to intervention)
Intervention: randomised unclear, analysed 324
Mean years in trial: control 1, randomised 1
% male: 0%
Age: mean not stated, but all aged 45 to 69 (27% 45-49, 43% 50-59, 30% 60-69 years)
Baseline BMI: Not stated, but weight ~69kg
Interventions Reduced fat vs usual diet
Control aims: maintain usual diet
Intervention aims: 20%E from fat
Control methods: no advice provided; encouraged to eat usual diet
Intervention methods: multiple group intervention sessions over 18 months, emphasising nutrition ed-
ucation and behavioural skills (including fat-counting); participants had to have been offered 8 group
sessions at least to be included in outcome assessment over 5-37 months.
WHT Full-scale 
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Weight goals: "there was no emphasis on weight change".
Total fat intake (at 1 year): intervention 26.8 (SD unclear), control 38.4 (SD unclear) %E
Saturated fat intake: intervention not stated, control not stated %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: breast cancer diagnosis
Available outcomes: weight
Notes Weight data provided at study end (on average 1 year after randomisation)
Recruitment was 1986-1988; trial terminated early in 1988.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "randomised"
Allocation concealment
(selection bias)
Unclear risk Not described
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants were not blinded.
Blinding of outcome as-
sessment (detection bias)
High risk Not blinded; measured by the nurse who went through dietary records.
Incomplete outcome data
(attrition bias)
All outcomes
Unclear risk Unclear due to early termination of study
Selective reporting (re-
porting bias)
Low risk Design paper published, weight and serum total cholesterol reported
Other bias High risk Data are partial as the trial was terminated early, in 1988. Risk of contamina-
tion with data on the WHT Vanguard part of the study
Free of systematic differ-
ence in care?
High risk Different levels of attention and time
Free of dietary differences
other than fat?
Low risk Focus on fat only
Compliance problems Low risk Statistically significant difference in total fat intake between arms at 1 year
WHT Full-scale  (Continued)
 
 
Study characteristics
WHT Vanguard 1991 
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Methods RCT
Women's Health Trial Vanguard Study (WHT Vanguard)
Summary risk of bias: moderate to high
Participants Women at increased risk of breast cancer (USA)
CVD risk: low
Control: randomised 184, analysed 159
Intervention: randomised 119, analysed 102
Mean years in trial: control 1.9, randomised 1.9
% male: 0%
Age: mean control 55.6 (SD 6.3), intervention 55.6 (SD 6.2)
Baseline BMI: mean intervention 26 (SD 4), control 25 (SD 4)
Interventions Reduced fat vs usual diet
Control aims: maintain usual diet
Intervention aims: 20%E from fat
Control methods: no advice provided, only seen at baseline, then 6, 12 and 24 months for assessment
Intervention methods: women were given flexible diet plans and responsible for their own monitor-
ing; they had individual appointments with a nutritionist at 2 and 12 weeks, plus small group meetings
(weekly for 8 weeks, then biweekly for 8 weeks, then monthly to 2 years).
Weight goals: "there was no emphasis on weight change".
Total fat intake (at 2 years): intervention 22.6 (SD 7.1), control 36.8 (SD 8.0) %E
Saturated fat intake (at 2 years): intervention 7.2 (SD 2.7), control 12.3 (SD 3.6) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: dietary intake/feasibility
Available outcomes: weight, total cholesterol
Notes Weight data provided at 6, 12 and 24 months. 2-year data used in main analysis
Recruitment was in 1985.
This trial has several names, but we called it "WHT Feasibility" in previous versions of this review.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "randomised"
Allocation concealment
(selection bias)
Unclear risk Not described
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants were not blinded.
WHT Vanguard 1991  (Continued)
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Blinding of outcome as-
sessment (detection bias)
High risk Not blinded; measured by the nurse who went through dietary records.
Incomplete outcome data
(attrition bias)
All outcomes
Low risk 42 of 303 (14%) lost over 2 years (< 10% per year)
Selective reporting (re-
porting bias)
Low risk Design paper published; weight and serum total cholesterol reported
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk Different levels of attention and time
Free of dietary differences
other than fat?
Low risk Focus on fat only
Compliance problems Low risk Statistically significant difference in total fat intake between arms at 2 years;
there was no lipid data to back this up.
WHT Vanguard 1991  (Continued)
 
 
Study characteristics
Methods RCT
Women's Health Trial: Feasibility Study in Minority Populations (WHTFSMP)
Summary risk of bias: moderate to high
Participants Postmenopausal women from diverse ethnic and socioeconomic backgrounds (USA)
CVD risk: low
Control: randomised 883, analysed 649 at 6 mo, 443 at 12 mo, 194 at 18 mo
Intervention: randomised 1325, analysed 1071 at 6 mo, 698 at 12 mo, 285 at 18 mo
Mean years in trial: unclear, follow-up from 6 to 18 months
% male: 0%
Age: mean control 59.8 (SD 6.6), intervention 60.1 (SD 6.6)
Baseline BMI: 28.8 (SD 4.7) for all
Interventions Reduced fat vs usual diet
Control aims: maintain usual diet
Intervention aims: up to 20%E from fat, reduced saturated fat and dietary cholesterol, increased fruit,
vegetables and whole grains
Control methods: pamphlet on general dietary guidelines provided, no other follow-up, seen at base-
line, then 6, 12 and 18 months for assessment
Intervention methods: women allocated to groups of 8 to 15 women with a nutritionist leader, meet-
ing weekly for 6 weeks, bi-weekly for 9 months then quarterly. Women provided with personal fat gram
goals
Weight goals: weight and calories not mentioned
Total fat intake (at 1 year): intervention 25.4 (SD unclear), control 36.0 (SD unclear) %E
WHTFSMP 2003 
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Saturated fat intake (at 1 year): intervention 8.7 (SD unclear), control 12.1 (SD unclear) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: dietary intake/feasibility
Available outcomes: weight, BMI, blood pressure (lipids and estradiol appear to have been measured,
but data not found)
Notes Weight and BMI data only found for 6 months of intervention
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomised using randomly permuted blocks after collection of baseline data
Allocation concealment
(selection bias)
Unclear risk Not discussed
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants not blinded
Blinding of outcome as-
sessment (detection bias)
Unclear risk Weight measured by trained and certified clinical sta$, but unclear whether
they were blinded to allocation
Incomplete outcome data
(attrition bias)
All outcomes
Low risk All those randomised were analysed for weight.
Selective reporting (re-
porting bias)
High risk Unclear; outcome measures not stated in trials register. Study conducted 1991
to 1995; design paper published in 1996. Lipids and estradiol appear to have
been measured but no data found.
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk Greater time and support provided to intervention group
Free of dietary differences
other than fat?
High risk Suggestion to intervention group to increase fruit, vegetable and whole grain
intakes
Compliance problems Low risk No reported serum lipids, but saturated fat intake statistically significantly dif-
ferent in intervention and control groups at 6, 12 and 18 months
WHTFSMP 2003  (Continued)
 
 
Study characteristics
Methods RCT
Women's Intervention Nutrition Study (WINS)
WINS 1993 
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Summary risk of bias: moderate to high
Participants Women with localised resected breast cancer (USA)
CVD risk: low
Control: 1462 randomised, 998 analysed
Intervention: 975 randomised, 386 analysed
Mean years in trial: overall 5.0
% men: 0
Age: control mean 58.5 (95% CI 43.6 to 73.4), intervention mean 58.6 (95% CI 44.4 to 72.8) (all post-
menopausal)
Baseline BMI: mean intervention 27.6 (95% CI 27.2 to 28.0), control 27.5 (95% CI 27.2 to 27.8)
Interventions Reduced fat intake vs usual diet
Control aims: minimal nutritional counselling focused on nutritional adequacy
Intervention aims: total fat 15%E to 20%E
Control methods: 1 baseline dietetic session plus 3-monthly sessions
Intervention methods: 8 biweekly individual dietetic sessions, then optional monthly group sessions,
incorporating individual fat gram goals, social cognitive theory, self-monitoring, goal-setting, model-
ling, social support and relapse prevention and management
Weight goals: "fat gram goals were based on energy needed to maintain weight, and no counselling on
weight reduction was provided"; not mentioned for control
Total fat intake (at 1 year): low fat 20.3 (SD 8.1), control 29.2 (SD 7.4) %E
Saturated fat intake (at 1 year): low fat 10.4 (SD 6.7), control 16.6 (SD 9.3) %E
Style: dietary advice
Setting: community
Outcomes Stated trial outcomes: dietary fat intake, total cholesterol, weight and waist
Available outcomes: weight, BMI
Notes Weight data reported at 1, 3 and 5 years. 3-year data used in main analysis
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random stratified permuted block design, carried out at the statistical coordi-
nating centre of WINS
Allocation concealment
(selection bias)
Low risk Statistical coordinating centre as above
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Participants not blinded
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear
WINS 1993  (Continued)
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Incomplete outcome data
(attrition bias)
All outcomes
Low risk 1053 of 2437 (43%) lost over 5 years (< 10% per year)
Selective reporting (re-
porting bias)
Unclear risk Protocol not seen
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk Differences in attention - more time for those in intervention group. See 'Con-
trol methods' and 'Intervention methods' in the 'Interventions' section above
Free of dietary differences
other than fat?
Low risk See 'Control aims' and 'Intervention aims' in the 'Interventions' section above
Compliance problems Low risk Significant difference in total fat intake between arms at 1 year
WINS 1993  (Continued)
 
 
Study characteristics
Methods RCT
Summary risk of bias: moderate to high
Participants People with relapsing-remitting multiple sclerosis (MS) (USA)
CVD risk: low
Control: 29 randomised, 27 analysed
Intervention: 32 randomised, 26 analysed
Mean years in trial: control 12 mo, intervention 12 mo
% male: control 3%, intervention 10%
Age: mean control 40.9 (SD 8.5), intervention 40.8 (SD 8.9)
Baseline BMI: mean control 28.4 (SD 6.76), intervention 29.3 (SD 7.42)
Interventions Low fat vs usual diet
Control: usual diet
Intervention: total fat 10%E, protein 14%E, carbohydrate 76%, focus on starchy plant foods while meat,
fish, eggs, dairy foods, vegetable oil are prohibited
Control methods: no dietary training; told to follow their usual diet; offered dietary training at end of
study period (waiting-list control)
Intervention methods: 10 days residential diet training initially, then monthly FFQ and phone contact,
plus additional counselling by dietitians in clinic or by phone. Secure online discussion board and per-
sonal meetings between participants to discuss diet
Weight goals: none mentioned
Total fat intake (at 1 year): low fat 14.4 (SD 6.1), control 39 (SD 6) %E
Saturated fat intake: unclear
Style: diet advice
Yadav 2016 
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Setting: community
Outcomes Stated trial outcomes: MS lesion formation (primary), clinical outcomes such as relapse rate, disability
progression, fatigue, depression, quality of life, inflammation, safety, tolerability (secondary)
Available outcomes: BMI and weight change, lipids (reported)
Notes Weight and BMI change data reported but without SDs
Funding: McDouglal Research and Education Foundation
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation stratified by medication use with random blocks of 2 and 4,
generated using the Excel random number generator function
Allocation concealment
(selection bias)
Unclear risk Unclear; not reported
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
High risk Study participants, neurologists, study coordinators and the dietitian knew
the group assignments.
Blinding of outcome as-
sessment (detection bias)
Unclear risk Unclear for weight as, although assessing neurologists were blinded, it was not
clear whether they took weight measurements.
Incomplete outcome data
(attrition bias)
All outcomes
High risk > 10% lost over 12 months, though reasons provided for half
Selective reporting (re-
porting bias)
Low risk No, all represented
Other bias Low risk None noted
Free of systematic differ-
ence in care?
High risk A residential programme, plus lots of support and counselling provided to in-
tervention participants, not to control participants
Free of dietary differences
other than fat?
High risk The focus was on plant-based carbohydrates and participants in intervention
group told to omit meat, fish, dairy foods, and vegetable oils so protein and fi-
bre will have been changed.
Compliance problems Low risk Dietary fat intake was significantly different between arms.
Yadav 2016  (Continued)
%E: percentage of total energy intake
AHA: American Heart Association
AusMed: AUStralian MEDiterranean diet trial for secondary prevention of heart disease
BDIT: Breast Dysplasia Intervention Trial
BMI: body mass index
BP: blood pressure
BRIDGES: Breast Research Initiative for Determining E$ective Strategies for Coping with Breast Cancer
CHD: coronary heart disease
CHO: carbohydrates
CI: confidence interval
CORDIOPREV: CORonary Diet Intervention with Olive oil and cardiovascular PREVention study
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CVD: cardiovascular disease
DASH: Dietary Approaches to Stop Hypertension
DBCP: Diet and Breast Cancer Prevention
DEER: Diet and Exercise for Elevated Risk
FFQ: food frequency questionnaire
GI: glycaemic index
HDL: high-density lipoprotein
HGI: High glycaemic index
HM: high monounsaturated fat
IHD: ischaemic heart disease
ITT: intention to treat
LDL: low-density lipoprotein
LF: low fat
LGI: low glycaemic index
MeDiet: Mediterranean Diet
MI: myocardial infarction
MS: multiple sclerosis
MUFA: monounsaturated fatty acid
NCEP: National Cholesterol Education Program
NDHS: National Diet Health Study
NEP: Nutrition Education Program
NDHS: National Diet-Heart Study
ODMDC: Optimal Dietary Macronutrient Distribution in China
P/S: polyunsaturated/saturated fat ratio
PUFA: polyunsaturated fatty acid
QoL: quality of life
RCT: randomised controlled trial
RISCK: Reading, Imperial, Surrey, Cambridge, and Kings Study
SD: standard deviation
SE: standard error
SF36: 36-item Short Form Survey (a quality of life assessment)
SFA: saturated fatty acid
TG: triglycerides
vs: versus
WHEL: Women's Healthy Eating and Living
WHI: Women's Health Initiative
WHT: Women's Health Trial
WHTFSMP: Woment's Health Trial, Feasibility Study in Minority Populations
WINS: Women's Intervention Nutrition Study
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Agewall 2001 Multifactorial intervention
Ammerman 2003 No appropriate control group (and not low fat vs modified fat)
Aquilani 2000 No appropriate control group (and not low fat vs modified fat)
Arne 2014 Intervention aimed at weight management
Arntzenius 1985 No appropriate control group (and not low fat vs modified fat)
ASSIST 2001 Intervention was not dietary fat modification or low fat diet
Bakx 1997 Multifactorial intervention
Ball 1965 Those who were overweight were encouraged to reduce their weight
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Study Reason for exclusion
Barnard 2009 Weight reduction encouraged in the conventional diet, but not in the vegan diet arm
Barndt 1977 No appropriate control group (and not low fat vs modified fat)
Baron 1990 Multifactorial intervention
Bazzano 2012 Participants selected on basis of BMI (30 to 45)
Beckmann 1995 Intervention was not dietary fat modification or low fat diet
Bierenbaum 1963 No appropriate control group (and not low fat vs modified fat)
Bloomgarden 1987 Multifactorial intervention
Bonnema 1995 No appropriate control group (and not low fat vs modified fat)
Brehm 2009 Participants recruited on basis of being overweight or obese
Brensike 1982 No appropriate control group (and not low fat vs modified fat)
Broekmans 2003 Intervention was not dietary fat modification or low fat diet
Brown 1984 No appropriate control group (and not low fat vs modified fat)
Bruce 1994 No appropriate control group (and not low fat vs modified fat)
Bruno 1983 Multifactorial intervention
Byers 1995 No appropriate control group (and not low fat vs modified fat)
Caggiula 1996 No appropriate control group (and not low fat vs modified fat)
CARMEN 2000 Participants recruited on basis of BMI (26 to 34)
CCD 2008 Dietary advice to support weight loss provided to all those wanting to lose weight.
Clark 1997 Multifactorial intervention
Cocinar para su salud 2016 Total fat goals unclear, but total fat was < 30%E at baseline and decreased further in both groups
Cohen 1991 Intervention was not dietary fat modification or low fat diet
Coppell 2010 Weight loss recommended
Cox 1996 Multifactorial intervention
CroK 1986 Intervention was not dietary fat modification or low fat diet
Da Qing IGT 1997 Intervention was not dietary fat modification or low fat diet
Dalgard 2001 No appropriate control group (and not low fat vs modified fat)
DAS 1989 No appropriate control group (and not low fat vs modified fat)
Davey Smith 2005 Multifactorial intervention
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Study Reason for exclusion
DeBusk 1994 Multifactorial intervention
Delahanty 2001 No appropriate control group (and not low fat vs modified fat)
Delius 1969 Intervention was not dietary fat modification or low fat diet
Dengel 1995 No appropriate control group (and not low fat vs modified fat)
Diabetes CCT 1995 Intervention was not dietary fat modification or low fat diet
DIET 1998 Multifactorial intervention
DIRECT 2009 Weight reduction aim
DO IT 2006 "Overweight subjects were encouraged to adopt a calorie-restricted diet"
Dobs 1991 No appropriate control group (and not low fat vs modified fat)
Drummond 1998 Both groups taught to reduce fat
Du$ield 1982 Multifactorial intervention
Eckard 2013 Energy restricted diet
Elder 2000 No appropriate control group (and not low fat vs modified fat)
Entwistle 2018 Post-transplant patients
Esposito 2003 No appropriate control group (and not low fat vs modified fat)
Esposito 2004 No appropriate control group (both groups aimed at < 30%E from fat)
Esposito 2014 Energy restricted diet
EUROACTION 2008 Multifactorial intervention
FARIS 1997 Multifactorial intervention
Fasting HGS 1997 No appropriate control group (and not low fat vs modified fat)
Ferrara 2000 No appropriate control group (and not low fat vs modified fat)
Finnish Diabetes 2000 Multifactorial intervention
Fleming 2002 No appropriate control group (and not low fat vs modified fat)
Fortmann 1988 Intervention was not dietary fat modification or low fat diet
Foster 2003 Weight reduction in one arm but not the other
Friedman 2012 Weight loss diets
Gaullier 2007 No appropriate control group (and not low fat vs modified fat)
German Fat Reduced Participants recruited on basis of their BMI (24 to 29)
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Glatzel 1966 No appropriate control group (and not low fat vs modified fat)
Goodpaster 1999 No appropriate control group (and not low fat vs modified fat)
Gower 2012 Participants recruited on basis of high BMI
Greenlee 2016 Both groups had < 30% E from fat at baseline
Gregg 2013 Participants recruited on basis of high BMI
Gudlaugsson 2013 Multifactorial intervention
Guelinckx 2010 Participants recruited on basis of high BMI
Guldbrand 2012 Weight loss intended
Hardcastle 2008 Multifactorial intervention
Hartman 1993 No appropriate control group (and not low fat vs modified fat)
Hartwell 1986 No appropriate control group (and not low fat vs modified fat)
Haynes 1984 Intervention was not dietary fat modification or low fat diet
Hellenius 1993 The study aimed for weight loss in one arm and not in the comparison arm
Hildreth 1951 No appropriate control group (and not low fat vs modified fat)
HIPERCOL 2018 No appropriate intervention (classic guidelines plus added educational support vs classic guide-
lines)
Hutchison 1983 No appropriate control group (and not low fat vs modified fat)
Hyman 1998 Neither mortality nor cardiovascular morbidity data available (only decided after contact with at
least one author)
IMPACT 1995A Multifactorial intervention
Iso 1991 No appropriate control group (and not low fat vs modified fat)
Ives 1993 Multifactorial intervention
Jalkanen 1991 Multifactorial intervention
Janus 2012 Weight loss intended
Jonasson 2014 Energy restricted diet
Juanola-Falgarona 2014 Energy restricted diet
Jula 1990 Multifactorial intervention
Karvetti 1992 Multifactorial intervention
Kastarinen 2002 Multifactorial intervention
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Kattelmann 2010 Weight loss intended
Katzel 1995 Intervention was not dietary fat modification or low fat diet
Kempner 1948 No appropriate control group (and not low fat vs modified fat)
Klemsdal 2010 Participants recruited on basis of high BMI
Korhonen 2003 Multifactorial intervention
Kristal 1997 Multifactorial intervention
Kromhout 1987 No appropriate control group (and not low fat vs modified fat)
Kummel 2008 Intervention was not dietary fat modification or low fat diet
Laitinen 1993 Multifactorial intervention
Laitinen 1994 Multifactorial intervention
Larsen 2011 Energy restricted diet
Leduc 1994 Multifactorial intervention
Leibbrandt 2010 Participants recruited on basis of high BMI
Lewis 1985 Multifactorial intervention
LIILAC 2015 Both arms had > 30% E from fat
Lipid Res Clinic 1984 No appropriate control group (and not low fat vs modified fat)
Luoto 2012 No assessment of total fat intake
Luszczynska 2007 No appropriate control group (and not low fat vs modified fat)
Lyon Diet Heart 1994 Intervention was not dietary fat modification or low fat diet
Mansel 1990 Intervention was not dietary fat modification or low fat diet
MARGARIN No appropriate control group (and not low fat vs modified fat)
Martin 2011 Participants recruited on basis of high BMI
Maruthur 2014 No relevant outcomes available
Mayneris-Perxachs 2014 No assessment of total fat intake
McCarron 2001 Intervention was not dietary fat modification or low fat diet
McManus 2001 Aimed at weight loss
Medi-RIVAGE 2004 Weight reduction for some low fat diet participants (those with BMI > 25) but not in Mediterranean
group
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Merrill 2011 Multifactorial intervention
Michalsen 2006 Diet plus stress management vs no intervention
Millar 1973 No appropriate control group (and not low fat vs modified fat)
Milne 1994 No appropriate control group (and not low fat vs modified fat) - the high CHO diet was neither 'usu-
al' or 'low fat' to compare with the modified fat diet
Minnesota HHP 1990 No appropriate control group (and not low fat vs modified fat)
MUFObes low fat 2007 Trial aimed to assess weight maintenance following major weight loss
MUFObes low vs mod 2007 Trial aimed to assess weight maintenance following major weight loss
Mujeres Felices 2003 Diet and breast self examination vs no intervention
Munsters 2010 Weight loss intended
Murillo-Ortiz 2017 Both groups aimed at low fat intake
Naglak 2000 Dietary fat intervention unclear
NCT02353416 Intervention aim > 30% fat, control aim close to 30% fat (as per Italian guidelines)
NCT02368405 Fat goals unclear
NCT02396264 Calories adjusted to maintain weight
Neil 1995 No appropriate control group (and not low fat vs modified fat)
Neverov 1997 Multifactorial intervention
Next Step 1995 Neither mortality nor cardiovascular morbidity data available (only decided after contact with at
least one author)
Norway Veg Oil 1968 No appropriate control group (and not low fat vs modified fat)
Novotny 2012 Weight loss intended
Nutri-EPA 2017 Intervention aim > 30% fat, control aim close to 30% fat (as per Italian guidelines)
Nutrition Ed Study 1980 Those who were overweight were provided with a weight reduction booklet
ODES 2006 The study aimed for weight loss in some participants
Oldroyd 2001 Multifactorial intervention
Orazio 2011 Weight loss intended
ORIGIN 2008 Intervention was not dietary fat modification or low fat diet
Ornish 1990 Multifactorial intervention (diet, smoking, stress and exercise) compared to no intervention
Oslo Study 1980 Multifactorial intervention
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Otago Weight Loss 2005 Although intake was ad libitum, the aim was for weight loss to occur - participants presumably
joined the study on the basis that it was assessing effects on weight loss, so were keen to lose
weight
Pascale 1995 Multifactorial intervention
Paz-Tal 2013 No relevant outcomes available
PEP 2001 Multifactorial intervention
PHYLLIS 1993 No appropriate control group (and not low fat vs modified fat)
Portfolio 5 No dietary fat aims in the low-fat arm (aimed for < 7%E SFA and < 200mg/d cholesterol), nor in
the portfolio arms (aimed for < 7%E SFA and < 200mg/d cholesterol and also introduced portfolio
foods such as sterol margarine, soy, nuts, and viscous fibre)
PREDIMED 2006 Modified fat group was clearly defined, but no fat goals were set for the low fat group. We were un-
able to verify whether the fat aim was ≤ 30%E
PREMIER 2003 Overweight participants were encouraged to lose weight
Pritchard 2002 The study aimed for weight loss in one arm and not in the comparison arm
Reid 2002 No appropriate control group (and not low fat vs modified fat)
Roderick 1997 Weight reducing advice provided
Roman CHD prev 1986 Multifactorial intervention
Rose 1987 No appropriate control group (and not low fat vs modified fat)
Rusu 2013 Energy restricted diet
Sacks 2009 All arms aimed at a 750 kcal/day deficit to ensure weight loss
Salas-Salvado 2014 No assessment of total fat intake
Schectman 1996 Multifactorial intervention
Schlierf 1995 Multifactorial intervention
Singh 1991 Multifactorial intervention
Singh 1992 No appropriate control group (and not low fat vs modified fat)
Siqueira-Catania 2010 Weight loss intended
SLIM 2008 Multifactorial intervention
Sondergaard 2003 Unlikely that either arm was aiming at less than 30%E from fat (Mediterranean vs usual diet)
Sopotsinskaia 1992 The study aimed for weight loss in one arm and not in the comparison arm
Stanford Weight The study aimed for weight loss in one arm and not in the comparison arm
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Steinbach 1996 Multifactorial intervention
Steptoe 2001 No appropriate control group (and not low fat vs modified fat)
Stevens 2002 Diet plus breast self examination vs no intervention
Stevenson 1988 No appropriate control group (and not low fat vs modified fat)
Sweeney 2004 Intervention was not dietary fat modification or low fat diet
TAIM 1989 Intervention was not dietary fat modification or low fat diet
THIS DIET 2008 Study stated "although this was not a weight loss intervention, participants who were overweight
or obese were encouraged to reduce calories to facilitate weight loss".
TOHP I 1992 Multifactorial intervention
TONE 1997 Intervention was not dietary fat modification or low fat diet
Toobert 2003 Multifactorial intervention
Toronto Polyp Prev 1994 No weight or BMI data presented
Tromso Heart 1989 Multifactorial intervention
Troyer 2010 Diet advice the same in both aims for intervention and control
Turku Weight Both intervention groups aimed to lose weight, while the control group did not
UK PDS 1996 No appropriate control group (and not low fat vs modified fat)
Urbach 1952 No appropriate control group (and not low fat vs modified fat)
Uusitupa 1993 Multifactorial intervention
Wassertheil 1985 Intervention was not dietary fat modification or low fat diet
Weintraub 1992 No appropriate control group (and not low fat vs modified fat)
Westman 2006 Intervention was not dietary fat modification or low fat diet
WHO primary prev 1979 Multifactorial intervention
Williams 1990 Intervention was not dietary fat modification or low fat diet
Williams 1992 Intervention was not dietary fat modification or low fat diet
Williams 1994 Intervention was not dietary fat modification or low fat diet
Wilmot 1952 No appropriate control group (and not low fat vs modified fat)
Wing 1998 No appropriate control group (and not low fat vs modified fat)
Wolever 2008 Weight loss intended in some participants
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WOMAN 2007 Lifestyle intervention included exercise and weight as well as diet
Wood 1988 Intervention was not dietary fat modification or low fat diet
Woollard 2003 Multifactorial intervention including smoking, weight, exercise and alcohol components
Working Well 1996 Multifactorial intervention
Young 2010 Weight loss intended
BMI: body mass index
RCT: randomised controlled trial
vs: versus
 
Characteristics of studies awaiting classification [ordered by study ID]
 
Methods RCT
Participants Volunteers aged 25 to 65 years (Spain)
CVD risk: moderate (presumed to be at moderate risk for developing CVD based on medical history,
physical examination and assessing risk of CVD by interview)
Control: NR
Intervention: NR
Mean years in trial: 1.0
% male: 135 men and 26 women (total 161)
Age: between 25 and 65 years
Baseline BMI: not reported
Interventions Skimmed (S; 0.3% fat) vs semi-skimmed (SS; 1.9% fat ) milk
Control aims: 500 mL semi-skimmed milk/d
Intervention aims: 500 mL skimmed milk/d
Control methods: 500 mL/d of semi-skimmed (SS) (1.9% fat), [232.5 kcal energy, 9.5 g fat, 6.69 g
SFAs, 2.58 g MUFAs, 0.21 PUFAs, 15.5 g protein, 23.5 g carbohydrates] in addition to their usual diet.
Intervention methods: 500 mL/d of skimmed (S) milk (0.3% fat), [175 kcal energy, 1.5 g fat, 1.05 g
SFAs, 0.40 g MUFAs, 0.03 PUFAs, 16.00 g protein, 24 g carbohydrates] in addition to their usual diet.
Weight goals: NR
Total fat intake (at 1 year): NR
Saturated fat intake (at 1 year): NR
Style: NR
Setting: community
Outcomes Stated trial outcomes: CVD risk biomarker
Available outcomes: BMI, total, LDL and HDL cholesterol, total cholesterol, triglyceride, SBP, DBP
Date trial is due to complete Not reported; no trials registry entry located
Casas-Agustench 2013 
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Notes Awaiting assessment because: the aims in reducing total fat intake (to < 30%E or not) were unclear
Casas-Agustench 2013  (Continued)
 
 
Methods RCT
Participants Adult Danish population with a minimum of one self-reported risk factor for Ischaemic heart dis-
ease (IHD) (Denmark),
CVD risk: medium
Control: NR
Intervention: NR
Mean years in trial: 1.0
% male: overall 41% male
Age: overall median age of 51 years
Baseline BMI: 73% were overweight or obese
Interventions Unclear
Targeted substitution dietary guidelines or the Danish official dietary guidelines vs habitual diet
Control aims: habitual diet
Intervention aims: either targeted substitution dietary guidelines or the Danish official dietary
guidelines
Control methods: NR
Intervention methods: NR
Weight goals: NR
Total fat intake (at one year): NR
Saturated fat intake (at one year): NR
Style: dietary advice
Setting: community
Outcomes Stated trial outcomes: dietary intake, blood lipids, glycaemic biomarkers, blood pressure, heart
rate, anthropometric measurements
Available outcomes: None
Date trial is due to complete  
Notes Awating assessment as exact fat goals were unclear. Control group advised to follow their habitual
diet with one of two intervention groups receiving either targeted substitution dietary guidelines or
the Danish official dietary guidelines
DIPI 
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Methods A Mediterranean diet for preventing heart failure and atrial fibrillation in hypertensive patients (IC-
FAMED)
RCT, 24 months
Participants People with hypertension aged 55 to 75 years at high cardiovascular risk, but without existing CVD
Interventions MedDiet: Mediterranean-style diet, dietary advice (individual and group) every three months
LFD: Low-fat diet according to American Heart Association guidelines, dietary advice (individual
and group) every three months
Outcomes Primary: heart failure and/or atrial fibrillation
Secondary: echocardiographic variables & BP variables
Actual outcomes from abstracts: MedDiet: 5 CVD events (atrial fibrillation (AF) 2; ischaemic heart
disease (IHD) 2; stroke 1), LFD: 11 CVD events (AF 6, IHD 2, stroke 3). The crude rate for the occur-
rence of events per 1000 patient-months of follow-up was 197 (95% CI: 06 to 46) for MedDiet, 451
(95% CI: 3 to 8.1) for LFD. The HR for patients with MedDiet compared to LFD was 0.44 (95% CI: 0,15
to 1,26, P > 005).
Date trial is due to complete Enrollment began in 2012; appeared to have completed in 2017; abstract and poster publications
only to date
Notes Trials registration: ISRCTN27497769
Awaiting assessment because: Unclear whether one arm was higher in saturated fat than the other;
awaiting fuller publication to assess
ICFAMED 
 
 
Methods RCT
Participants Ninety-four eligible patients who have non-alcoholic fatty liver disease and who are insulin resis-
tant (Australia)
Control: 47 to be randomised to control group
Intervention: 47 to be randomised to intervention
Mean years in trial: 2.0
% male: NR
Age: 18 years and older eligible
Baseline BMI: between 20 and 39.9 kg/m2 eligible
Interventions Mediterranean diet versus a Low Fat Diet (LFD)
Control aims: MedDiet
Intervention aims: Low fat diet (LFD)
Control methods: diet rich in plant based foods including vegetables, whole grains and fruit with
the main added fat being extra virgin olive oil. It emphasises increased legumes and raw unsalted
nut intake and oily fish. Moderate amounts of fermented dairy and poultry with small amounts of
red meat and homemade sweets. Comprised of 44% fat (> 50% monounsaturated), 36% carbohy-
drate and 17–20% protein and up to 5% alcohol
MEDINA 
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Intervention methods: the Australian Guide to Healthy Eating with an emphasis on portions, low fat
options and cooking methods
The LFD group will follow the same structure as the MedDiet arm with three face-to-face consulta-
tions at baseline, 6 weeks (mid-intervention) and 12 weeks (end of intervention). There will also be
the same number of phone call follow-ups at weeks 2, 4 and 9. Participants will be given a super-
market giK voucher to purchase some of the suggested food items. Breakfast is also provided on
the day of all face-to-face appointments (Jalna © and Carmen’s ©).
Weight goals: NR
Total fat intake (6 months): NR
Saturated fat intake (6 months): NR
Style: dietary advice and supermarket giK voucher (for low fat diet group)
Setting: community
Outcomes Stated trial outcomes: Weight, height, waist circumference, hip circumference, neck girth and
blood pressure, dietary intake, intrahepatic lipid, plasma fatty acids and urinary metabolites
Date trial is due to complete Trial started March 2015, final enrolment expected Apr 2017, completion expected Apr 2018
Notes Awaiting assessment because: Meddiet is 44% fat (> 50 % monounsaturated), 36% carbohydrate
and 17–20% protein and up to 5% alcohol; composition of LFD unclear
No results publications located
MEDINA  (Continued)
 
 
Methods RCT
Participants 72 participants with uncontrolled T2D (USA)
CVD risk: NR
Control: NR
Intervention: NR
Mean years in trial: 0.5
% male: 44% overall
Age: mean age overall 59 ± 8 years
Baseline BMI: NR
Interventions Low fat dairy vs full fat dairy or non-fat dairy
Control aims: ≥ 3 daily servings of full fat dairy or ≥ 3 daily servings of non-fat dairy
Intervention aims: ≥ 3 daily servings of low fat dairy
Control methods: dietary advice
Intervention methods: dietary advice
Weight goals: maintain daily caloric intake and body weight
Total fat intake (6 months): NR
Mottalib 2018 
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Saturated fat intake (6 months): sat fat % calories increased by 3.7 ± 0.8% in full fat group (control)
and decreased by 4.4 ± 1.7% in group low fat group (intervention)
Style: dietary advice
Setting: community
Outcomes Stated trial outcomes: HbA1c, lipid profile and blood pressure
Available outcomes: None yet
Date trial is due to complete  
Notes Awaiting assessment as: fat goals of the two arms are unclear (full fat and low/non-fat dairy).
Characteristics taken from a conference poster
Mottalib 2018  (Continued)
 
 
Methods RCT
Participants African-American adults with Type 2 diabetes, 18 years and above (USA)
CVD risk: low
Control: 48 randomised, 27 retained
Intervention: 49 randomised, 38 retained
Mean years in trial: 0.5
% male: control 25%, intervention 22% (total 97)
Age: mean control 55.7 (12.1), range 32-86, intervention 58.9 (10.1), range 40-77
Baseline BMI: mean control 34 (8.3), range 18-57; intervention 35.39 (8.1), range 23-55
Interventions Educational classes (including peer professional groups & supportive family relationships) vs con-
trol (diabetes class)
Low fat diet vs usual care
Control aims: usual care
Intervention aims: low fat diet
Control methods: referral to a local 8-hour traditional diabetes class
Intervention methods: educational classes in low fat dietary strategies, peer professional group
discussions, and follow-up by a nurse case manager
Weight goals: NR
Total fat intake (at 6 months): NR
Saturated fat intake (at 6 months): NR
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: (HbA1C, lipids, BMI) and dietary behaviours
Available outcomes: change in weight, BMI, dietary behaviours, cholesterol and HbA1C
Soul Food Light 
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Date trial is due to complete NR
Notes Awaiting assessment because: fat goals in both arms are unclear
Soul Food Light  (Continued)
AF: atrial fibrillation
BMI: body mass index
BP: blood pressure
CVD: cardiovascular disease
DBP: diastolic blood pressure
HbA1c: Haemoglobin A1C
HDL: high density lipoprotein
ICFAMED: A Mediterranean diet for preventing heart failure and atrial fibrillation in hypertensive patients
IHD: ischaemic heart disease
LDL: low density lipoprotein
LFD: low fat diet
MedDiet: Mediterranean-style diet
MUFA: monounsaturated fatty acids
NR: not reported
PUFA: polyunsaturated fatty acid
RCT: randomised controlled trial
S: skimmed
SBP: systolic blood pressure
SFA: saturated fatty acid
SS: semi-skimmed
T2D: type 2 diabetes
 
Characteristics of ongoing studies [ordered by study ID]
 
Study name PortfolioEx
Methods RCT
Participants 200 participants estimated, 21 years and older, BMI less or equal to 40 kg/m2, measurable arterial
thickening (>/= 1.2 mm) at screening, with at least one of (type 2 diabetes, non-diabetic on statin,
hypercholesterolaemic and treated with statins or have been prescribed statins but are not taking
it because they are either unable (intolerant) or unwilling to take statin drugs, raised blood pres-
sure, > 140/90 (untreated) (Canada)
CVD risk: high
Control: NR
Intervention: NR
Mean years in trial: 3.0
% male: NR
Age: 21 years and older eligible
Baseline BMI: BMI less or equal to 40 kg/m2
Interventions Portfolio diet and structured exercise vs DASH-like diet and structured exercise
Control aims: DASH-like diet and structured exercise
Intervention aims: Portfolio diet and structured exercise
NCT02481466 due 2020 
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Control methods: advice to follow a DASH-like diet of whole grains, and low fat dairy products with
fruits and vegetables and be instructed on the Laval exercise programme—a standardised physical
activity/exercise component supervised by trained kinesiologists (exercise physiologists).
Intervention methods: participants will receive advice on a therapeutic diet appropriate for hyper-
cholesterolaemia (i.e. < 7% of energy from saturated fat, < 200 mg/d cholesterol) PLUS the combi-
nation of viscous fibres, soy protein, plant sterols and nuts, 5% extra monounsaturated fat, and se-
lection of low glycaemic index foods and be instructed on a standardised physical activity/exercise
component supervised by kinesiologists
Weight goals: NR
Total fat intake (1 and 3 years): NR
Saturated fat intake (1 and 3 years): NR
Style: dietary advice
Setting: community
Outcomes Stated trial outcomes: maximum vessel wall volume of the carotid arteries, coronary atheroma in
the large vessels, lipid rich necrotic core, intra-plaque haemorrhage, blood pressure and pulse rate,
serum lipids, blood pressure, diet history, quality of life, etc.
Available outcomes: none yet
Starting date Nov 2016, estimated primary completion date Dec 2020, estimated study completion date Dec 2022
Contact information  
Notes Information based on trial register
NCT02481466 due 2020  (Continued)
 
 
Study name Cardiodiet
Methods RCT
Participants Patients treated for ischaemic heart disease who are followed up at the cardiac rehabilitation units
(Sweden)
CVD risk: high
Control: NR
Intervention: NR
Mean years in trial: 3.0
% male: NR
Age: 18 years and older eligible
Baseline BMI: NR
Interventions Traditional low fat diet vs Mediterranean diet
Control aims: Mediterranean diet with an energy content (E%) from carbohydrates between
25-30%
Intervention aims: traditional low fat diet with 45-60E% from carbohydrates
NCT02938832 due 2023 
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Control methods: Advice on a Mediterranean dietary regimen with reduced carbohydrates
Intervention methods: Advice on traditional low fat diet by dietitian
Weight goals: NR
Total fat intake (3 years): NR
Saturated fat intake (3 years): NR
Style: dietary advice
Setting: community
Outcomes Stated trial outcomes: Hba1c > 48 mmol/mol, CVD incidence, blood lipid levels and quality of life
Available outcomes: None yet
Starting date Oct 2016, estimated primary completion date Oct 2021, estimated study completion date Oct 2023
Contact information  
Notes Information obtained from trial register
NCT02938832 due 2023  (Continued)
 
 
Study name ReDuCtion
Methods RCT
Participants Adult Danish population with established type 2 diabetes for more than six months and less than
five years and HbA1c in compliance with T2D (above 48 mmol/mol), but without need for adjust-
ment of antidiabetic treatment (Denmark)
CVD risk: medium
Control: 45 to be randomised to control group
Intervention: 90 to be randomised to intervention
Mean years in trial: 0.5
% male: NR
Age: 18 years and older eligible
Baseline BMI: NR
Interventions Low carbohydrate diet, high in monounsaturated fats (LCD) vs regular diabetes diet (RDD)
Control aims: regular diabetes diet (RDD)
Intervention aims: Low carbohydrate diet, high in monounsaturated fats (LCD)
Control methods: NR
Intervention methods: NR
Weight goals: NR
Total fat intake (6 months): NR
Saturated fat intake (6 months): NR
NCT03068078 due 2020 
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Style: NR
Setting: community
Outcomes Stated trial outcomes: Measured by HbA1c, serum cholesterol, blood glucose and metabolic mark-
ers, NAFLD activity score, quality of life, gut dysbiosis and diet compliance
Available outcomes: None yet
Starting date Nov 2016, due to complete Dec 2019
Contact information  
Notes Information based on trial register
NCT03068078 due 2020  (Continued)
BMI: body mass index
CVD: cardiovascular disease
DASH: Dietary Approaches to Stop Hypertension
HbA1c: Haemoglobin A1C
LCD: Low carbohydrate diet
NAFLD: non-alcoholic fatty liver disease
NR: not reported
RCT: randomised controlled trial
RDD: regular diabetic diet
T2D: type 2 diabetes
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Lower fat vs higher fat diet
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1.1 Weight, kg 26 53875 Mean Difference (IV, Random, 95% CI) -1.42 [-1.73, -1.10]
1.2 BMI, kg/m2 14 46539 Mean Difference (IV, Random, 95% CI) -0.47 [-0.64, -0.30]
1.3 Waist circumference, cm 3 16620 Mean Difference (IV, Random, 95% CI) -0.47 [-0.73, -0.22]
1.4 Body fat, % 2 2350 Mean Difference (IV, Random, 95% CI) -0.28 [-0.57, 0.00]
1.5 Total cholesterol, mmol/L 22 9812 Mean Difference (IV, Random, 95% CI) -0.23 [-0.32, -0.14]
1.6 LDL cholesterol, mmol/L 19 8137 Mean Difference (IV, Random, 95% CI) -0.13 [-0.21, -0.05]
1.7 HDL cholesterol, mmol/L 20 8268 Mean Difference (IV, Random, 95% CI) -0.02 [-0.03, 0.00]
1.8 Triglycerides, mmol/L 18 8672 Mean Difference (IV, Random, 95% CI) 0.01 [-0.05, 0.07]
1.9 Total cholesterol/HDL 5 3639 Mean Difference (IV, Random, 95% CI) -0.05 [-0.14, 0.04]
1.10 Systolic blood pressure,
mmHg
10 6078 Mean Difference (IV, Random, 95% CI) -0.75 [-1.42, -0.07]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1.11 Diastolic blood pressure,
mmHg
10 6077 Mean Difference (IV, Random, 95% CI) -0.52 [-0.95, -0.09]
1.12 Quality of life 1 40130 Mean Difference (IV, Random, 95% CI) 0.04 [0.01, 0.07]
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Analysis 1.1.   Comparison 1: Lower fat vs higher fat diet, Outcome 1: Weight, kg
Study or Subgroup
Anderson 1990
BDIT Pilot Studies 1996
BRIDGES 2001
Bloemberg 1991
CORDIOPREV 2016 (1)
CORDIOPREV 2016 (2)
CORDIOPREV 2016 (3)
Canadian DBCP 1997
DEER 1998 (4)
DEER 1998 (5)
DEER 1998 (6)
DEER 1998 (7)
De Bont 1981 (8)
De Bont 1981 (9)
MSFAT 1995
Ma 2016
Nordevang 1990
Nutrition & Breast Health
ODMDC 2017
Pilkington 1960
Polyp Prevention 1996
RISCK 2010 (10)
RISCK 2010 (11)
Simon 1997
Strychar 2009
Swinburn 2001
WHEL 2007
WHI 2006 (12)
WHT Full-scale
WHT Vanguard 1991
WHTFSMP 2003
WINS 1993
Yadav 2016 (13)
Total (95% CI)
Heterogeneity: Tau² = 0.39; Chi² = 128.06, df = 32 (P < 0.00001); I² = 75%
Test for overall effect: Z = 8.78 (P < 0.00001)
Test for subgroup differences: Not applicable
Reduced fat
Mean
1.06
59.6
0.1
-0.94
-0.18
-1.27
-1.34
62
-3.1
-4.2
-2.8
-2.7
-0.4
-2.7
0.4
-1.2
-0.4
67.3
-1.6
66.7
-0.65
-0.8734
-0.8877
63.4
-0.83
-1.6
74.1
-0.8
-1.9
-1.91
-1.8
-2.7
-7.4
SD
2.49
7.3
4.85
2.68
5.4225
7.1294
6.3357
9.1
3.7
4.2
3.5
3.5
2.8
3.6
2.36
4.7476
5.5
13.8
1.0131
5.9
5.22
2.6017
2.1451
11.1
3
5.4
19.53
10.1
4.2
4.9
4
15.3
7.9
Total
47
76
48
39
30
88
98
388
43
48
49
46
36
34
117
46
63
47
101
12
943
117
111
34
15
48
1308
16297
176
159
1325
386
22
22397
Usual or modified fat
Mean
0.44
60.4
0.5
0.06
2.21
0.61
0.47
63.5
-0.4
-0.6
0.5
0.8
0.1
-0.9
1.12
-1.1
1.3
66.4
-1.0019
70.8
0.31
0.1674
-0.0402
71.9
1.6
2.13
73.7
-0.1
-0.2
-0.08
-0.3
0
0.7
SD
2.68
8.4
4.07
1.86
6.0576
7.8652
11.7962
9.4
2.5
3.1
2.7
4.2
2
3.5
2.36
4.6433
5.5
12
1.0262
5.2
5.22
1.8124
0.213
11.7
1.8
5
19.2
10.1
3.7
4.3
4.2
15.3
5.4
Total
51
78
46
40
39
92
115
401
43
47
46
45
29
35
103
44
106
50
206
23
943
115
110
38
15
51
1313
25056
188
102
883
998
27
31478
Weight
3.9%
1.3%
2.1%
3.9%
1.1%
1.6%
1.3%
3.1%
3.0%
2.7%
3.2%
2.5%
3.5%
2.3%
5.3%
1.9%
2.2%
0.4%
6.4%
0.6%
5.8%
5.4%
6.0%
0.3%
2.2%
1.7%
2.7%
6.5%
4.6%
3.6%
6.1%
2.1%
0.6%
100.0%
Mean Difference
IV, Random, 95% CI
0.62 [-0.40 , 1.64]
-0.80 [-3.28 , 1.68]
-0.40 [-2.21 , 1.41]
-1.00 [-2.02 , 0.02]
-2.39 [-5.11 , 0.33]
-1.88 [-4.07 , 0.31]
-1.81 [-4.30 , 0.68]
-1.50 [-2.79 , -0.21]
-2.70 [-4.03 , -1.37]
-3.60 [-5.08 , -2.12]
-3.30 [-4.55 , -2.05]
-3.50 [-5.09 , -1.91]
-0.50 [-1.67 , 0.67]
-1.80 [-3.48 , -0.12]
-0.72 [-1.34 , -0.10]
-0.10 [-2.04 , 1.84]
-1.70 [-3.41 , 0.01]
0.90 [-4.26 , 6.06]
-0.60 [-0.84 , -0.36]
-4.10 [-8.06 , -0.14]
-0.96 [-1.43 , -0.49]
-1.04 [-1.62 , -0.46]
-0.85 [-1.25 , -0.45]
-8.50 [-13.77 , -3.23]
-2.43 [-4.20 , -0.66]
-3.73 [-5.78 , -1.68]
0.40 [-1.08 , 1.88]
-0.70 [-0.90 , -0.50]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-2.70 [-4.50 , -0.90]
-8.10 [-11.98 , -4.22]
-1.42 [-1.73 , -1.10]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) Non-preDM, change to 5 years
(2) preDM by HbA1c, change to 5 years
(3) preDM by IFT/IGT, change to 5 years
(4) Women with exercise
(5) Men with exercise
(6) Men, no exercise
(7) Women, no exercise
(8) non-obese participants (BMI < 28)
(9) obese participants (BMI 28+)
(10) Low GI arms, Calculated from % change based on median baseline
(11) High GI arms; Calculated from % change based on median baseline
(12) Change from baseline to 7.5 years
(13) Data for 22 of 26 intervention participants who were compliant with diet
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Analysis 1.2.   Comparison 1: Lower fat vs higher fat diet, Outcome 2: BMI, kg/m2
Study or Subgroup
BDIT Pilot Studies 1996
CORDIOPREV 2016 (1)
CORDIOPREV 2016 (2)
CORDIOPREV 2016 (3)
CORDIOPREV 2016 (4)
Diet and Hormone Study 2003
Ma 2016
Moy 2001
Sarkkinen Low & Mod 1993
Sarkkinen Low Fat 1993
Simon 1997
Strychar 2009
WHEL 2007 (5)
WHI 2006 (6)
WHTFSMP 2003
WINS 1993
Yadav 2016
Total (95% CI)
Heterogeneity: Tau² = 0.04; Chi² = 40.18, df = 16 (P = 0.0007); I² = 60%
Test for overall effect: Z = 5.34 (P < 0.00001)
Test for subgroup differences: Not applicable
Reduced fat
Mean
24.3
-0.64
-0.61
-0.51
-0.33
23.5
-0.5
-0.1
26
26.2
23.8
-0.24
0.71
0.03
-0.7
26.8
-2.16
SD
3.8
1.9
1.74
0.82
1.19
4.4
1.3565
1
4
3.2
4.7
1
1.96
3.2
1.2
5.608
6.1
Total
76
156
57
47
55
81
46
117
41
40
34
15
21
16230
1094
755
26
18891
Usual or modified fat
Mean
24.3
-0.35
-0.19
0.15
0.29
23.7
-0.4
0.21
26.3
25.7
27.4
0.56
1.26
0.3
-0.1
27.6
-0.22
SD
3.6
1.5
2.09
1.15
2.76
3.5
1.3266
2
3.6
4.2
4.9
0.6
3.02
3.1
1.4
5.368
5.2
Total
81
166
52
59
50
96
44
118
41
12
38
15
30
24943
646
1230
27
27648
Weight
2.0%
10.0%
4.3%
10.0%
3.5%
1.9%
6.4%
9.3%
1.0%
0.4%
0.6%
5.9%
1.5%
18.6%
17.2%
7.3%
0.3%
100.0%
Mean Difference
IV, Random, 95% CI
0.00 [-1.16 , 1.16]
-0.29 [-0.67 , 0.09]
-0.42 [-1.15 , 0.31]
-0.66 [-1.04 , -0.28]
-0.62 [-1.45 , 0.21]
-0.20 [-1.39 , 0.99]
-0.10 [-0.65 , 0.45]
-0.31 [-0.71 , 0.09]
-0.30 [-1.95 , 1.35]
0.50 [-2.07 , 3.07]
-3.60 [-5.82 , -1.38]
-0.80 [-1.39 , -0.21]
-0.55 [-1.92 , 0.82]
-0.27 [-0.33 , -0.21]
-0.60 [-0.73 , -0.47]
-0.80 [-1.30 , -0.30]
-1.94 [-5.00 , 1.12]
-0.47 [-0.64 , -0.30]
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours reduced fat Favours moderate fat
Footnotes
(1) No insulin resistance, change to 2 years (SDs assumed to be SEs)
(2) Liver insulin resistance, change to 2 years (SDs assumed to be SEs)
(3) Muscle insulin resistance, change to 2 years (SDs assumed to be SEs)
(4) Muscle & liver insulin resistance, change to 2 years (SDs assumed to be SEs)
(5) Change in BMI in a subgroup of participants at 4 years
(6) Change from baseline to 7.5 years
 
 
Analysis 1.3.   Comparison 1: Lower fat vs higher fat diet, Outcome 3: Waist circumference, cm
Study or Subgroup
CORDIOPREV 2016 (1)
CORDIOPREV 2016 (2)
CORDIOPREV 2016 (3)
CORDIOPREV 2016 (4)
ODMDC 2017
WHI 2006 (5)
Total (95% CI)
Heterogeneity: Tau² = 0.02; Chi² = 6.31, df = 5 (P = 0.28); I² = 21%
Test for overall effect: Z = 3.69 (P = 0.0002)
Test for subgroup differences: Not applicable
Reduced fat
Mean
-2.2
-1.5
-1.9
-0.9
-1.1
1.6
SD
8.74
4.11
4.15
4.82
1.0131
8.6
Total
156
47
57
55
101
6154
6570
Usual or modified fat
Mean
-1.4
-1.7
-2.2
0.6
-0.4529
1.9
SD
7.73
4.61
3.97
6.08
0.8116
8.8
Total
166
59
52
50
206
9517
10050
Weight
1.9%
2.2%
2.6%
1.4%
50.2%
41.6%
100.0%
Mean Difference
IV, Random, 95% CI
-0.80 [-2.61 , 1.01]
0.20 [-1.46 , 1.86]
0.30 [-1.22 , 1.82]
-1.50 [-3.61 , 0.61]
-0.65 [-0.87 , -0.42]
-0.30 [-0.58 , -0.02]
-0.47 [-0.73 , -0.22]
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours reduced fat Favours moderate fat
Footnotes
(1) No insulin resistance, change to 2 years (SDs assumed to be SEs)
(2) Muscle insulin resistance, change to 2 years (SDs assumed to be SEs)
(3) Liver insulin resistance, change to 2 years (SDs assumed to be SEs)
(4) Liver & muscle insulin resistance, change to 2 years (SDs assumed to be SEs)
(5) Change from baseline to 7.5 years
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Analysis 1.4.   Comparison 1: Lower fat vs higher fat diet, Outcome 4: Body fat, %
Study or Subgroup
WHEL 2007 (1)
WHI 2006 (2)
Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.51, df = 1 (P = 0.48); I² = 0%
Test for overall effect: Z = 1.93 (P = 0.05)
Test for subgroup differences: Not applicable
Reduced fat
Mean
1.04
0.4
SD
4.99
3.46
Total
21
905
926
Usual or modified fat
Mean
2.27
0.67
SD
4.19
3.38
Total
29
1395
1424
Weight
1.2%
98.8%
100.0%
Mean Difference
IV, Random, 95% CI
-1.23 [-3.85 , 1.39]
-0.27 [-0.56 , 0.02]
-0.28 [-0.57 , 0.00]
Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Favours lower fat Favours higher fat
Footnotes
(1) Change in percentage of body fat in a subgroup of 52 participants at 4 years
(2) Change in % body fat from baseline at 6 years, Carty 2011
 
 
Analysis 1.5.   Comparison 1: Lower fat vs higher fat diet, Outcome 5: Total cholesterol, mmol/L
Study or Subgroup
Anderson 1990
BDIT Pilot Studies 1996
Bloemberg 1991
CORDIOPREV 2016 (1)
CORDIOPREV 2016 (2)
DEER 1998 (3)
DEER 1998 (4)
DEER 1998 (5)
DEER 1998 (6)
De Bont 1981
MSFAT 1995
Ma 2016
ODMDC 2017
Pilkington 1960
Polyp Prevention 1996
RISCK 2010 (7)
RISCK 2010 (8)
Rivellese 1994
Sarkkinen Low & Mod 1993
Sarkkinen Low Fat 1993
Simon 1997
Strychar 2009
Swinburn 2001
WHEL 2007
WHI 2006
WHT Vanguard 1991
Yadav 2016 (9)
Total (95% CI)
Heterogeneity: Tau² = 0.03; Chi² = 93.70, df = 26 (P < 0.00001); I² = 72%
Test for overall effect: Z = 5.05 (P < 0.00001)
Test for subgroup differences: Not applicable
Reduced fat
Mean
-0.59
5.14
-0.32
3.34
3.98
-0.45
-0.34
-0.2
-0.53
-0.9
5.61
-0.23
-0.2
5.66
-0.13
-0.3685
-0.3135
6.78
6.24
6.35
4.87
-0.12
-0.2
5.07
-0.264
5.53
-0.28
SD
0.62
0.84
0.85
0.7892
0.8367
0.55
0.5
0.53
0.52
1.09
1.08
1.0852
0.4052
0.88
0.77
4.4258
2.6704
0.78
1.06
1.18
0.87
0.66
0.79
11.902
0.828
0.96
0.74
Total
47
54
39
173
280
43
49
46
48
70
117
46
101
12
370
120
112
27
41
40
34
15
51
1308
1133
202
26
4604
Usual or modified fat
Mean
-0.42
5.38
-0.02
4.16
4.14
0.15
-0.1
-0.03
-0.13
-0.28
5.75
-0.08
0.0192
5.43
-0.07
-0.392
-0.2223
6.63
6.51
6.51
5.21
-0.24
-0.15
4.99
-0.178
5.63
-0.04
SD
0.57
0.81
0.79
0.8602
0.8559
0.59
0.56
0.5
0.53
0.99
1.01
1.0613
0.4354
0.85
0.77
4.253
3.1603
0.58
1.07
1.07
0.18
0.66
1.3
11.924
0.825
1.03
0.74
Total
51
61
40
151
293
43
46
45
47
65
103
44
206
23
374
111
109
17
12
12
38
15
52
1313
1699
211
27
5208
Weight
4.7%
3.9%
3.2%
5.5%
6.1%
4.7%
5.0%
5.1%
5.1%
3.4%
4.2%
2.5%
6.5%
1.6%
6.4%
0.6%
1.1%
2.9%
1.3%
1.3%
3.9%
2.3%
2.8%
0.8%
6.9%
5.3%
2.9%
100.0%
Mean Difference
IV, Random, 95% CI
-0.17 [-0.41 , 0.07]
-0.24 [-0.54 , 0.06]
-0.30 [-0.66 , 0.06]
-0.82 [-1.00 , -0.64]
-0.16 [-0.30 , -0.02]
-0.60 [-0.84 , -0.36]
-0.24 [-0.45 , -0.03]
-0.17 [-0.38 , 0.04]
-0.40 [-0.61 , -0.19]
-0.62 [-0.97 , -0.27]
-0.14 [-0.42 , 0.14]
-0.15 [-0.59 , 0.29]
-0.22 [-0.32 , -0.12]
0.23 [-0.38 , 0.84]
-0.06 [-0.17 , 0.05]
0.02 [-1.10 , 1.14]
-0.09 [-0.86 , 0.68]
0.15 [-0.25 , 0.55]
-0.27 [-0.96 , 0.42]
-0.16 [-0.87 , 0.55]
-0.34 [-0.64 , -0.04]
0.12 [-0.35 , 0.59]
-0.05 [-0.46 , 0.36]
0.08 [-0.83 , 0.99]
-0.09 [-0.15 , -0.02]
-0.10 [-0.29 , 0.09]
-0.24 [-0.64 , 0.16]
-0.23 [-0.32 , -0.14]
Mean Difference
IV, Random, 95% CI
-0.5 -0.25 0 0.25 0.5
Favours reduced fat Favours moderate fat
Footnotes
(1) rs4580704 SNP C/C data at 12 months
(2) rs4580704 SNP G/G & C/G data at 12 months
(3) Women with exercise
(4) Men, no exercise
(5) Women, no exercise
(6) Men with exercise
(7) 1. Low GI arms, Calculated from % change based on median baseline
(8) 1. High GI arms; Calculated from % change based on median baseline
(9) Data for all completers, but no SDs provided, so SDs used from compliant only participants
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Analysis 1.6.   Comparison 1: Lower fat vs higher fat diet, Outcome 6: LDL cholesterol, mmol/L
Study or Subgroup
AUSMED 2018 (1)
Anderson 1990
DEER 1998 (2)
DEER 1998 (3)
DEER 1998 (4)
DEER 1998 (5)
MSFAT 1995
Ma 2016
Moy 2001
ODMDC 2017
Pilkington 1960
RISCK 2010 (6)
RISCK 2010 (7)
Rivellese 1994
Sarkkinen Low & Mod 1993
Sarkkinen Low Fat 1993
Simon 1997
Strychar 2009
Swinburn 2001
WHEL 2007
WHI 2006
Yadav 2016 (8)
beFIT 1997
Total (95% CI)
Heterogeneity: Tau² = 0.01; Chi² = 49.31, df = 21 (P = 0.0005); I² = 57%
Test for overall effect: Z = 3.30 (P = 0.0010)
Test for subgroup differences: Not applicable
Reduced fat
Mean
0.22
-0.56
-0.52
-0.3
-0.37
-0.19
3.68
-0.15
-0.69
-0.17
1.76
-0.245
-0.252
4.82
4.21
4.26
2.79
-0.25
-0.32
2.92
-0.251
-0.24
4.2
SD
0
0.55
0.45
0.49
0.57
0.49
0.97
0.9495
1.1
0.3546
0.39
16.5968
13.1595
0.94
0.89
1.03
0.82
0.7
0.64
11.902
0.758
0.58
0.94
Total
31
47
48
49
43
46
117
46
117
101
12
120
112
27
41
40
34
15
51
1308
1133
26
217
3781
Usual or modified fat
Mean
0.03
-0.4
-0.09
-0.12
-0.14
-0.06
3.79
-0.15
-0.4
-0.0406
1.16
-0.2808
-0.1872
4.85
4.36
4.36
3.09
-0.21
-0.16
2.95
-0.16
-0.02
4.42
SD
0
0.43
0.49
0.55
0.5
0.43
0.81
0.9287
0.8
0.3354
0.29
13.7577
14.7205
0.87
0.97
0.97
0.99
0.57
1.15
11.277
0.753
0.64
0.88
Total
34
51
47
46
43
45
103
44
118
206
23
112
108
17
12
12
37
15
52
1313
1699
27
192
4356
Weight
6.8%
7.0%
6.4%
6.0%
7.0%
5.8%
3.1%
5.5%
10.4%
5.4%
0.0%
0.0%
1.8%
1.5%
1.4%
2.7%
2.4%
3.4%
0.7%
11.1%
3.9%
7.4%
100.0%
Mean Difference
IV, Random, 95% CI
Not estimable
-0.16 [-0.36 , 0.04]
-0.43 [-0.62 , -0.24]
-0.18 [-0.39 , 0.03]
-0.23 [-0.46 , -0.00]
-0.13 [-0.32 , 0.06]
-0.11 [-0.35 , 0.13]
0.00 [-0.39 , 0.39]
-0.29 [-0.54 , -0.04]
-0.13 [-0.21 , -0.05]
0.60 [0.35 , 0.85]
0.04 [-3.88 , 3.95]
-0.06 [-3.76 , 3.63]
-0.03 [-0.57 , 0.51]
-0.15 [-0.76 , 0.46]
-0.10 [-0.73 , 0.53]
-0.30 [-0.72 , 0.12]
-0.04 [-0.50 , 0.42]
-0.16 [-0.52 , 0.20]
-0.03 [-0.92 , 0.86]
-0.09 [-0.15 , -0.03]
-0.22 [-0.55 , 0.11]
-0.22 [-0.40 , -0.04]
-0.13 [-0.21 , -0.05]
Mean Difference
IV, Random, 95% CI
-0.5 -0.25 0 0.25 0.5
Favours reduced fat Favours moderate fat
Footnotes
(1) Change data reported as data were too different at baseline to use end data, however no variance for change was presented
(2) Men with exercise
(3) Men, no exercise
(4) Women with exercise
(5) Women, no exercise
(6) 1. Low GI arms, Calculated from % change based on median baseline
(7) 1. High GI arms; Calculated from % change based on median baseline
(8) Data for all completers, but no SDs provided, so SDs used from compliant only participants
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Analysis 1.7.   Comparison 1: Lower fat vs higher fat diet, Outcome 7: HDL cholesterol, mmol/L
Study or Subgroup
AUSMED 2018
Anderson 1990
BDIT Pilot Studies 1996
Bloemberg 1991
CORDIOPREV 2016 (1)
DEER 1998 (2)
DEER 1998 (3)
DEER 1998 (4)
DEER 1998 (5)
De Bont 1981
MSFAT 1995
Ma 2016
Moy 2001
ODMDC 2017
RISCK 2010 (6)
RISCK 2010 (7)
Rivellese 1994
Sarkkinen Low & Mod 1993
Sarkkinen Low Fat 1993
Simon 1997
Strychar 2009
Swinburn 2001
WHEL 2007
WHI 2006
Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 29.94, df = 23 (P = 0.15); I² = 23%
Test for overall effect: Z = 1.61 (P = 0.11)
Test for subgroup differences: Not applicable
Reduced fat
Mean
1.24
0.01
1.62
-0.02
1.13
0.01
-0.03
0.01
-0.02
-0.09
1.34
0.01
0.044
-0.07
-0.0767
-0.0936
1.22
1.43
1.38
1.44
0.06
0.01
1.45
-0.018
SD
0.2784
0.14
0.41
0.2
0.2631
0.16
0.17
0.14
0.11
0.4
0.32
0.2713
0.3
0.2026
10.7573
9.0911
0.31
0.28
0.34
0.58
0.27
0.14
4.705
0.243
Total
31
47
53
39
173
46
43
48
49
70
117
46
117
101
108
104
27
41
40
34
15
51
1308
1133
3841
Usual or modified fat
Mean
1.25
0.01
1.56
0.01
1.11
0.03
0.06
0.03
-0.01
-0.19
1.4
-0.05
0.008
0.0147
-0.0351
-0.0559
1.12
1.53
1.53
1.56
-0.01
0.06
1.53
-0.008
SD
0.2915
0.14
0.38
0.16
0.2458
0.17
0.17
0.11
0.11
0.43
0.41
0.2653
0.2
0.1803
10.0488
12.5614
0.16
0.39
0.39
0.55
0.22
0.36
4.345
0.264
Total
34
51
57
40
151
45
43
47
46
65
103
44
118
206
107
112
17
12
12
38
15
52
1313
1699
4427
Weight
1.6%
7.5%
1.5%
4.3%
7.5%
5.6%
5.1%
8.5%
9.9%
1.6%
3.1%
2.5%
5.9%
9.4%
0.0%
0.0%
1.6%
0.6%
0.6%
0.5%
1.0%
2.7%
0.3%
18.7%
100.0%
Mean Difference
IV, Random, 95% CI
-0.01 [-0.15 , 0.13]
0.00 [-0.06 , 0.06]
0.06 [-0.09 , 0.21]
-0.03 [-0.11 , 0.05]
0.02 [-0.04 , 0.08]
-0.02 [-0.09 , 0.05]
-0.09 [-0.16 , -0.02]
-0.02 [-0.07 , 0.03]
-0.01 [-0.05 , 0.03]
0.10 [-0.04 , 0.24]
-0.06 [-0.16 , 0.04]
0.06 [-0.05 , 0.17]
0.04 [-0.03 , 0.10]
-0.08 [-0.13 , -0.04]
-0.04 [-2.82 , 2.74]
-0.04 [-2.95 , 2.87]
0.10 [-0.04 , 0.24]
-0.10 [-0.34 , 0.14]
-0.15 [-0.39 , 0.09]
-0.12 [-0.38 , 0.14]
0.07 [-0.11 , 0.25]
-0.05 [-0.16 , 0.06]
-0.08 [-0.43 , 0.27]
-0.01 [-0.03 , 0.01]
-0.02 [-0.03 , 0.00]
Mean Difference
IV, Random, 95% CI
-0.2 -0.1 0 0.1 0.2
Favours moderate fat Favours reduced fat
Footnotes
(1) rs4580704 SNP C/C data at 12 months
(2) Women, no exercise
(3) Women with exercise
(4) Men with exercise
(5) Men, no exercise
(6) 1. High GI arms; Calculated from % change based on median baseline
(7) 1. Low GI arms, Calculated from % change based on median baseline
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Analysis 1.8.   Comparison 1: Lower fat vs higher fat diet, Outcome 8: Triglycerides, mmol/L
Study or Subgroup
AUSMED 2018 (1)
Anderson 1990
CORDIOPREV 2016 (2)
CORDIOPREV 2016 (3)
DEER 1998 (4)
DEER 1998 (5)
DEER 1998 (6)
DEER 1998 (7)
De Bont 1981
MSFAT 1995
Ma 2016
Moy 2001
ODMDC 2017
RISCK 2010 (8)
RISCK 2010 (9)
Rivellese 1994
Sarkkinen Low & Mod 1993
Sarkkinen Low Fat 1993
Simon 1997
Strychar 2009
Swinburn 2001
WHEL 2007
WHI 2006
Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 42.17, df = 21 (P = 0.004); I² = 50%
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Not applicable
Reduced fat
Mean
-0.05
-1.05
1.4
1.37
-0.08
-0.07
-0.12
-0.05
-0.03
1.3
0.03
-0.4
0.13
0.0042
0.0348
1.5
1.24
1.44
1.35
0.14
0.37
1.17
0.011
SD
0
1.99
0.6576
0.6693
0.62
0.67
0.56
0.73
0.83
0.76
0.7461
2
0.2533
30.9187
32.94
0.68
0.6
0.79
1.05
0.46
0.71
7.842
0.005
Total
31
47
173
280
48
49
43
46
70
117
46
117
101
121
113
27
41
40
34
15
51
1308
1133
4051
Usual or modified fat
Mean
0.03
1.06
1.32
1.43
-0.15
0.1
-0.14
0.02
-0.11
1.24
0.1
-0.06
0.0651
-0.072
0.021
1.57
1.38
1.38
1.25
-0.03
0.12
1.02
0.011
SD
0
2.03
0.6144
0.6847
0.57
0.94
0.51
0.48
0.6
0.61
0.7297
1.9
0.2322
32.0151
28.3086
0.7
0.84
0.84
0.61
0.22
1.59
9.983
0.003
Total
34
51
151
293
47
46
43
45
65
103
44
118
206
108
110
17
12
12
37
15
52
1313
1699
4621
Weight
0.5%
9.2%
11.3%
4.5%
2.7%
4.9%
4.2%
4.4%
6.7%
3.1%
1.3%
16.0%
0.0%
0.0%
1.8%
1.2%
1.1%
1.9%
4.0%
1.4%
0.7%
19.0%
100.0%
Mean Difference
IV, Random, 95% CI
Not estimable
-2.11 [-2.91 , -1.31]
0.08 [-0.06 , 0.22]
-0.06 [-0.17 , 0.05]
0.07 [-0.17 , 0.31]
-0.17 [-0.50 , 0.16]
0.02 [-0.21 , 0.25]
-0.07 [-0.32 , 0.18]
0.08 [-0.16 , 0.32]
0.06 [-0.12 , 0.24]
-0.07 [-0.37 , 0.23]
-0.34 [-0.84 , 0.16]
0.06 [0.01 , 0.12]
0.08 [-8.10 , 8.25]
0.01 [-8.04 , 8.07]
-0.07 [-0.49 , 0.35]
-0.14 [-0.65 , 0.37]
0.06 [-0.47 , 0.59]
0.10 [-0.30 , 0.50]
0.17 [-0.09 , 0.43]
0.25 [-0.22 , 0.72]
0.15 [-0.54 , 0.84]
0.00 [-0.00 , 0.00]
0.01 [-0.05 , 0.07]
Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Favours reduced fat Favours moderate fat
Footnotes
(1) Change data reported as data were too different at baseline to use end data, however no variance for change was presente
(2) rs4580704 SNP C/C data at 12 months
(3) rs4580704 SNP C/G & G/G data at 12 months
(4) Men with exercise
(5) Men, no exercise
(6) Women with exercise
(7) Women, no exercise
(8) 1. High GI arms; Calculated from % change based on median baseline
(9) 1. Low GI arms, Calculated from % change based on median baseline
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Analysis 1.9.   Comparison 1: Lower fat vs higher fat diet, Outcome 9: Total cholesterol/HDL
Study or Subgroup
DEER 1998 (1)
DEER 1998 (2)
DEER 1998 (3)
DEER 1998 (4)
ODMDC 2017
Strychar 2009
Swinburn 2001
WHI 2006
Total (95% CI)
Heterogeneity: Tau² = 0.01; Chi² = 12.46, df = 7 (P = 0.09); I² = 44%
Test for overall effect: Z = 1.01 (P = 0.31)
Test for subgroup differences: Not applicable
Reduced fat
Mean
-0.2
-0.2
-0.6
-0.2
0.04
-0.22
-0.34
-0.2
SD
0.7
0.9
0.9
0.8
0.3039
0.55
1
0.8
Total
46
49
48
43
101
15
51
1133
1486
Usual or modified fat
Mean
0
-0.1
-0.3
-0.4
0.0053
-0.13
-0.53
-0.1
SD
0.7
1
1
0.8
0.358
0.37
1.73
1
Total
45
46
47
43
206
15
52
1699
2153
Weight
8.3%
5.1%
5.1%
6.4%
32.0%
6.4%
2.7%
33.9%
100.0%
Mean Difference
IV, Random, 95% CI
-0.20 [-0.49 , 0.09]
-0.10 [-0.48 , 0.28]
-0.30 [-0.68 , 0.08]
0.20 [-0.14 , 0.54]
0.03 [-0.04 , 0.11]
-0.09 [-0.43 , 0.25]
0.19 [-0.35 , 0.73]
-0.10 [-0.17 , -0.03]
-0.05 [-0.14 , 0.04]
Mean Difference
IV, Random, 95% CI
-0.5 -0.25 0 0.25 0.5
Favours reduced fat Favours moderate fat
Footnotes
(1) Women, no exercise
(2) Men, no exercise
(3) Men with exercise
(4) Women with exercise
 
 
Analysis 1.10.   Comparison 1: Lower fat vs higher fat diet, Outcome 10: Systolic blood pressure, mmHg
Study or Subgroup
AUSMED 2018 (1)
DEER 1998 (2)
DEER 1998 (3)
DEER 1998 (4)
DEER 1998 (5)
Ma 2016
ODMDC 2017
RISCK 2010 (6)
RISCK 2010 (7)
Sarkkinen Low & Mod 1993
Strychar 2009
Swinburn 2001
WHI 2006
WHTFSMP 2003
Total (95% CI)
Heterogeneity: Tau² = 0.13; Chi² = 13.13, df = 12 (P = 0.36); I² = 9%
Test for overall effect: Z = 2.16 (P = 0.03)
Test for subgroup differences: Not applicable
Reduced fat
Mean
-1.1
-1.7
-3.5
-3.1
-3
-5.5
-2.6
-1.921
-2.21
-2.59
3.9
-3.5
-2.2
-3.1
SD
0
6.4
9.2
8.4
6.8
11.53
5.0655
7.8812
9.9581
11.19
14.4
17.71
16.3
14.5
Total
31
49
46
43
48
46
101
120
113
41
15
51
1133
1101
2938
Usual or modified fat
Mean
-1.4
0.3
-2.4
-1.1
-0.6
-3.6
-2.2464
-3.25
-2.52
2.49
-0.2
1.31
-2.1
-1.4
SD
0
7.9
7.6
8.9
7.3
10.6132
5.3579
9.8956
9.0937
15.8
21.1
24.37
16.4
14.7
Total
34
46
45
43
47
44
207
113
110
37
15
52
1699
648
3140
Weight
5.1%
3.7%
3.3%
5.4%
2.1%
22.7%
7.9%
6.8%
1.2%
0.3%
0.7%
22.7%
18.2%
100.0%
Mean Difference
IV, Random, 95% CI
Not estimable
-2.00 [-4.90 , 0.90]
-1.10 [-4.56 , 2.36]
-2.00 [-5.66 , 1.66]
-2.40 [-5.24 , 0.44]
-1.90 [-6.48 , 2.68]
-0.35 [-1.58 , 0.87]
1.33 [-0.98 , 3.63]
0.31 [-2.19 , 2.81]
-5.08 [-11.22 , 1.06]
4.10 [-8.83 , 17.03]
-4.81 [-13.03 , 3.41]
-0.10 [-1.33 , 1.13]
-1.70 [-3.12 , -0.28]
-0.75 [-1.42 , -0.07]
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours reduced fat Favours moderate fat
Footnotes
(1) Change data reported as data were too different at baseline to use end data, however no variance for change was presented
(2) Men, no exercise
(3) Women, no exercise
(4) Women with exercise
(5) Men with exercise
(6) 1. High GI arms; Calculated from % change based on median baseline
(7) 1. Low GI arms, Calculated from % change based on median baseline
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Analysis 1.11.   Comparison 1: Lower fat vs higher fat diet, Outcome 11: Diastolic blood pressure, mmHg
Study or Subgroup
AUSMED 2018 (1)
DEER 1998 (2)
DEER 1998 (3)
DEER 1998 (4)
DEER 1998 (5)
Ma 2016
ODMDC 2017
RISCK 2010 (6)
RISCK 2010 (7)
Sarkkinen Low & Mod 1993
Strychar 2009
Swinburn 2001
WHI 2006
WHTFSMP 2003
Total (95% CI)
Heterogeneity: Tau² = 0.05; Chi² = 12.96, df = 12 (P = 0.37); I² = 7%
Test for overall effect: Z = 2.38 (P = 0.02)
Test for subgroup differences: Not applicable
Reduced fat
Mean
-0.3
-1.9
-3
-0.3
-2.7
-1.5
-1.3
-1.215
-1.3515
-0.93
4.7
-7.16
-2.6
-1.06
SD
0
5
6.6
5.2
4.6
7.4606
3.0393
6.9531
9.9581
7.13
11
12
9.4
7.4
Total
31
46
48
49
43
46
101
113
120
41
15
51
1133
1101
2938
Usual or modified fat
Mean
-0.4
-0.6
-1.1
1.8
-1.4
0.7
-1.049
-1.744
-0.711
1.38
-2.6
-4.2
-2.3
-0.64
SD
0
5.9
7.1
6.1
5.9
7.2966
3.3021
9.7599
10.4444
10
8.9
13.85
9.4
7.7
Total
34
45
47
46
43
44
206
109
114
37
15
52
1699
648
3139
Weight
3.5%
2.3%
3.4%
3.5%
1.9%
24.9%
3.5%
2.6%
1.2%
0.4%
0.7%
26.9%
25.3%
100.0%
Mean Difference
IV, Random, 95% CI
Not estimable
-1.30 [-3.55 , 0.95]
-1.90 [-4.66 , 0.86]
-2.10 [-4.39 , 0.19]
-1.30 [-3.54 , 0.94]
-2.20 [-5.25 , 0.85]
-0.25 [-1.00 , 0.49]
0.53 [-1.71 , 2.77]
-0.64 [-3.26 , 1.98]
-2.31 [-6.20 , 1.58]
7.30 [0.14 , 14.46]
-2.96 [-7.96 , 2.04]
-0.30 [-1.01 , 0.41]
-0.42 [-1.16 , 0.32]
-0.52 [-0.95 , -0.09]
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours reduced fat Favours moderate fat
Footnotes
(1) Change data reported as data were too different at baseline to use end data, however no variance for change was presented
(2) Women, no exercise
(3) Men with exercise
(4) Men, no exercise
(5) Women with exercise
(6) 1. High GI arms; Calculated from % change based on median baseline
(7) 1. Low GI arms, Calculated from % change based on median baseline
 
 
Analysis 1.12.   Comparison 1: Lower fat vs higher fat diet, Outcome 12: Quality of life
Study or Subgroup
WHI 2006 (1)
Total (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 2.75 (P = 0.006)
Test for subgroup differences: Not applicable
Reduced fat
Mean
0.07
SD
1.41
Total
15788
15788
Usual or modified fat
Mean
0.03
SD
1.44
Total
24342
24342
Weight
100.0%
100.0%
Mean Difference
IV, Random, 95% CI
0.04 [0.01 , 0.07]
0.04 [0.01 , 0.07]
Mean Difference
IV, Random, 95% CI
-0.2 -0.1 0 0.1 0.2
Favours moderate fat Favours lower fat
Footnotes
(1) Change in Global Quality of Life to trial close-out (0 worst to 10 best), Assaf 2016
 
 
Comparison 2.   Lower fat vs higher fat diet on body weight, sensitivity analyses
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
2.1 Weight, kg SA fixed effects 26 53875 Mean Difference (IV, Fixed, 95% CI) -0.94 [-1.05, -0.82]
2.2 Weight, kg SA including only RCTs at
low summary RoB
26 53875 Mean Difference (IV, Random, 95% CI) -1.42 [-1.73, -1.10]
2.2.1 Low summary RoB 4 42212 Mean Difference (IV, Random, 95% CI) -0.67 [-0.82, -0.52]
2.2.2 Moderate /High RoB 22 11663 Mean Difference (IV, Random, 95% CI) -1.60 [-2.00, -1.20]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
2.3 Weight, kg SA excluding the largest
trial, WHI
25 12522 Mean Difference (IV, Random, 95% CI) -1.51 [-1.86, -1.15]
2.4 Weight, kg SA excluding RCTs not
free of systematic differences in care
7 1641 Mean Difference (IV, Random, 95% CI) -0.89 [-1.17, -0.60]
2.5 Weight, kg SA excluding studies not
free of dietary differences other than fat
18 5112 Mean Difference (IV, Random, 95% CI) -1.63 [-2.07, -1.19]
2.6 Weight, kg SA excluding studies with
potential compliance problems
20 50907 Mean Difference (IV, Random, 95% CI) -1.56 [-1.88, -1.23]
2.7 Weight, kg including partial data 35 59013 Mean Difference (IV, Random, 95% CI) -1.42 [-1.73, -1.10]
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Analysis 2.1.   Comparison 2: Lower fat vs higher fat diet on body
weight, sensitivity analyses, Outcome 1: Weight, kg SA fixed eects
Study or Subgroup
Anderson 1990
BDIT Pilot Studies 1996
BRIDGES 2001
Bloemberg 1991
CORDIOPREV 2016 (1)
CORDIOPREV 2016 (2)
CORDIOPREV 2016 (3)
Canadian DBCP 1997
DEER 1998 (4)
DEER 1998 (5)
DEER 1998 (6)
DEER 1998 (7)
De Bont 1981 (8)
De Bont 1981 (9)
MSFAT 1995
Ma 2016
Nordevang 1990
Nutrition & Breast Health
ODMDC 2017
Pilkington 1960
Polyp Prevention 1996
RISCK 2010 (10)
RISCK 2010 (11)
Simon 1997
Strychar 2009
Swinburn 2001
WHEL 2007
WHI 2006 (12)
WHT Full-scale
WHT Vanguard 1991
WHTFSMP 2003
WINS 1993
Yadav 2016 (13)
Total (95% CI)
Heterogeneity: Chi² = 128.06, df = 32 (P < 0.00001); I² = 75%
Test for overall effect: Z = 16.17 (P < 0.00001)
Test for subgroup differences: Not applicable
Reduced fat
Mean
1.06
59.6
0.1
-0.94
-1.27
-1.34
-0.18
62
-4.2
-3.1
-2.8
-2.7
-0.4
-2.7
0.4
-1.2
-0.4
67.3
-1.6
66.7
-0.65
-0.8734
-0.8877
63.4
-0.83
-1.6
74.1
-0.8
-1.9
-1.91
-1.8
-2.7
-7.4
SD
2.49
7.3
4.85
2.68
7.1294
6.3357
5.4225
9.1
4.2
3.7
3.5
3.5
2.8
3.6
2.36
4.7476
5.5
13.8
1.0131
5.9
5.22
2.6017
2.1451
11.1
3
5.4
19.53
10.1
4.2
4.9
4
15.3
7.9
Total
47
76
48
39
88
98
30
388
48
43
49
46
36
34
117
46
63
47
101
12
943
117
111
34
15
48
1308
16297
176
159
1325
386
22
22397
Usual or modified fat
Mean
0.44
60.4
0.5
0.06
0.61
0.47
2.21
63.5
-0.6
-0.4
0.5
0.8
0.1
-0.9
1.12
-1.1
1.3
66.4
-1.0019
70.8
0.31
0.1674
-0.0402
71.9
1.6
2.13
73.7
-0.1
-0.2
-0.08
-0.3
0
0.7
SD
2.68
8.4
4.07
1.86
7.8652
11.7962
6.0576
9.4
3.1
2.5
2.7
4.2
2
3.5
2.36
4.6433
5.5
12
1.0262
5.2
5.22
1.8124
0.213
11.7
1.8
5
19.2
10.1
3.7
4.3
4.2
15.3
5.4
Total
51
78
46
40
92
115
39
401
47
43
46
45
29
35
103
44
106
50
206
23
943
115
110
38
15
51
1313
25056
188
102
883
998
27
31478
Weight
1.2%
0.2%
0.4%
1.2%
0.3%
0.2%
0.2%
0.8%
0.6%
0.7%
0.8%
0.5%
0.9%
0.5%
3.3%
0.3%
0.4%
0.0%
21.9%
0.1%
5.8%
3.9%
8.0%
0.0%
0.4%
0.3%
0.6%
32.4%
1.9%
1.0%
10.5%
0.4%
0.1%
100.0%
Mean Difference
IV, Fixed, 95% CI
0.62 [-0.40 , 1.64]
-0.80 [-3.28 , 1.68]
-0.40 [-2.21 , 1.41]
-1.00 [-2.02 , 0.02]
-1.88 [-4.07 , 0.31]
-1.81 [-4.30 , 0.68]
-2.39 [-5.11 , 0.33]
-1.50 [-2.79 , -0.21]
-3.60 [-5.08 , -2.12]
-2.70 [-4.03 , -1.37]
-3.30 [-4.55 , -2.05]
-3.50 [-5.09 , -1.91]
-0.50 [-1.67 , 0.67]
-1.80 [-3.48 , -0.12]
-0.72 [-1.34 , -0.10]
-0.10 [-2.04 , 1.84]
-1.70 [-3.41 , 0.01]
0.90 [-4.26 , 6.06]
-0.60 [-0.84 , -0.36]
-4.10 [-8.06 , -0.14]
-0.96 [-1.43 , -0.49]
-1.04 [-1.62 , -0.46]
-0.85 [-1.25 , -0.45]
-8.50 [-13.77 , -3.23]
-2.43 [-4.20 , -0.66]
-3.73 [-5.78 , -1.68]
0.40 [-1.08 , 1.88]
-0.70 [-0.90 , -0.50]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-2.70 [-4.50 , -0.90]
-8.10 [-11.98 , -4.22]
-0.94 [-1.05 , -0.82]
Mean Difference
IV, Fixed, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) pre-DM by HbA1c, change to 5 years
(2) preDM by IFT/IGT, change to 5 years
(3) Non-preDM, change to 5 years
(4) Men with exercise
(5) Women with exercise
(6) Men, no exercise
(7) Women, no exercise
(8) non-obese participants (BMI < 28)
(9) obese participants (BMI 28+)
(10) Low GI arms, Calculated from % change based on median baseline
(11) High GI arms; Calculated from % change based on median baseline
(12) Change from baseline to 7.5 years
(13) Data for 22 of 26 intervention participants who were compliant with diet
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Analysis 2.2.   Comparison 2: Lower fat vs higher fat diet on body weight, sensitivity
analyses, Outcome 2: Weight, kg SA including only RCTs at low summary RoB
Study or Subgroup
2.2.1 Low summary RoB
CORDIOPREV 2016 (1)
CORDIOPREV 2016 (2)
CORDIOPREV 2016 (3)
Ma 2016
ODMDC 2017
WHI 2006 (4)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 4.27, df = 5 (P = 0.51); I² = 0%
Test for overall effect: Z = 8.63 (P < 0.00001)
2.2.2 Moderate /High RoB
Anderson 1990
BDIT Pilot Studies 1996
BRIDGES 2001
Bloemberg 1991
Canadian DBCP 1997
DEER 1998 (5)
DEER 1998 (6)
DEER 1998 (7)
DEER 1998 (8)
De Bont 1981 (9)
De Bont 1981 (10)
MSFAT 1995
Nordevang 1990
Nutrition & Breast Health
Pilkington 1960
Polyp Prevention 1996
RISCK 2010 (11)
RISCK 2010 (12)
Simon 1997
Strychar 2009
Swinburn 2001
WHEL 2007
WHT Full-scale
WHT Vanguard 1991
WHTFSMP 2003
WINS 1993
Yadav 2016 (13)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.61; Chi² = 97.77, df = 26 (P < 0.00001); I² = 73%
Test for overall effect: Z = 7.77 (P < 0.00001)
Total (95% CI)
Heterogeneity: Tau² = 0.39; Chi² = 128.06, df = 32 (P < 0.00001); I² = 75%
Test for overall effect: Z = 8.78 (P < 0.00001)
Test for subgroup differences: Chi² = 17.80, df = 1 (P < 0.0001), I² = 94.4%
Reduced fat
Mean
-0.18
-1.27
-1.34
-1.2
-1.6
-0.8
1.06
59.6
0.1
-0.94
62
-3.1
-4.2
-2.8
-2.7
-2.7
-0.4
0.4
-0.4
67.3
66.7
-0.65
-0.8734
-0.8877
63.4
-0.83
-1.6
74.1
-1.9
-1.91
-1.8
-2.7
-7.4
SD
5.4225
7.1294
6.3357
4.7476
1.0131
10.1
2.49
7.3
4.85
2.68
9.1
3.7
4.2
3.5
3.5
3.6
2.8
2.36
5.5
13.8
5.9
5.22
2.6017
2.1451
11.1
3
5.4
19.53
4.2
4.9
4
15.3
7.9
Total
30
88
98
46
101
16297
16660
47
76
48
39
388
43
48
49
46
34
36
117
63
47
12
943
117
111
34
15
48
1308
176
159
1325
386
22
5737
22397
Usual or modified fat
Mean
2.21
0.61
0.47
-1.1
-1.0019
-0.1
0.44
60.4
0.5
0.06
63.5
-0.4
-0.6
0.5
0.8
-0.9
0.1
1.12
1.3
66.4
70.8
0.31
0.1674
-0.0402
71.9
1.6
2.13
73.7
-0.2
-0.08
-0.3
0
0.7
SD
6.0576
7.8652
11.7962
4.6433
1.0262
10.1
2.68
8.4
4.07
1.86
9.4
2.5
3.1
2.7
4.2
3.5
2
2.36
5.5
12
5.2
5.22
1.8124
0.213
11.7
1.8
5
19.2
3.7
4.3
4.2
15.3
5.4
Total
39
92
115
44
206
25056
25552
51
78
46
40
401
43
47
46
45
35
29
103
106
50
23
943
115
110
38
15
51
1313
188
102
883
998
27
5926
31478
Weight
1.1%
1.6%
1.3%
1.9%
6.4%
6.5%
18.7%
3.9%
1.3%
2.1%
3.9%
3.1%
3.0%
2.7%
3.2%
2.5%
2.3%
3.5%
5.3%
2.2%
0.4%
0.6%
5.8%
5.4%
6.0%
0.3%
2.2%
1.7%
2.7%
4.6%
3.6%
6.1%
2.1%
0.6%
81.3%
100.0%
Mean Difference
IV, Random, 95% CI
-2.39 [-5.11 , 0.33]
-1.88 [-4.07 , 0.31]
-1.81 [-4.30 , 0.68]
-0.10 [-2.04 , 1.84]
-0.60 [-0.84 , -0.36]
-0.70 [-0.90 , -0.50]
-0.67 [-0.82 , -0.52]
0.62 [-0.40 , 1.64]
-0.80 [-3.28 , 1.68]
-0.40 [-2.21 , 1.41]
-1.00 [-2.02 , 0.02]
-1.50 [-2.79 , -0.21]
-2.70 [-4.03 , -1.37]
-3.60 [-5.08 , -2.12]
-3.30 [-4.55 , -2.05]
-3.50 [-5.09 , -1.91]
-1.80 [-3.48 , -0.12]
-0.50 [-1.67 , 0.67]
-0.72 [-1.34 , -0.10]
-1.70 [-3.41 , 0.01]
0.90 [-4.26 , 6.06]
-4.10 [-8.06 , -0.14]
-0.96 [-1.43 , -0.49]
-1.04 [-1.62 , -0.46]
-0.85 [-1.25 , -0.45]
-8.50 [-13.77 , -3.23]
-2.43 [-4.20 , -0.66]
-3.73 [-5.78 , -1.68]
0.40 [-1.08 , 1.88]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-2.70 [-4.50 , -0.90]
-8.10 [-11.98 , -4.22]
-1.60 [-2.00 , -1.20]
-1.42 [-1.73 , -1.10]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) Non-preDM, change to 5 years
(2) pre-DM by HbA1c, change to 5 years
(3) preDM by IFT/IGT, change to 5 years
(4) Change from baseline to 7.5 years
(5) Women with exercise
(6) Men with exercise
(7) Men, no exercise
(8) Women, no exercise
(9) obese participants (BMI 28+)
(10) non-obese participants (BMI < 28)
(11) Low GI arms, Calculated from % change based on median baseline
(12) High GI arms; Calculated from % change based on median baseline
(13) Data for 22 of 26 intervention participants who were compliant with diet
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Analysis 2.3.   Comparison 2: Lower fat vs higher fat diet on body weight,
sensitivity analyses, Outcome 3: Weight, kg SA excluding the largest trial, WHI
Study or Subgroup
Anderson 1990
BDIT Pilot Studies 1996
BRIDGES 2001
Bloemberg 1991
CORDIOPREV 2016 (1)
CORDIOPREV 2016 (2)
CORDIOPREV 2016 (3)
Canadian DBCP 1997
DEER 1998 (4)
DEER 1998 (5)
DEER 1998 (6)
DEER 1998 (7)
De Bont 1981 (8)
De Bont 1981 (9)
MSFAT 1995
Ma 2016
Nordevang 1990
Nutrition & Breast Health
ODMDC 2017
Pilkington 1960
Polyp Prevention 1996
RISCK 2010 (10)
RISCK 2010 (11)
Simon 1997
Strychar 2009
Swinburn 2001
WHEL 2007
WHT Full-scale
WHT Vanguard 1991
WHTFSMP 2003
WINS 1993
Yadav 2016 (12)
Total (95% CI)
Heterogeneity: Tau² = 0.53; Chi² = 120.06, df = 31 (P < 0.00001); I² = 74%
Test for overall effect: Z = 8.25 (P < 0.00001)
Test for subgroup differences: Not applicable
Reduced fat
Mean
1.06
59.6
0.1
-0.94
-1.27
-1.34
-0.18
62
-2.8
-3.1
-2.7
-4.2
-2.7
-0.4
0.4
-1.2
-0.4
67.3
-1.6
66.7
-0.65
-0.8877
-0.8734
63.4
-0.83
-1.6
74.1
-1.9
-1.91
-1.8
-2.7
-7.4
SD
2.49
7.3
4.85
2.68
7.1294
6.3357
5.4225
9.1
3.5
3.7
3.5
4.2
3.6
2.8
2.36
4.7476
5.5
13.8
1.0131
5.9
5.22
2.1451
2.6017
11.1
3
5.4
19.53
4.2
4.9
4
15.3
7.9
Total
47
76
48
39
88
98
30
388
49
43
46
48
34
36
117
46
63
47
101
12
943
111
117
34
15
48
1308
176
159
1325
386
22
6100
Usual or modified fat
Mean
0.44
60.4
0.5
0.06
0.61
0.47
2.21
63.5
0.5
-0.4
0.8
-0.6
-0.9
0.1
1.12
-1.1
1.3
66.4
-1.0019
70.8
0.31
-0.0402
0.1674
71.9
1.6
2.13
73.7
-0.2
-0.08
-0.3
0
0.7
SD
2.68
8.4
4.07
1.86
7.8652
11.7962
6.0576
9.4
2.7
2.5
4.2
3.1
3.5
2
2.36
4.6433
5.5
12
1.0262
5.2
5.22
0.213
1.8124
11.7
1.8
5
19.2
3.7
4.3
4.2
15.3
5.4
Total
51
78
46
40
92
115
39
401
46
43
45
47
35
29
103
44
106
50
206
23
943
110
115
38
15
51
1313
188
102
883
998
27
6422
Weight
4.2%
1.6%
2.4%
4.2%
1.9%
1.6%
1.4%
3.5%
3.6%
3.4%
2.8%
3.0%
2.6%
3.8%
5.3%
2.2%
2.6%
0.4%
6.2%
0.7%
5.7%
5.9%
5.4%
0.4%
2.5%
2.0%
3.0%
4.8%
3.9%
6.0%
2.4%
0.7%
100.0%
Mean Difference
IV, Random, 95% CI
0.62 [-0.40 , 1.64]
-0.80 [-3.28 , 1.68]
-0.40 [-2.21 , 1.41]
-1.00 [-2.02 , 0.02]
-1.88 [-4.07 , 0.31]
-1.81 [-4.30 , 0.68]
-2.39 [-5.11 , 0.33]
-1.50 [-2.79 , -0.21]
-3.30 [-4.55 , -2.05]
-2.70 [-4.03 , -1.37]
-3.50 [-5.09 , -1.91]
-3.60 [-5.08 , -2.12]
-1.80 [-3.48 , -0.12]
-0.50 [-1.67 , 0.67]
-0.72 [-1.34 , -0.10]
-0.10 [-2.04 , 1.84]
-1.70 [-3.41 , 0.01]
0.90 [-4.26 , 6.06]
-0.60 [-0.84 , -0.36]
-4.10 [-8.06 , -0.14]
-0.96 [-1.43 , -0.49]
-0.85 [-1.25 , -0.45]
-1.04 [-1.62 , -0.46]
-8.50 [-13.77 , -3.23]
-2.43 [-4.20 , -0.66]
-3.73 [-5.78 , -1.68]
0.40 [-1.08 , 1.88]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-2.70 [-4.50 , -0.90]
-8.10 [-11.98 , -4.22]
-1.51 [-1.86 , -1.15]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) pre-DM by HbA1c, change to 5 years
(2) preDM by IFT/IGT, change to 5 years
(3) Non-preDM, change to 5 years
(4) Men, no exercise
(5) Women with exercise
(6) Women, no exercise
(7) Men with exercise
(8) obese participants (BMI 28+)
(9) non-obese participants (BMI < 28)
(10) High GI arms; Calculated from % change based on median baseline
(11) Low GI arms, Calculated from % change based on median baseline
(12) Data for 22 of 26 intervention participants who were compliant with diet
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Analysis 2.4.   Comparison 2: Lower fat vs higher fat diet on body weight, sensitivity
analyses, Outcome 4: Weight, kg SA excluding RCTs not free of systematic dierences in care
Study or Subgroup
CORDIOPREV 2016 (1)
CORDIOPREV 2016 (2)
CORDIOPREV 2016 (3)
De Bont 1981 (4)
De Bont 1981 (5)
MSFAT 1995
ODMDC 2017
Pilkington 1960
RISCK 2010 (6)
RISCK 2010 (7)
Strychar 2009
Total (95% CI)
Heterogeneity: Tau² = 0.05; Chi² = 13.72, df = 10 (P = 0.19); I² = 27%
Test for overall effect: Z = 6.11 (P < 0.00001)
Test for subgroup differences: Not applicable
Reduced fat
Mean
-1.34
-1.27
-0.18
-0.4
-2.7
0.4
-1.6
66.7
-0.8877
-0.8734
-0.83
SD
6.3357
7.1294
5.4225
2.8
3.6
2.36
1.0131
5.9
2.1451
2.6017
3
Total
98
88
30
36
34
117
101
12
111
117
15
759
Usual or modified fat
Mean
0.47
0.61
2.21
0.1
-0.9
1.12
-1.0019
70.8
-0.0402
0.1674
1.6
SD
11.7962
7.8652
6.0576
2
3.5
2.36
1.0262
5.2
0.213
1.8124
1.8
Total
115
92
39
29
35
103
206
23
110
115
15
882
Weight
1.3%
1.6%
1.1%
5.2%
2.7%
14.0%
32.6%
0.5%
23.1%
15.5%
2.4%
100.0%
Mean Difference
IV, Random, 95% CI
-1.81 [-4.30 , 0.68]
-1.88 [-4.07 , 0.31]
-2.39 [-5.11 , 0.33]
-0.50 [-1.67 , 0.67]
-1.80 [-3.48 , -0.12]
-0.72 [-1.34 , -0.10]
-0.60 [-0.84 , -0.36]
-4.10 [-8.06 , -0.14]
-0.85 [-1.25 , -0.45]
-1.04 [-1.62 , -0.46]
-2.43 [-4.20 , -0.66]
-0.89 [-1.17 , -0.60]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) preDM by IFT/IGT, change to 5 years
(2) pre-DM by HbA1c, change to 5 years
(3) Non-preDM, change to 5 years
(4) non-obese participants (BMI < 28)
(5) obese participants (BMI 28+)
(6) High GI arms; Calculated from % change based on median baseline
(7) Low GI arms, Calculated from % change based on median baseline
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Analysis 2.5.   Comparison 2: Lower fat vs higher fat diet on body weight, sensitivity analyses,
Outcome 5: Weight, kg SA excluding studies not free of dietary dierences other than fat
Study or Subgroup
Anderson 1990
BDIT Pilot Studies 1996
Bloemberg 1991
Canadian DBCP 1997
DEER 1998 (1)
DEER 1998 (2)
DEER 1998 (3)
DEER 1998 (4)
De Bont 1981 (5)
De Bont 1981 (6)
MSFAT 1995
Nordevang 1990
Nutrition & Breast Health
ODMDC 2017
Pilkington 1960
RISCK 2010 (7)
RISCK 2010 (8)
Simon 1997
Strychar 2009
Swinburn 2001
WHT Full-scale
WHT Vanguard 1991
WINS 1993
Total (95% CI)
Heterogeneity: Tau² = 0.64; Chi² = 93.01, df = 22 (P < 0.00001); I² = 76%
Test for overall effect: Z = 7.30 (P < 0.00001)
Test for subgroup differences: Not applicable
Reduced fat
Mean
1.06
59.6
-0.94
62
-4.2
-2.8
-2.7
-3.1
-0.4
-2.7
0.4
-0.4
67.3
-1.6
66.7
-0.8734
-0.8877
63.4
-0.83
-1.6
-1.9
-1.91
-2.7
SD
2.49
7.3
2.68
9.1
4.2
3.5
3.5
3.7
2.8
3.6
2.36
5.5
13.8
1.0131
5.9
2.6017
2.1451
11.1
3
5.4
4.2
4.9
15.3
Total
47
76
39
388
48
49
46
43
36
34
117
63
47
101
12
117
111
34
15
48
176
159
386
2192
Usual or modified fat
Mean
0.44
60.4
0.06
63.5
-0.6
0.5
0.8
-0.4
0.1
-0.9
1.12
1.3
66.4
-1.0019
70.8
0.1674
-0.0402
71.9
1.6
2.13
-0.2
-0.08
0
SD
2.68
8.4
1.86
9.4
3.1
2.7
4.2
2.5
2
3.5
2.36
5.5
12
1.0262
5.2
1.8124
0.213
11.7
1.8
5
3.7
4.3
15.3
Total
51
78
40
401
47
46
45
43
29
35
103
106
50
206
23
115
110
38
15
51
188
102
998
2920
Weight
5.5%
2.2%
5.5%
4.7%
4.2%
4.8%
3.9%
4.6%
5.1%
3.7%
6.8%
3.6%
0.7%
7.7%
1.1%
6.9%
7.4%
0.6%
3.5%
2.9%
6.2%
5.2%
3.4%
100.0%
Mean Difference
IV, Random, 95% CI
0.62 [-0.40 , 1.64]
-0.80 [-3.28 , 1.68]
-1.00 [-2.02 , 0.02]
-1.50 [-2.79 , -0.21]
-3.60 [-5.08 , -2.12]
-3.30 [-4.55 , -2.05]
-3.50 [-5.09 , -1.91]
-2.70 [-4.03 , -1.37]
-0.50 [-1.67 , 0.67]
-1.80 [-3.48 , -0.12]
-0.72 [-1.34 , -0.10]
-1.70 [-3.41 , 0.01]
0.90 [-4.26 , 6.06]
-0.60 [-0.84 , -0.36]
-4.10 [-8.06 , -0.14]
-1.04 [-1.62 , -0.46]
-0.85 [-1.25 , -0.45]
-8.50 [-13.77 , -3.23]
-2.43 [-4.20 , -0.66]
-3.73 [-5.78 , -1.68]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-2.70 [-4.50 , -0.90]
-1.63 [-2.07 , -1.19]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) Men with exercise
(2) Men, no exercise
(3) Women, no exercise
(4) Women with exercise
(5) non-obese participants (BMI < 28)
(6) obese participants (BMI 28+)
(7) Low GI arms, Calculated from % change based on median baseline
(8) High GI arms; Calculated from % change based on median baseline
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Analysis 2.6.   Comparison 2: Lower fat vs higher fat diet on body weight, sensitivity
analyses, Outcome 6: Weight, kg SA excluding studies with potential compliance problems
Study or Subgroup
BDIT Pilot Studies 1996
Bloemberg 1991
CORDIOPREV 2016 (1)
CORDIOPREV 2016 (2)
CORDIOPREV 2016 (3)
Canadian DBCP 1997
DEER 1998 (4)
DEER 1998 (5)
DEER 1998 (6)
DEER 1998 (7)
De Bont 1981 (8)
De Bont 1981 (9)
MSFAT 1995
Nordevang 1990
Nutrition & Breast Health
ODMDC 2017
Polyp Prevention 1996
RISCK 2010 (10)
RISCK 2010 (11)
Simon 1997
Swinburn 2001
WHI 2006 (12)
WHT Full-scale
WHT Vanguard 1991
WHTFSMP 2003
WINS 1993
Yadav 2016 (13)
Total (95% CI)
Heterogeneity: Tau² = 0.36; Chi² = 109.65, df = 26 (P < 0.00001); I² = 76%
Test for overall effect: Z = 9.26 (P < 0.00001)
Test for subgroup differences: Not applicable
Reduced fat
Mean
59.6
-0.94
-1.34
-1.27
-0.18
62
-2.8
-3.1
-2.7
-4.2
-0.4
-2.7
0.4
-0.4
67.3
-1.6
-0.65
-0.8734
-0.8877
63.4
-1.6
-0.8
-1.9
-1.91
-1.8
-2.7
-7.4
SD
7.3
2.68
6.3357
7.1294
5.4225
9.1
3.5
3.7
3.5
4.2
2.8
3.6
2.36
5.5
13.8
1.0131
5.22
2.6017
2.1451
11.1
5.4
10.1
4.2
4.9
4
15.3
7.9
Total
76
39
98
88
30
388
49
43
46
48
36
34
117
63
47
101
943
117
111
34
48
16297
176
159
1325
386
22
20921
Usual or modified fat
Mean
60.4
0.06
0.47
0.61
2.21
63.5
0.5
-0.4
0.8
-0.6
0.1
-0.9
1.12
1.3
66.4
-1.0019
0.31
0.1674
-0.0402
71.9
2.13
-0.1
-0.2
-0.08
-0.3
0
0.7
SD
8.4
1.86
11.7962
7.8652
6.0576
9.4
2.7
2.5
4.2
3.1
2
3.5
2.36
5.5
12
1.0262
5.22
1.8124
0.213
11.7
5
10.1
3.7
4.3
4.2
15.3
5.4
Total
78
40
115
92
39
401
46
43
45
47
29
35
103
106
50
206
943
115
110
38
51
25056
188
102
883
998
27
29986
Weight
1.4%
4.5%
1.4%
1.8%
1.2%
3.6%
3.7%
3.4%
2.8%
3.0%
4.0%
2.6%
6.2%
2.5%
0.4%
7.6%
6.8%
6.4%
7.1%
0.4%
1.9%
7.7%
5.3%
4.1%
7.3%
2.4%
0.7%
100.0%
Mean Difference
IV, Random, 95% CI
-0.80 [-3.28 , 1.68]
-1.00 [-2.02 , 0.02]
-1.81 [-4.30 , 0.68]
-1.88 [-4.07 , 0.31]
-2.39 [-5.11 , 0.33]
-1.50 [-2.79 , -0.21]
-3.30 [-4.55 , -2.05]
-2.70 [-4.03 , -1.37]
-3.50 [-5.09 , -1.91]
-3.60 [-5.08 , -2.12]
-0.50 [-1.67 , 0.67]
-1.80 [-3.48 , -0.12]
-0.72 [-1.34 , -0.10]
-1.70 [-3.41 , 0.01]
0.90 [-4.26 , 6.06]
-0.60 [-0.84 , -0.36]
-0.96 [-1.43 , -0.49]
-1.04 [-1.62 , -0.46]
-0.85 [-1.25 , -0.45]
-8.50 [-13.77 , -3.23]
-3.73 [-5.78 , -1.68]
-0.70 [-0.90 , -0.50]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-2.70 [-4.50 , -0.90]
-8.10 [-11.98 , -4.22]
-1.56 [-1.88 , -1.23]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) preDM by IFT/IGT, change to 5 years
(2) pre-DM by HbA1c, change to 5 years
(3) Non-preDM, change to 5 years
(4) Men, no exercise
(5) Women with exercise
(6) Women, no exercise
(7) Men with exercise
(8) non-obese participants (BMI < 28)
(9) obese participants (BMI 28+)
(10) Low GI arms, Calculated from % change based on median baseline
(11) High GI arms; Calculated from % change based on median baseline
(12) Change from baseline to 7.5 years
(13) Data for 22 of 26 intervention participants who were compliant with diet
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Analysis 2.7.   Comparison 2: Lower fat vs higher fat diet on body weight,
sensitivity analyses, Outcome 7: Weight, kg including partial data
Study or Subgroup
AUSMED 2018 (1)
Anderson 1990
BDIT Pilot Studies 1996
BRIDGES 2001
Black 1994
Bloemberg 1991
Boyd 1988
CORDIOPREV 2016 (2)
CORDIOPREV 2016 (3)
CORDIOPREV 2016 (4)
Canadian DBCP 1997
DEER 1998 (5)
DEER 1998 (6)
DEER 1998 (7)
DEER 1998 (8)
De Bont 1981 (9)
De Bont 1981 (10)
Diet and Hormone Study 2003
MSFAT 1995
Ma 2016
MeDiet 2006
NDHS Open 1st L&M 1968
NDHS Open 2nd L&M 1968
Nordevang 1990
Nutrition & Breast Health
ODMDC 2017
Pilkington 1960
Polyp Prevention 1996
RISCK 2010 (11)
RISCK 2010 (12)
Rivellese 1994
Simon 1997
Strychar 2009
Swinburn 2001
WHEL 2007
WHI 2006 (13)
WHT Full-scale
WHT Vanguard 1991
WHTFSMP 2003
WINS 1993
Yadav 2016 (14)
beFIT 1997
Total (95% CI)
Heterogeneity: Tau² = 0.39; Chi² = 128.06, df = 32 (P < 0.00001); I² = 75%
Test for overall effect: Z = 8.78 (P < 0.00001)
Test for subgroup differences: Not applicable
Reduced fat
Mean
-0.3
1.06
59.6
0.1
-2
-0.94
-2.1
-1.27
-0.18
-1.34
62
-3.1
-2.8
-4.2
-2.7
-0.4
-2.7
-0.68
0.4
-1.2
-1.3
-2.45
-1.8
-0.4
67.3
-1.6
66.7
-0.65
-0.8734
-0.8877
-1.8
63.4
-0.83
-1.6
74.1
-0.8
-1.9
-1.91
-1.8
-2.7
-7.4
-2.7
SD
0
2.49
7.3
4.85
0
2.68
0
7.1294
5.4225
6.3357
9.1
3.7
3.5
4.2
3.5
2.8
3.6
0
2.36
4.7476
0
0
0
5.5
13.8
1.0131
5.9
5.22
2.6017
2.1451
0
11.1
3
5.4
19.53
10.1
4.2
4.9
4
15.3
7.9
0
Total
31
47
76
48
38
39
1491
88
30
98
388
43
49
48
46
36
34
81
117
46
51
332
179
63
47
101
12
943
117
111
27
34
15
48
1308
16297
176
159
1325
386
22
217
24844
Usual or modified fat
Mean
0
0.44
60.4
0.5
0.5
0.06
0
0.61
2.21
0.47
63.5
-0.4
0.5
-0.6
0.8
0.1
-0.9
-0.14
1.12
-1.1
-0.6
-1.91
-1.2
1.3
66.4
-1.0019
70.8
0.31
0.1674
-0.0402
-1.6
71.9
1.6
2.13
73.7
-0.1
-0.2
-0.08
-0.3
0
0.7
0
SD
0
2.68
8.4
4.07
0
1.86
0
7.8652
6.0576
11.7962
9.4
2.5
2.7
3.1
4.2
2
3.5
0
2.36
4.6433
0
0
0
5.5
12
1.0262
5.2
5.22
1.8124
0.213
0
11.7
1.8
5
19.2
10.1
3.7
4.3
4.2
15.3
5.4
0
Total
34
51
78
46
58
40
1676
92
39
115
401
43
46
47
45
29
35
96
103
44
55
348
215
106
50
206
23
943
115
110
17
38
15
51
1313
25056
188
102
883
998
27
192
34169
Weight
3.9%
1.3%
2.1%
3.9%
1.6%
1.1%
1.3%
3.1%
3.0%
3.2%
2.7%
2.5%
3.5%
2.3%
5.3%
1.9%
2.2%
0.4%
6.4%
0.6%
5.8%
5.4%
6.0%
0.3%
2.2%
1.7%
2.7%
6.5%
4.6%
3.6%
6.1%
2.1%
0.6%
100.0%
Mean Difference
IV, Random, 95% CI
Not estimable
0.62 [-0.40 , 1.64]
-0.80 [-3.28 , 1.68]
-0.40 [-2.21 , 1.41]
Not estimable
-1.00 [-2.02 , 0.02]
Not estimable
-1.88 [-4.07 , 0.31]
-2.39 [-5.11 , 0.33]
-1.81 [-4.30 , 0.68]
-1.50 [-2.79 , -0.21]
-2.70 [-4.03 , -1.37]
-3.30 [-4.55 , -2.05]
-3.60 [-5.08 , -2.12]
-3.50 [-5.09 , -1.91]
-0.50 [-1.67 , 0.67]
-1.80 [-3.48 , -0.12]
Not estimable
-0.72 [-1.34 , -0.10]
-0.10 [-2.04 , 1.84]
Not estimable
Not estimable
Not estimable
-1.70 [-3.41 , 0.01]
0.90 [-4.26 , 6.06]
-0.60 [-0.84 , -0.36]
-4.10 [-8.06 , -0.14]
-0.96 [-1.43 , -0.49]
-1.04 [-1.62 , -0.46]
-0.85 [-1.25 , -0.45]
Not estimable
-8.50 [-13.77 , -3.23]
-2.43 [-4.20 , -0.66]
-3.73 [-5.78 , -1.68]
0.40 [-1.08 , 1.88]
-0.70 [-0.90 , -0.50]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-2.70 [-4.50 , -0.90]
-8.10 [-11.98 , -4.22]
Not estimable
-1.42 [-1.73 , -1.10]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) Change data reported as data were too different at baseline to use end data, however no variance for change was presented
(2) pre-DM by HbA1c, change to 5 years
(3) Non-preDM, change to 5 years
(4) preDM by IFT/IGT, change to 5 years
(5) Women with exercise
(6) Men, no exercise
(7) Men with exercise
(8) Women, no exercise
(9) non-obese participants (BMI < 28)
(10) obese participants (BMI 28+)
(11) Low GI arms, Calculated from % change based on median baseline
(12) High GI arms; Calculated from % change based on median baseline
(13) Change from baseline to 7.5 years
(14) Data for 22 of 26 intervention participants who were compliant with diet
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Comparison 3.   Lower fat vs higher fat diet on body weight, subgrouping
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
3.1 Weight, kg Subgrouping
by trial duration
26   Mean Difference (IV, Random, 95% CI) Subtotals only
3.1.1 duration 6 to < 12
months
12 4298 Mean Difference (IV, Random, 95% CI) -1.35 [-1.78, -0.92]
3.1.2 duration 12 to < 24
months
16 51665 Mean Difference (IV, Random, 95% CI) -2.07 [-2.57, -1.56]
3.1.3 duration 24 to < 60
months
9 49171 Mean Difference (IV, Random, 95% CI) -1.18 [-1.65, -0.70]
3.1.4 duration 60+ months 5 41300 Mean Difference (IV, Random, 95% CI) -1.00 [-1.79, -0.21]
3.2 Weight, kg Subgrouping
by baseline fat intake
26 53875 Mean Difference (IV, Random, 95% CI) -1.42 [-1.73, -1.10]
3.2.1 > 35%E from fat 13 45802 Mean Difference (IV, Random, 95% CI) -1.25 [-1.59, -0.91]
3.2.2 > 30 to 35%E from fat 11 6322 Mean Difference (IV, Random, 95% CI) -0.81 [-1.40, -0.22]
3.2.3 > 25 to 30%E from fat 2 1751 Mean Difference (IV, Random, 95% CI) -3.17 [-3.82, -2.52]
3.3 Weight, kg Subgrouping
by decade of first publica-
tion
26 53875 Mean Difference (IV, Random, 95% CI) -1.42 [-1.73, -1.10]
3.3.1 1960s 1 35 Mean Difference (IV, Random, 95% CI) -4.10 [-8.06, -0.14]
3.3.2 1970s 0 0 Mean Difference (IV, Random, 95% CI) Not estimable
3.3.3 1980s 2 288 Mean Difference (IV, Random, 95% CI) -0.91 [-1.80, -0.01]
3.3.4 1990s 11 5689 Mean Difference (IV, Random, 95% CI) -1.86 [-2.49, -1.22]
3.3.5 2000s 7 46502 Mean Difference (IV, Random, 95% CI) -1.15 [-1.85, -0.46]
3.3.6 2010s 5 1361 Mean Difference (IV, Random, 95% CI) -1.04 [-1.58, -0.51]
3.4 Weight, kg Subgrouping
by sex
26 53875 Mean Difference (IV, Random, 95% CI) -1.42 [-1.73, -1.10]
3.4.1 Studies of women only 14 49877 Mean Difference (IV, Random, 95% CI) -1.49 [-1.98, -1.00]
3.4.2 Studies of men only 3 304 Mean Difference (IV, Random, 95% CI) -2.74 [-4.32, -1.17]
3.4.3 Studies of men &
women
10 3694 Mean Difference (IV, Random, 95% CI) -1.02 [-1.45, -0.59]
3.5 Weight, kg Subgrouping
by difference in %E from fat
26 53875 Mean Difference (IV, Random, 95% CI) -1.36 [-1.67, -1.06]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
between control & reduced
fat groups
3.5.1 Up to 5%E fat differ-
ence
6 3136 Mean Difference (IV, Random, 95% CI) -0.15 [-0.77, 0.47]
3.5.2 5% to < 10% E fat dif-
ference
9 44641 Mean Difference (IV, Random, 95% CI) -1.76 [-2.25, -1.28]
3.5.3 10% to < 15%E fat dif-
ference
6 5664 Mean Difference (IV, Random, 95% CI) -1.23 [-1.72, -0.74]
3.5.4 15+%E fat difference 5 404 Mean Difference (IV, Random, 95% CI) -3.91 [-7.61, -0.22]
3.5.5 %E fat difference not
stated
1 30 Mean Difference (IV, Random, 95% CI) -2.43 [-4.20, -0.66]
3.6 Weight, kg Subgrouping
by achieving < 30%E from
fat
26 53875 Mean Difference (IV, Random, 95% CI) -1.42 [-1.73, -1.10]
3.6.1 Intervention did not
achieve < 30%E from fat or
less
6 1139 Mean Difference (IV, Random, 95% CI) -0.90 [-1.32, -0.47]
3.6.2 Intervention achieved
< 30%E from fat or less
20 52736 Mean Difference (IV, Random, 95% CI) -1.55 [-1.93, -1.18]
3.7 Weight, kg Subgrouping
by type of intervention
26 53875 Mean Difference (IV, Random, 95% CI) -1.42 [-1.73, -1.10]
3.7.1 Dietary advice 22 52433 Mean Difference (IV, Random, 95% CI) -1.65 [-2.09, -1.21]
3.7.2 Dietary advice plus
supplements
2 915 Mean Difference (IV, Random, 95% CI) -0.97 [-1.29, -0.65]
3.7.3 Diet provided 2 527 Mean Difference (IV, Random, 95% CI) -0.61 [-0.84, -0.39]
3.8 Weight, kg Subgrouping
by lower fat arm fat goal
26 53875 Mean Difference (IV, Random, 95% CI) -1.42 [-1.73, -1.10]
3.8.1 Goal 30%E from fat 2 213 Mean Difference (IV, Random, 95% CI) -0.96 [-1.66, -0.26]
3.8.2 Goal 25 to < 30%E
from fat
5 1470 Mean Difference (IV, Random, 95% CI) -1.77 [-2.56, -0.99]
3.8.3 Goal 20 to < 25%E
from fat
4 2456 Mean Difference (IV, Random, 95% CI) -0.71 [-0.96, -0.46]
3.8.4 Goal 15 to < 20%E
from fat
13 49481 Mean Difference (IV, Random, 95% CI) -1.73 [-2.35, -1.10]
3.8.5 Goal 10 to < 15%E
from fat
0 0 Mean Difference (IV, Random, 95% CI) Not estimable
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
3.8.6 Goal unclear 2 255 Mean Difference (IV, Random, 95% CI) -1.82 [-4.93, 1.28]
3.9 Weight, kg Subgrouping
by mean BMI at baseline
26 53875 Mean Difference (IV, Random, 95% CI) -1.42 [-1.73, -1.10]
3.9.1 BMI at baseline < 25 9 1936 Mean Difference (IV, Random, 95% CI) -0.86 [-1.34, -0.37]
3.9.2 BMI at baseline ≥ 25 to
29.9
15 51113 Mean Difference (IV, Random, 95% CI) -1.66 [-2.11, -1.21]
3.9.3 BMI at baseline ≥ 30 1 462 Mean Difference (IV, Random, 95% CI) -1.99 [-3.40, -0.59]
3.9.4 BMI at baseline un-
clear
1 364 Mean Difference (IV, Random, 95% CI) -1.70 [-2.52, -0.88]
3.10 Weight, kg Subgroup-
ing by baseline health sta-
tus
26 53875 Mean Difference (IV, Random, 95% CI) -1.42 [-1.73, -1.10]
3.10.1 Healthy people, not
recruited on the basis of risk
factors or illness
4 44088 Mean Difference (IV, Random, 95% CI) -0.88 [-1.26, -0.49]
3.10.2 People recruited on
the basis of risk factors such
as lipids, BMI, hormone lev-
els, risk scores
11 2833 Mean Difference (IV, Random, 95% CI) -1.85 [-2.49, -1.21]
3.10.3 People with disease
such as DM, MI, cancer,
polypsp
11 6954 Mean Difference (IV, Random, 95% CI) -1.48 [-2.16, -0.80]
3.11 Weight, kg Subgroup-
ing by assessed energy re-
duction
26 53875 Mean Difference (IV, Random, 95% CI) -1.42 [-1.73, -1.10]
3.11.1 E intake the same or
greater in low fat group
4 3159 Mean Difference (IV, Random, 95% CI) -0.59 [-0.85, -0.32]
3.11.2 E intake 1 to 100kcal/
d less in low fat group
5 2442 Mean Difference (IV, Random, 95% CI) -1.04 [-1.68, -0.41]
3.11.3 E intake 101 to 200
kcal/d less in low fat group
5 43221 Mean Difference (IV, Random, 95% CI) -0.74 [-1.38, -0.10]
3.11.4 E intake > 201 kcal/d
less in low fat group
7 4406 Mean Difference (IV, Random, 95% CI) -2.22 [-2.83, -1.61]
3.11.5 E intake unclear 6 647 Mean Difference (IV, Random, 95% CI) -2.07 [-3.33, -0.80]
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Analysis 3.1.   Comparison 3: Lower fat vs higher fat diet on body weight, subgrouping, Outcome 1: Weight, kg
Subgrouping by trial duration
Study or Subgroup
3.1.1 duration 6 to < 12 months
BDIT Pilot Studies 1996
Bloemberg 1991
De Bont 1981 (1)
De Bont 1981 (2)
MSFAT 1995
Ma 2016
ODMDC 2017
RISCK 2010 (3)
RISCK 2010 (4)
Simon 1997
Strychar 2009
Swinburn 2001
WHT Vanguard 1991
WHTFSMP 2003
Subtotal (95% CI)
Heterogeneity: Tau² = 0.39; Chi² = 60.77, df = 13 (P < 0.00001); I² = 79%
Test for overall effect: Z = 6.15 (P < 0.00001)
3.1.2 duration 12 to < 24 months
Anderson 1990
BDIT Pilot Studies 1996
BRIDGES 2001
Canadian DBCP 1997
DEER 1998 (5)
DEER 1998 (6)
DEER 1998 (7)
DEER 1998 (8)
Nutrition & Breast Health
Pilkington 1960
Polyp Prevention 1996
Simon 1997
Swinburn 2001
WHEL 2007
WHI 2006
WHT Full-scale
WHT Vanguard 1991
WINS 1993
Yadav 2016 (9)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.62; Chi² = 65.89, df = 18 (P < 0.00001); I² = 73%
Test for overall effect: Z = 8.06 (P < 0.00001)
3.1.3 duration 24 to < 60 months
BDIT Pilot Studies 1996
Canadian DBCP 1997
Nordevang 1990
Polyp Prevention 1996
Swinburn 2001
WHEL 2007
WHI 2006 (10)
WHT Vanguard 1991
WINS 1993
Subtotal (95% CI)
Heterogeneity: Tau² = 0.20; Chi² = 18.01, df = 8 (P = 0.02); I² = 56%
Test for overall effect: Z = 4.86 (P < 0.00001)
3.1.4 duration 60+ months
CORDIOPREV 2016 (11)
CORDIOPREV 2016 (12)
CORDIOPREV 2016 (13)
Swinburn 2001
WHEL 2007
WHI 2006
Reduced fat
Mean
58
-0.94
-0.4
-2.7
0.4
-1.2
-1.6
-0.8734
-0.8877
63.82
-0.83
-2.97
-3.16
-1.8
1.06
59
0.1
61.4
-2.8
-3.1
-4.2
-2.7
67.3
66.7
-1.96
63.4
-3.32
73
74
-1.9
-2.93
-2.3
-7.4
59.6
62
-0.4
-0.65
-1.6
74.2
-0.8
-1.91
-1.8
-1.34
-0.18
-1.27
1.06
74.1
75.6
SD
7
2.68
2.8
3.6
2.36
4.7476
1.0131
2.6017
2.1451
10.4
3
4.39
3.7
4
2.49
7
4.85
8.6
3.5
3.7
4.2
3.5
13.8
5.9
4.06
11.1
5.52
17.21
16.5
4.2
4.8
15.1
7.9
7.3
9.1
5.5
5.22
5.4
18.77
10.1
4.9
15.1
6.3357
5.4225
7.1294
4.57
19.53
16.8
Total
100
39
36
34
117
46
101
117
111
67
15
66
179
1325
2353
47
100
48
385
49
43
48
46
47
12
975
34
66
1463
17026
176
177
854
22
21618
76
388
63
943
48
1355
16297
159
698
20027
98
30
88
51
1308
14409
Usual or modified fat
Mean
60
0.06
0.1
-0.9
1.12
-1.1
-1.0019
0.1674
-0.0402
68.45
1.6
-0.08
-0.22
-0.3
0.44
60
0.5
62.9
0.5
-0.4
-0.6
0.8
66.4
70.8
0.01
71.9
0.59
73.8
75.9
-0.2
-0.62
0
0.7
60.4
63.5
1.3
0.31
2.13
74.1
-0.1
-0.08
0
0.47
2.21
0.61
1.26
73.7
76.2
SD
8
1.86
2
3.5
2.36
4.6433
1.0262
1.8124
0.213
12.29
1.8
3.6
3
4.2
2.68
8
4.07
9.2
2.7
2.5
3.1
4.2
12
5.2
3.46
11.7
13.47
18.11
16.5
3.7
3.8
15.1
5.4
8.4
9.4
5.5
5.22
5
18.46
10.1
4.3
15.1
11.7962
6.0576
7.8652
4.9
19.2
16.6
Total
106
40
29
35
103
44
206
115
110
76
15
70
113
883
1945
51
106
46
397
46
43
47
45
50
23
989
38
70
1484
24977
188
110
1310
27
30047
78
401
106
943
51
1363
25056
102
1044
29144
115
39
92
52
1313
22321
Weight
3.3%
7.4%
6.5%
4.3%
9.9%
3.5%
12.1%
10.3%
11.3%
1.2%
4.0%
5.6%
8.9%
11.6%
100.0%
7.4%
3.8%
4.5%
6.4%
6.4%
6.1%
5.5%
5.1%
0.9%
1.4%
10.1%
0.8%
1.8%
6.3%
10.2%
8.3%
7.5%
6.2%
1.4%
100.0%
3.2%
9.2%
6.1%
22.5%
4.5%
8.2%
27.5%
11.0%
7.8%
100.0%
7.9%
6.9%
9.6%
12.4%
16.1%
34.4%
Mean Difference
IV, Random, 95% CI
-2.00 [-4.05 , 0.05]
-1.00 [-2.02 , 0.02]
-0.50 [-1.67 , 0.67]
-1.80 [-3.48 , -0.12]
-0.72 [-1.34 , -0.10]
-0.10 [-2.04 , 1.84]
-0.60 [-0.84 , -0.36]
-1.04 [-1.62 , -0.46]
-0.85 [-1.25 , -0.45]
-4.63 [-8.35 , -0.91]
-2.43 [-4.20 , -0.66]
-2.89 [-4.24 , -1.54]
-2.94 [-3.71 , -2.17]
-1.50 [-1.85 , -1.15]
-1.35 [-1.78 , -0.92]
0.62 [-0.40 , 1.64]
-1.00 [-3.05 , 1.05]
-0.40 [-2.21 , 1.41]
-1.50 [-2.75 , -0.25]
-3.30 [-4.55 , -2.05]
-2.70 [-4.03 , -1.37]
-3.60 [-5.08 , -2.12]
-3.50 [-5.09 , -1.91]
0.90 [-4.26 , 6.06]
-4.10 [-8.06 , -0.14]
-1.97 [-2.30 , -1.64]
-8.50 [-13.77 , -3.23]
-3.91 [-7.33 , -0.49]
-0.80 [-2.08 , 0.48]
-1.90 [-2.22 , -1.58]
-1.70 [-2.52 , -0.88]
-2.31 [-3.31 , -1.31]
-2.30 [-3.60 , -1.00]
-8.10 [-11.98 , -4.22]
-2.07 [-2.57 , -1.56]
-0.80 [-3.28 , 1.68]
-1.50 [-2.79 , -0.21]
-1.70 [-3.41 , 0.01]
-0.96 [-1.43 , -0.49]
-3.73 [-5.78 , -1.68]
0.10 [-1.30 , 1.50]
-0.70 [-0.90 , -0.50]
-1.83 [-2.96 , -0.70]
-1.80 [-3.25 , -0.35]
-1.18 [-1.65 , -0.70]
-1.81 [-4.30 , 0.68]
-2.39 [-5.11 , 0.33]
-1.88 [-4.07 , 0.31]
-0.20 [-2.03 , 1.63]
0.40 [-1.08 , 1.88]
-0.60 [-0.95 , -0.25]
Mean Difference
IV, Random, 95% CI
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Analysis 3.1.   (Continued)
WHEL 2007
WHI 2006
WINS 1993
Subtotal (95% CI)
Heterogeneity: Tau² = 0.44; Chi² = 10.82, df = 6 (P = 0.09); I² = 45%
Test for overall effect: Z = 2.47 (P = 0.01)
Test for subgroup differences: Chi² = 8.47, df = 3 (P = 0.04), I² = 64.6%
74.1
75.6
-2.7
19.53
16.8
15.3
1308
14409
386
16370
73.7
76.2
0
19.2
16.6
15.3
1313
22321
998
24930
16.1%
34.4%
12.7%
100.0%
0.40 [-1.08 , 1.88]
-0.60 [-0.95 , -0.25]
-2.70 [-4.50 , -0.90]
-1.00 [-1.79 , -0.21]
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) non-obese participants (BMI < 28)
(2) obese participants (BMI 28+)
(3) Low GI arms, Calculated from % change based on median baseline
(4) High GI arms; Calculated from % change based on median baseline
(5) Men, no exercise
(6) Women with exercise
(7) Men with exercise
(8) Women, no exercise
(9) Data for 22 of 26 intervention participants who were compliant with diet
(10) Change from baseline to 7.5 years
(11) preDM by IFT/IGT, change to 5 years
(12) Non-preDM, change to 5 years
(13) pre-DM by HbA1c, change to 5 years
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Analysis 3.2.   Comparison 3: Lower fat vs higher fat diet on body weight, subgrouping, Outcome 2: Weight, kg
Subgrouping by baseline fat intake
Study or Subgroup
3.2.1 > 35%E from fat
BDIT Pilot Studies 1996
Bloemberg 1991
CORDIOPREV 2016 (1)
CORDIOPREV 2016 (2)
CORDIOPREV 2016 (3)
De Bont 1981 (4)
De Bont 1981 (5)
MSFAT 1995
Pilkington 1960
RISCK 2010 (6)
RISCK 2010 (7)
Strychar 2009
WHI 2006 (8)
WHT Full-scale
WHT Vanguard 1991
WHTFSMP 2003
Yadav 2016 (9)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.20; Chi² = 43.88, df = 16 (P = 0.0002); I² = 64%
Test for overall effect: Z = 7.15 (P < 0.00001)
3.2.2 > 30 to 35%E from fat
Anderson 1990
BRIDGES 2001
Canadian DBCP 1997
Ma 2016
Nordevang 1990
Nutrition & Breast Health
ODMDC 2017
Polyp Prevention 1996
Simon 1997
Swinburn 2001
WHEL 2007
Subtotal (95% CI)
Heterogeneity: Tau² = 0.44; Chi² = 30.66, df = 10 (P = 0.0007); I² = 67%
Test for overall effect: Z = 2.68 (P = 0.007)
3.2.3 > 25 to 30%E from fat
DEER 1998 (10)
DEER 1998 (11)
DEER 1998 (12)
DEER 1998 (13)
WINS 1993
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 1.27, df = 4 (P = 0.87); I² = 0%
Test for overall effect: Z = 9.54 (P < 0.00001)
Total (95% CI)
Heterogeneity: Tau² = 0.39; Chi² = 128.06, df = 32 (P < 0.00001); I² = 75%
Test for overall effect: Z = 8.78 (P < 0.00001)
Test for subgroup differences: Chi² = 32.53, df = 2 (P < 0.00001), I² = 93.9%
Reduced fat
Mean
59.6
-0.94
-1.34
-1.27
-0.18
-2.7
-0.4
0.4
66.7
-0.8734
-0.8877
-0.83
-0.8
-1.9
-1.91
-1.8
-7.4
1.06
0.1
62
-1.2
-0.4
67.3
-1.6
-0.65
63.4
-1.6
74.1
-2.8
-2.7
-4.2
-3.1
-2.7
SD
7.3
2.68
6.3357
7.1294
5.4225
3.6
2.8
2.36
5.9
2.6017
2.1451
3
10.1
4.2
4.9
4
7.9
2.49
4.85
9.1
4.7476
5.5
13.8
1.0131
5.22
11.1
5.4
19.53
3.5
3.5
4.2
3.7
15.3
Total
76
39
98
88
30
34
36
117
12
117
111
15
16297
176
159
1325
22
18752
47
48
388
46
63
47
101
943
34
48
1308
3073
49
46
48
43
386
572
22397
Usual or modified fat
Mean
60.4
0.06
0.47
0.61
2.21
-0.9
0.1
1.12
70.8
0.1674
-0.0402
1.6
-0.1
-0.2
-0.08
-0.3
0.7
0.44
0.5
63.5
-1.1
1.3
66.4
-1.0019
0.31
71.9
2.13
73.7
0.5
0.8
-0.6
-0.4
0
SD
8.4
1.86
11.7962
7.8652
6.0576
3.5
2
2.36
5.2
1.8124
0.213
1.8
10.1
3.7
4.3
4.2
5.4
2.68
4.07
9.4
4.6433
5.5
12
1.0262
5.22
11.7
5
19.2
2.7
4.2
3.1
2.5
15.3
Total
78
40
115
92
39
35
29
103
23
115
110
15
25056
188
102
883
27
27050
51
46
401
44
106
50
206
943
38
51
1313
3249
46
45
47
43
998
1179
31478
Weight
1.3%
3.9%
1.3%
1.6%
1.1%
2.3%
3.5%
5.3%
0.6%
5.4%
6.0%
2.2%
6.5%
4.6%
3.6%
6.1%
0.6%
55.8%
3.9%
2.1%
3.1%
1.9%
2.2%
0.4%
6.4%
5.8%
0.3%
1.7%
2.7%
30.6%
3.2%
2.5%
2.7%
3.0%
2.1%
13.6%
100.0%
Mean Difference
IV, Random, 95% CI
-0.80 [-3.28 , 1.68]
-1.00 [-2.02 , 0.02]
-1.81 [-4.30 , 0.68]
-1.88 [-4.07 , 0.31]
-2.39 [-5.11 , 0.33]
-1.80 [-3.48 , -0.12]
-0.50 [-1.67 , 0.67]
-0.72 [-1.34 , -0.10]
-4.10 [-8.06 , -0.14]
-1.04 [-1.62 , -0.46]
-0.85 [-1.25 , -0.45]
-2.43 [-4.20 , -0.66]
-0.70 [-0.90 , -0.50]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-8.10 [-11.98 , -4.22]
-1.25 [-1.59 , -0.91]
0.62 [-0.40 , 1.64]
-0.40 [-2.21 , 1.41]
-1.50 [-2.79 , -0.21]
-0.10 [-2.04 , 1.84]
-1.70 [-3.41 , 0.01]
0.90 [-4.26 , 6.06]
-0.60 [-0.84 , -0.36]
-0.96 [-1.43 , -0.49]
-8.50 [-13.77 , -3.23]
-3.73 [-5.78 , -1.68]
0.40 [-1.08 , 1.88]
-0.81 [-1.40 , -0.22]
-3.30 [-4.55 , -2.05]
-3.50 [-5.09 , -1.91]
-3.60 [-5.08 , -2.12]
-2.70 [-4.03 , -1.37]
-2.70 [-4.50 , -0.90]
-3.17 [-3.82 , -2.52]
-1.42 [-1.73 , -1.10]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) preDM by IFT/IGT, change to 5 years
(2) pre-DM by HbA1c, change to 5 years
(3) Non-preDM, change to 5 years
(4) obese participants (BMI 28+)
(5) non-obese participants (BMI < 28)
(6) Low GI arms, Calculated from % change based on median baseline
(7) High GI arms; Calculated from % change based on median baseline
(8) Change from baseline to 7.5 years
(9) Data for 22 of 26 intervention participants who were compliant with diet
(10) Men, no exercise
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Analysis 3.2.   (Continued)
(9) Data for 22 of 26 intervention participants who were compliant with diet
(10) Men, no exercise
(11) Women, no exercise
(12) Men with exercise
(13) Women with exercise
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Analysis 3.3.   Comparison 3: Lower fat vs higher fat diet on body weight, subgrouping, Outcome 3: Weight, kg
Subgrouping by decade of first publication
Study or Subgroup
3.3.1 1960s
Pilkington 1960
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 2.03 (P = 0.04)
3.3.2 1970s
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
3.3.3 1980s
BDIT Pilot Studies 1996
De Bont 1981 (1)
De Bont 1981 (2)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 1.56, df = 2 (P = 0.46); I² = 0%
Test for overall effect: Z = 1.99 (P = 0.05)
3.3.4 1990s
Anderson 1990
Bloemberg 1991
Canadian DBCP 1997
DEER 1998 (3)
DEER 1998 (4)
DEER 1998 (5)
DEER 1998 (6)
MSFAT 1995
Nordevang 1990
Polyp Prevention 1996
Simon 1997
WHT Full-scale
WHT Vanguard 1991
WINS 1993
Subtotal (95% CI)
Heterogeneity: Tau² = 1.02; Chi² = 61.18, df = 13 (P < 0.00001); I² = 79%
Test for overall effect: Z = 5.71 (P < 0.00001)
3.3.5 2000s
BRIDGES 2001
Nutrition & Breast Health
Strychar 2009
Swinburn 2001
WHEL 2007
WHI 2006 (7)
WHTFSMP 2003
Subtotal (95% CI)
Heterogeneity: Tau² = 0.41; Chi² = 28.98, df = 6 (P < 0.0001); I² = 79%
Test for overall effect: Z = 3.27 (P = 0.001)
3.3.6 2010s
CORDIOPREV 2016 (8)
CORDIOPREV 2016 (9)
CORDIOPREV 2016 (10)
Ma 2016
ODMDC 2017
RISCK 2010 (11)
RISCK 2010 (12)
Yadav 2016 (13)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.23; Chi² = 20.05, df = 7 (P = 0.005); I² = 65%
Test for overall effect: Z = 3.84 (P = 0.0001)
Total (95% CI)
Reduced fat
Mean
66.7
59.6
-2.7
-0.4
1.06
-0.94
62
-2.8
-3.1
-4.2
-2.7
0.4
-0.4
-0.65
63.4
-1.9
-1.91
-2.7
0.1
67.3
-0.83
-1.6
74.1
-0.8
-1.8
-0.18
-1.27
-1.34
-1.2
-1.6
-0.8734
-0.8877
-7.4
SD
5.9
7.3
3.6
2.8
2.49
2.68
9.1
3.5
3.7
4.2
3.5
2.36
5.5
5.22
11.1
4.2
4.9
15.3
4.85
13.8
3
5.4
19.53
10.1
4
5.4225
7.1294
6.3357
4.7476
1.0131
2.6017
2.1451
7.9
Total
12
12
0
76
34
36
146
47
39
388
49
43
48
46
117
63
943
34
176
159
386
2538
48
47
15
48
1308
16297
1325
19088
30
88
98
46
101
117
111
22
613
22397
Usual or modified fat
Mean
70.8
60.4
-0.9
0.1
0.44
0.06
63.5
0.5
-0.4
-0.6
0.8
1.12
1.3
0.31
71.9
-0.2
-0.08
0
0.5
66.4
1.6
2.13
73.7
-0.1
-0.3
2.21
0.61
0.47
-1.1
-1.0019
0.1674
-0.0402
0.7
SD
5.2
8.4
3.5
2
2.68
1.86
9.4
2.7
2.5
3.1
4.2
2.36
5.5
5.22
11.7
3.7
4.3
15.3
4.07
12
1.8
5
19.2
10.1
4.2
6.0576
7.8652
11.7962
4.6433
1.0262
1.8124
0.213
5.4
Total
23
23
0
78
35
29
142
51
40
401
46
43
47
45
103
106
943
38
188
102
998
3151
46
50
15
51
1313
25056
883
27414
39
92
115
44
206
115
110
27
748
31478
Weight
0.6%
0.6%
1.3%
2.3%
3.5%
7.1%
3.9%
3.9%
3.1%
3.2%
3.0%
2.7%
2.5%
5.3%
2.2%
5.8%
0.3%
4.6%
3.6%
2.1%
46.4%
2.1%
0.4%
2.2%
1.7%
2.7%
6.5%
6.1%
21.6%
1.1%
1.6%
1.3%
1.9%
6.4%
5.4%
6.0%
0.6%
24.3%
100.0%
Mean Difference
IV, Random, 95% CI
-4.10 [-8.06 , -0.14]
-4.10 [-8.06 , -0.14]
Not estimable
-0.80 [-3.28 , 1.68]
-1.80 [-3.48 , -0.12]
-0.50 [-1.67 , 0.67]
-0.91 [-1.80 , -0.01]
0.62 [-0.40 , 1.64]
-1.00 [-2.02 , 0.02]
-1.50 [-2.79 , -0.21]
-3.30 [-4.55 , -2.05]
-2.70 [-4.03 , -1.37]
-3.60 [-5.08 , -2.12]
-3.50 [-5.09 , -1.91]
-0.72 [-1.34 , -0.10]
-1.70 [-3.41 , 0.01]
-0.96 [-1.43 , -0.49]
-8.50 [-13.77 , -3.23]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-2.70 [-4.50 , -0.90]
-1.86 [-2.49 , -1.22]
-0.40 [-2.21 , 1.41]
0.90 [-4.26 , 6.06]
-2.43 [-4.20 , -0.66]
-3.73 [-5.78 , -1.68]
0.40 [-1.08 , 1.88]
-0.70 [-0.90 , -0.50]
-1.50 [-1.85 , -1.15]
-1.15 [-1.85 , -0.46]
-2.39 [-5.11 , 0.33]
-1.88 [-4.07 , 0.31]
-1.81 [-4.30 , 0.68]
-0.10 [-2.04 , 1.84]
-0.60 [-0.84 , -0.36]
-1.04 [-1.62 , -0.46]
-0.85 [-1.25 , -0.45]
-8.10 [-11.98 , -4.22]
-1.04 [-1.58 , -0.51]
-1.42 [-1.73 , -1.10]
Mean Difference
IV, Random, 95% CI
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Analysis 3.3.   (Continued)
Total (95% CI)
Heterogeneity: Tau² = 0.39; Chi² = 128.06, df = 32 (P < 0.00001); I² = 75%
Test for overall effect: Z = 8.78 (P < 0.00001)
Test for subgroup differences: Chi² = 6.64, df = 4 (P = 0.16), I² = 39.8%
22397 31478 100.0% -1.42 [-1.73 , -1.10]
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) obese participants (BMI 28+)
(2) non-obese participants (BMI < 28)
(3) Men, no exercise
(4) Women with exercise
(5) Men with exercise
(6) Women, no exercise
(7) Change from baseline to 7.5 years
(8) Non-preDM, change to 5 years
(9) pre-DM by HbA1c, change to 5 years
(10) preDM by IFT/IGT, change to 5 years
(11) Low GI arms, Calculated from % change based on median baseline
(12) High GI arms; Calculated from % change based on median baseline
(13) Data for 22 of 26 intervention participants who were compliant with diet
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Analysis 3.4.   Comparison 3: Lower fat vs higher fat diet on body weight, subgrouping, Outcome 4: Weight, kg
Subgrouping by sex
Study or Subgroup
3.4.1 Studies of women only
BDIT Pilot Studies 1996
BRIDGES 2001
Canadian DBCP 1997
DEER 1998 (1)
DEER 1998 (2)
De Bont 1981 (3)
De Bont 1981 (4)
Nordevang 1990
Nutrition & Breast Health
Simon 1997
WHEL 2007
WHI 2006 (5)
WHT Full-scale
WHT Vanguard 1991
WHTFSMP 2003
WINS 1993
Subtotal (95% CI)
Heterogeneity: Tau² = 0.48; Chi² = 55.53, df = 15 (P < 0.00001); I² = 73%
Test for overall effect: Z = 5.94 (P < 0.00001)
3.4.2 Studies of men only
Bloemberg 1991
DEER 1998 (6)
DEER 1998 (7)
Pilkington 1960
Subtotal (95% CI)
Heterogeneity: Tau² = 1.77; Chi² = 12.43, df = 3 (P = 0.006); I² = 76%
Test for overall effect: Z = 3.41 (P = 0.0006)
3.4.3 Studies of men & women
Anderson 1990
CORDIOPREV 2016 (8)
CORDIOPREV 2016 (9)
CORDIOPREV 2016 (10)
MSFAT 1995
Ma 2016
ODMDC 2017
Polyp Prevention 1996
RISCK 2010 (11)
RISCK 2010 (12)
Strychar 2009
Swinburn 2001
Yadav 2016 (13)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.28; Chi² = 39.21, df = 12 (P < 0.0001); I² = 69%
Test for overall effect: Z = 4.66 (P < 0.00001)
Total (95% CI)
Heterogeneity: Tau² = 0.39; Chi² = 128.06, df = 32 (P < 0.00001); I² = 75%
Test for overall effect: Z = 8.78 (P < 0.00001)
Test for subgroup differences: Chi² = 5.45, df = 2 (P = 0.07), I² = 63.3%
Reduced fat
Mean
59.6
0.1
62
-3.1
-2.7
-0.4
-2.7
-0.4
67.3
63.4
74.1
-0.8
-1.9
-1.91
-1.8
-2.7
-0.94
-4.2
-2.8
66.7
1.06
-1.27
-0.18
-1.34
0.4
-1.2
-1.6
-0.65
-0.8734
-0.8877
-0.83
-1.6
-7.4
SD
7.3
4.85
9.1
3.7
3.5
2.8
3.6
5.5
13.8
11.1
19.53
10.1
4.2
4.9
4
15.3
2.68
4.2
3.5
5.9
2.49
7.1294
5.4225
6.3357
2.36
4.7476
1.0131
5.22
2.6017
2.1451
3
5.4
7.9
Total
76
48
388
43
46
36
34
63
47
34
1308
16297
176
159
1325
386
20466
39
48
49
12
148
47
88
30
98
117
46
101
943
117
111
15
48
22
1783
22397
Usual or modified fat
Mean
60.4
0.5
63.5
-0.4
0.8
0.1
-0.9
1.3
66.4
71.9
73.7
-0.1
-0.2
-0.08
-0.3
0
0.06
-0.6
0.5
70.8
0.44
0.61
2.21
0.47
1.12
-1.1
-1.0019
0.31
0.1674
-0.0402
1.6
2.13
0.7
SD
8.4
4.07
9.4
2.5
4.2
2
3.5
5.5
12
11.7
19.2
10.1
3.7
4.3
4.2
15.3
1.86
3.1
2.7
5.2
2.68
7.8652
6.0576
11.7962
2.36
4.6433
1.0262
5.22
1.8124
0.213
1.8
5
5.4
Total
78
46
401
43
45
29
35
106
50
38
1313
25056
188
102
883
998
29411
40
47
46
23
156
51
92
39
115
103
44
206
943
115
110
15
51
27
1911
31478
Weight
1.3%
2.1%
3.1%
3.0%
2.5%
3.5%
2.3%
2.2%
0.4%
0.3%
2.7%
6.5%
4.6%
3.6%
6.1%
2.1%
46.4%
3.9%
2.7%
3.2%
0.6%
10.4%
3.9%
1.6%
1.1%
1.3%
5.3%
1.9%
6.4%
5.8%
5.4%
6.0%
2.2%
1.7%
0.6%
43.2%
100.0%
Mean Difference
IV, Random, 95% CI
-0.80 [-3.28 , 1.68]
-0.40 [-2.21 , 1.41]
-1.50 [-2.79 , -0.21]
-2.70 [-4.03 , -1.37]
-3.50 [-5.09 , -1.91]
-0.50 [-1.67 , 0.67]
-1.80 [-3.48 , -0.12]
-1.70 [-3.41 , 0.01]
0.90 [-4.26 , 6.06]
-8.50 [-13.77 , -3.23]
0.40 [-1.08 , 1.88]
-0.70 [-0.90 , -0.50]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-2.70 [-4.50 , -0.90]
-1.49 [-1.98 , -1.00]
-1.00 [-2.02 , 0.02]
-3.60 [-5.08 , -2.12]
-3.30 [-4.55 , -2.05]
-4.10 [-8.06 , -0.14]
-2.74 [-4.32 , -1.17]
0.62 [-0.40 , 1.64]
-1.88 [-4.07 , 0.31]
-2.39 [-5.11 , 0.33]
-1.81 [-4.30 , 0.68]
-0.72 [-1.34 , -0.10]
-0.10 [-2.04 , 1.84]
-0.60 [-0.84 , -0.36]
-0.96 [-1.43 , -0.49]
-1.04 [-1.62 , -0.46]
-0.85 [-1.25 , -0.45]
-2.43 [-4.20 , -0.66]
-3.73 [-5.78 , -1.68]
-8.10 [-11.98 , -4.22]
-1.02 [-1.45 , -0.59]
-1.42 [-1.73 , -1.10]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) Women with exercise
(2) Women, no exercise
(3) non-obese participants (BMI < 28)
(4) obese participants (BMI 28+)
(5) Change from baseline to 7.5 years
(6) Men with exercise
(7) Men, no exercise
(8) pre-DM by HbA1c, change to 5 years
(9) Non-preDM, change to 5 years
(10) preDM by IFT/IGT, change to 5 years
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Analysis 3.4.   (Continued)
(9) Non-preDM, change to 5 years
(10) preDM by IFT/IGT, change to 5 years
(11) Low GI arms, Calculated from % change based on median baseline
(12) High GI arms; Calculated from % change based on median baseline
(13) Data for 22 of 26 intervention participants who were compliant with diet
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Analysis 3.5.   Comparison 3: Lower fat vs higher fat diet on body weight, subgrouping, Outcome 5: Weight, kg
Subgrouping by dierence in %E from fat between control & reduced fat groups
Study or Subgroup
3.5.1 Up to 5%E fat difference
Anderson 1990
BDIT Pilot Studies 1996
BRIDGES 2001
Bloemberg 1991
Ma 2016
WHEL 2007
Subtotal (95% CI)
Heterogeneity: Tau² = 0.08; Chi² = 5.71, df = 5 (P = 0.34); I² = 12%
Test for overall effect: Z = 0.47 (P = 0.64)
3.5.2 5% to < 10% E fat difference
CORDIOPREV 2016 (1)
CORDIOPREV 2016 (2)
CORDIOPREV 2016 (3)
DEER 1998 (4)
DEER 1998 (5)
DEER 1998 (6)
DEER 1998 (7)
De Bont 1981 (8)
De Bont 1981 (9)
MSFAT 1995
Nordevang 1990
RISCK 2010 (10)
RISCK 2010 (11)
Swinburn 2001
WHI 2006 (12)
WINS 1993
Subtotal (95% CI)
Heterogeneity: Tau² = 0.52; Chi² = 64.36, df = 15 (P < 0.00001); I² = 77%
Test for overall effect: Z = 7.14 (P < 0.00001)
3.5.3 10% to < 15%E fat difference
Canadian DBCP 1997
ODMDC 2017
Polyp Prevention 1996
WHT Full-scale
WHT Vanguard 1991
WHTFSMP 2003
Subtotal (95% CI)
Heterogeneity: Tau² = 0.24; Chi² = 21.16, df = 5 (P = 0.0008); I² = 76%
Test for overall effect: Z = 4.95 (P < 0.00001)
3.5.4 15+%E fat difference
Nutrition & Breast Health
ODMDC 2017
Pilkington 1960
Simon 1997
Yadav 2016 (13)
Subtotal (95% CI)
Heterogeneity: Tau² = 13.75; Chi² = 25.22, df = 4 (P < 0.0001); I² = 84%
Test for overall effect: Z = 2.08 (P = 0.04)
3.5.5 %E fat difference not stated
Strychar 2009
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 2.69 (P = 0.007)
Total (95% CI)
Heterogeneity: Tau² = 0.38; Chi² = 128.67, df = 33 (P < 0.00001); I² = 74%
Test for overall effect: Z = 8.81 (P < 0.00001)
Test for subgroup differences: Chi² = 19.98, df = 4 (P = 0.0005), I² = 80.0%
Reduced fat
Mean
1.06
59.6
0.1
-0.94
-1.2
74.1
-0.18
-1.34
-1.27
-2.8
-2.7
-3.1
-4.2
-2.7
-0.4
0.4
-0.4
-0.8734
-0.8877
-1.6
-0.8
-2.7
62
-1.6
-0.65
-1.9
-1.91
-1.8
67.3
-1.6
66.7
63.4
-7.4
-0.83
SD
2.49
7.3
4.85
2.68
4.7476
19.53
5.4225
6.3357
7.1294
3.5
3.5
3.7
4.2
3.6
2.8
2.36
5.5
2.6017
2.1451
5.4
10.1
15.3
9.1
1.0131
5.22
4.2
4.9
4
13.8
1.0131
5.9
11.1
7.9
3
Total
47
76
48
39
46
1308
1564
30
98
88
49
46
43
48
34
36
117
63
117
111
48
16297
386
17611
388
51
943
176
159
1325
3042
47
50
12
34
22
165
15
15
22397
Usual or modified fat
Mean
0.44
60.4
0.5
0.06
-1.1
73.7
2.21
0.47
0.61
0.5
0.8
-0.4
-0.6
-0.9
0.1
1.12
1.3
0.1674
-0.0402
2.13
-0.1
0
63.5
-1.1
0.31
-0.2
-0.08
-0.3
66.4
-0.9
70.8
71.9
0.7
1.6
SD
2.68
8.4
4.07
1.86
4.6433
19.2
6.0576
11.7962
7.8652
2.7
4.2
2.5
3.1
3.5
2
2.36
5.5
1.8124
0.213
5
10.1
15.3
9.4
1.0335
5.22
3.7
4.3
4.2
12
1.0131
5.2
11.7
5.4
1.8
Total
51
78
46
40
44
1313
1572
39
115
92
46
45
43
47
35
29
103
106
115
110
51
25056
998
27030
401
105
943
188
102
883
2622
50
101
23
38
27
239
15
15
31478
Weight
3.7%
1.2%
2.0%
3.7%
1.8%
2.5%
14.8%
1.0%
1.2%
1.5%
3.1%
2.3%
2.9%
2.5%
2.2%
3.3%
5.0%
2.1%
5.2%
5.7%
1.6%
6.2%
2.0%
47.6%
3.0%
5.9%
5.5%
4.4%
3.4%
5.8%
27.9%
0.3%
5.9%
0.5%
0.3%
0.6%
7.6%
2.0%
2.0%
100.0%
Mean Difference
IV, Random, 95% CI
0.62 [-0.40 , 1.64]
-0.80 [-3.28 , 1.68]
-0.40 [-2.21 , 1.41]
-1.00 [-2.02 , 0.02]
-0.10 [-2.04 , 1.84]
0.40 [-1.08 , 1.88]
-0.15 [-0.77 , 0.47]
-2.39 [-5.11 , 0.33]
-1.81 [-4.30 , 0.68]
-1.88 [-4.07 , 0.31]
-3.30 [-4.55 , -2.05]
-3.50 [-5.09 , -1.91]
-2.70 [-4.03 , -1.37]
-3.60 [-5.08 , -2.12]
-1.80 [-3.48 , -0.12]
-0.50 [-1.67 , 0.67]
-0.72 [-1.34 , -0.10]
-1.70 [-3.41 , 0.01]
-1.04 [-1.62 , -0.46]
-0.85 [-1.25 , -0.45]
-3.73 [-5.78 , -1.68]
-0.70 [-0.90 , -0.50]
-2.70 [-4.50 , -0.90]
-1.76 [-2.25 , -1.28]
-1.50 [-2.79 , -0.21]
-0.50 [-0.84 , -0.16]
-0.96 [-1.43 , -0.49]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-1.23 [-1.72 , -0.74]
0.90 [-4.26 , 6.06]
-0.70 [-1.04 , -0.36]
-4.10 [-8.06 , -0.14]
-8.50 [-13.77 , -3.23]
-8.10 [-11.98 , -4.22]
-3.91 [-7.61 , -0.22]
-2.43 [-4.20 , -0.66]
-2.43 [-4.20 , -0.66]
-1.36 [-1.67 , -1.06]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
 
Eects of total fat intake on body fatness in adults (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
148
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
 
Analysis 3.5.   (Continued)
Test for subgroup differences: Chi² = 19.98, df = 4 (P = 0.0005), I² = 80.0%
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) Non-preDM, change to 5 years
(2) preDM by IFT/IGT, change to 5 years
(3) pre-DM by HbA1c, change to 5 years
(4) Men, no exercise
(5) Women, no exercise
(6) Women with exercise
(7) Men with exercise
(8) obese participants (BMI 28+)
(9) non-obese participants (BMI < 28)
(10) Low GI arms, Calculated from % change based on median baseline
(11) High GI arms; Calculated from % change based on median baseline
(12) Change from baseline to 7.5 years
(13) Data for 22 of 26 intervention participants who were compliant with diet
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Analysis 3.6.   Comparison 3: Lower fat vs higher fat diet on body weight,
subgrouping, Outcome 6: Weight, kg Subgrouping by achieving < 30%E from fat
Study or Subgroup
3.6.1 Intervention did not achieve < 30%E from fat or less
BDIT Pilot Studies 1996
Bloemberg 1991
CORDIOPREV 2016 (1)
CORDIOPREV 2016 (2)
CORDIOPREV 2016 (3)
De Bont 1981 (4)
De Bont 1981 (5)
MSFAT 1995
Ma 2016
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 5.01, df = 8 (P = 0.76); I² = 0%
Test for overall effect: Z = 4.14 (P < 0.0001)
3.6.2 Intervention achieved < 30%E from fat or less
Anderson 1990
BRIDGES 2001
Canadian DBCP 1997
DEER 1998 (6)
DEER 1998 (7)
DEER 1998 (8)
DEER 1998 (9)
Nordevang 1990
Nutrition & Breast Health
ODMDC 2017
Pilkington 1960
Polyp Prevention 1996
RISCK 2010 (10)
RISCK 2010 (11)
Simon 1997
Strychar 2009
Swinburn 2001
WHEL 2007
WHI 2006 (12)
WHT Full-scale
WHT Vanguard 1991
WHTFSMP 2003
WINS 1993
Yadav 2016 (13)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.45; Chi² = 123.01, df = 23 (P < 0.00001); I² = 81%
Test for overall effect: Z = 8.09 (P < 0.00001)
Total (95% CI)
Heterogeneity: Tau² = 0.39; Chi² = 128.06, df = 32 (P < 0.00001); I² = 75%
Test for overall effect: Z = 8.78 (P < 0.00001)
Test for subgroup differences: Chi² = 5.12, df = 1 (P = 0.02), I² = 80.5%
Reduced fat
Mean
59.6
-0.94
-0.18
-1.27
-1.34
-2.7
-0.4
0.4
-1.2
1.06
0.1
62
-3.1
-2.7
-2.8
-4.2
-0.4
67.3
-1.6
66.7
-0.65
-0.8877
-0.8734
63.4
-0.83
-1.6
74.1
-0.8
-1.9
-1.91
-1.8
-2.7
-7.4
SD
7.3
2.68
5.4225
7.1294
6.3357
3.6
2.8
2.36
4.7476
2.49
4.85
9.1
3.7
3.5
3.5
4.2
5.5
13.8
1.0131
5.9
5.22
2.1451
2.6017
11.1
3
5.4
19.53
10.1
4.2
4.9
4
15.3
7.9
Total
76
39
30
88
98
34
36
117
46
564
47
48
388
43
46
49
48
63
47
101
12
943
111
117
34
15
48
1308
16297
176
159
1325
386
22
21833
22397
Usual or modified fat
Mean
60.4
0.06
2.21
0.61
0.47
-0.9
0.1
1.12
-1.1
0.44
0.5
63.5
-0.4
0.8
0.5
-0.6
1.3
66.4
-1.0019
70.8
0.31
-0.0402
0.1674
71.9
1.6
2.13
73.7
-0.1
-0.2
-0.08
-0.3
0
0.7
SD
8.4
1.86
6.0576
7.8652
11.7962
3.5
2
2.36
4.6433
2.68
4.07
9.4
2.5
4.2
2.7
3.1
5.5
12
1.0262
5.2
5.22
0.213
1.8124
11.7
1.8
5
19.2
10.1
3.7
4.3
4.2
15.3
5.4
Total
78
40
39
92
115
35
29
103
44
575
51
46
401
43
45
46
47
106
50
206
23
943
110
115
38
15
51
1313
25056
188
102
883
998
27
30903
31478
Weight
1.3%
3.9%
1.1%
1.6%
1.3%
2.3%
3.5%
5.3%
1.9%
22.2%
3.9%
2.1%
3.1%
3.0%
2.5%
3.2%
2.7%
2.2%
0.4%
6.4%
0.6%
5.8%
6.0%
5.4%
0.3%
2.2%
1.7%
2.7%
6.5%
4.6%
3.6%
6.1%
2.1%
0.6%
77.8%
100.0%
Mean Difference
IV, Random, 95% CI
-0.80 [-3.28 , 1.68]
-1.00 [-2.02 , 0.02]
-2.39 [-5.11 , 0.33]
-1.88 [-4.07 , 0.31]
-1.81 [-4.30 , 0.68]
-1.80 [-3.48 , -0.12]
-0.50 [-1.67 , 0.67]
-0.72 [-1.34 , -0.10]
-0.10 [-2.04 , 1.84]
-0.90 [-1.32 , -0.47]
0.62 [-0.40 , 1.64]
-0.40 [-2.21 , 1.41]
-1.50 [-2.79 , -0.21]
-2.70 [-4.03 , -1.37]
-3.50 [-5.09 , -1.91]
-3.30 [-4.55 , -2.05]
-3.60 [-5.08 , -2.12]
-1.70 [-3.41 , 0.01]
0.90 [-4.26 , 6.06]
-0.60 [-0.84 , -0.36]
-4.10 [-8.06 , -0.14]
-0.96 [-1.43 , -0.49]
-0.85 [-1.25 , -0.45]
-1.04 [-1.62 , -0.46]
-8.50 [-13.77 , -3.23]
-2.43 [-4.20 , -0.66]
-3.73 [-5.78 , -1.68]
0.40 [-1.08 , 1.88]
-0.70 [-0.90 , -0.50]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-2.70 [-4.50 , -0.90]
-8.10 [-11.98 , -4.22]
-1.55 [-1.93 , -1.18]
-1.42 [-1.73 , -1.10]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) Non-preDM, change to 5 years
(2) pre-DM by HbA1c, change to 5 years
(3) preDM by IFT/IGT, change to 5 years
(4) obese participants (BMI 28+)
(5) non-obese participants (BMI < 28)
(6) Women with exercise
(7) Women, no exercise
(8) Men, no exercise
(9) Men with exercise
(10) High GI arms; Calculated from % change based on median baseline
(11) Low GI arms, Calculated from % change based on median baseline
(12) Change from baseline to 7.5 years
(13) Data for 22 of 26 intervention participants who were compliant with diet
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Analysis 3.7.   Comparison 3: Lower fat vs higher fat diet on body weight, subgrouping, Outcome 7: Weight, kg
Subgrouping by type of intervention
Study or Subgroup
3.7.1 Dietary advice
Anderson 1990
BDIT Pilot Studies 1996
BRIDGES 2001
Bloemberg 1991
Canadian DBCP 1997
DEER 1998 (1)
DEER 1998 (2)
DEER 1998 (3)
DEER 1998 (4)
De Bont 1981 (5)
De Bont 1981 (6)
Ma 2016
Nordevang 1990
Nutrition & Breast Health
Pilkington 1960
Polyp Prevention 1996
Simon 1997
Strychar 2009
Swinburn 2001
WHEL 2007
WHI 2006 (7)
WHT Full-scale
WHT Vanguard 1991
WHTFSMP 2003
WINS 1993
Yadav 2016 (8)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.70; Chi² = 114.64, df = 25 (P < 0.00001); I² = 78%
Test for overall effect: Z = 7.35 (P < 0.00001)
3.7.2 Dietary advice plus supplements
CORDIOPREV 2016 (9)
CORDIOPREV 2016 (10)
CORDIOPREV 2016 (11)
RISCK 2010 (12)
RISCK 2010 (13)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 2.56, df = 4 (P = 0.63); I² = 0%
Test for overall effect: Z = 5.91 (P < 0.00001)
3.7.3 Diet provided
MSFAT 1995
ODMDC 2017
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.13, df = 1 (P = 0.72); I² = 0%
Test for overall effect: Z = 5.33 (P < 0.00001)
Total (95% CI)
Heterogeneity: Tau² = 0.39; Chi² = 128.06, df = 32 (P < 0.00001); I² = 75%
Test for overall effect: Z = 8.78 (P < 0.00001)
Test for subgroup differences: Chi² = 17.40, df = 2 (P = 0.0002), I² = 88.5%
Reduced fat
Mean
1.06
59.6
0.1
-0.94
62
-4.2
-3.1
-2.7
-2.8
-0.4
-2.7
-1.2
-0.4
67.3
66.7
-0.65
63.4
-0.83
-1.6
74.1
-0.8
-1.9
-1.91
-1.8
-2.7
-7.4
-1.34
-0.18
-1.27
-0.8877
-0.8734
0.4
-1.6
SD
2.49
7.3
4.85
2.68
9.1
4.2
3.7
3.5
3.5
2.8
3.6
4.7476
5.5
13.8
5.9
5.22
11.1
3
5.4
19.53
10.1
4.2
4.9
4
15.3
7.9
6.3357
5.4225
7.1294
2.1451
2.6017
2.36
1.0131
Total
47
76
48
39
388
48
43
46
49
36
34
46
63
47
12
943
34
15
48
1308
16297
176
159
1325
386
22
21735
98
30
88
111
117
444
117
101
218
22397
Usual or modified fat
Mean
0.44
60.4
0.5
0.06
63.5
-0.6
-0.4
0.8
0.5
0.1
-0.9
-1.1
1.3
66.4
70.8
0.31
71.9
1.6
2.13
73.7
-0.1
-0.2
-0.08
-0.3
0
0.7
0.47
2.21
0.61
-0.0402
0.1674
1.12
-1.0019
SD
2.68
8.4
4.07
1.86
9.4
3.1
2.5
4.2
2.7
2
3.5
4.6433
5.5
12
5.2
5.22
11.7
1.8
5
19.2
10.1
3.7
4.3
4.2
15.3
5.4
11.7962
6.0576
7.8652
0.213
1.8124
2.36
1.0262
Total
51
78
46
40
401
47
43
45
46
29
35
44
106
50
23
943
38
15
51
1313
25056
188
102
883
998
27
30698
115
39
92
110
115
471
103
206
309
31478
Weight
3.9%
1.3%
2.1%
3.9%
3.1%
2.7%
3.0%
2.5%
3.2%
3.5%
2.3%
1.9%
2.2%
0.4%
0.6%
5.8%
0.3%
2.2%
1.7%
2.7%
6.5%
4.6%
3.6%
6.1%
2.1%
0.6%
72.9%
1.3%
1.1%
1.6%
6.0%
5.4%
15.4%
5.3%
6.4%
11.7%
100.0%
Mean Difference
IV, Random, 95% CI
0.62 [-0.40 , 1.64]
-0.80 [-3.28 , 1.68]
-0.40 [-2.21 , 1.41]
-1.00 [-2.02 , 0.02]
-1.50 [-2.79 , -0.21]
-3.60 [-5.08 , -2.12]
-2.70 [-4.03 , -1.37]
-3.50 [-5.09 , -1.91]
-3.30 [-4.55 , -2.05]
-0.50 [-1.67 , 0.67]
-1.80 [-3.48 , -0.12]
-0.10 [-2.04 , 1.84]
-1.70 [-3.41 , 0.01]
0.90 [-4.26 , 6.06]
-4.10 [-8.06 , -0.14]
-0.96 [-1.43 , -0.49]
-8.50 [-13.77 , -3.23]
-2.43 [-4.20 , -0.66]
-3.73 [-5.78 , -1.68]
0.40 [-1.08 , 1.88]
-0.70 [-0.90 , -0.50]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-2.70 [-4.50 , -0.90]
-8.10 [-11.98 , -4.22]
-1.65 [-2.09 , -1.21]
-1.81 [-4.30 , 0.68]
-2.39 [-5.11 , 0.33]
-1.88 [-4.07 , 0.31]
-0.85 [-1.25 , -0.45]
-1.04 [-1.62 , -0.46]
-0.97 [-1.29 , -0.65]
-0.72 [-1.34 , -0.10]
-0.60 [-0.84 , -0.36]
-0.61 [-0.84 , -0.39]
-1.42 [-1.73 , -1.10]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) Men with exercise
(2) Women with exercise
(3) Women, no exercise
(4) Men, no exercise
(5) non-obese participants (BMI < 28)
(6) obese participants (BMI 28+)
(7) Change from baseline to 7.5 years
(8) Data for 22 of 26 intervention participants who were compliant with diet
(9) preDM by IFT/IGT, change to 5 years
(10) Non-preDM, change to 5 years
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Analysis 3.7.   (Continued)
(9) preDM by IFT/IGT, change to 5 years
(10) Non-preDM, change to 5 years
(11) pre-DM by HbA1c, change to 5 years
(12) High GI arms; Calculated from % change based on median baseline
(13) Low GI arms, Calculated from % change based on median baseline
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Analysis 3.8.   Comparison 3: Lower fat vs higher fat diet on body weight, subgrouping, Outcome 8: Weight, kg
Subgrouping by lower fat arm fat goal
Study or Subgroup
3.8.1 Goal 30%E from fat
Bloemberg 1991
De Bont 1981 (1)
De Bont 1981 (2)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 1.57, df = 2 (P = 0.46); I² = 0%
Test for overall effect: Z = 2.69 (P = 0.007)
3.8.2 Goal 25 to < 30%E from fat
Anderson 1990
CORDIOPREV 2016 (3)
CORDIOPREV 2016 (4)
CORDIOPREV 2016 (5)
DEER 1998 (6)
DEER 1998 (7)
DEER 1998 (8)
DEER 1998 (9)
Ma 2016
RISCK 2010 (10)
RISCK 2010 (11)
Subtotal (95% CI)
Heterogeneity: Tau² = 1.18; Chi² = 51.73, df = 10 (P < 0.00001); I² = 81%
Test for overall effect: Z = 4.41 (P < 0.0001)
3.8.3 Goal 20 to < 25%E from fat
BRIDGES 2001
Nordevang 1990
ODMDC 2017
Polyp Prevention 1996
Subtotal (95% CI)
Heterogeneity: Tau² = 0.01; Chi² = 3.24, df = 3 (P = 0.36); I² = 8%
Test for overall effect: Z = 5.53 (P < 0.00001)
3.8.4 Goal 15 to < 20%E from fat
BDIT Pilot Studies 1996
Canadian DBCP 1997
Nutrition & Breast Health
Simon 1997
Strychar 2009
Swinburn 2001
WHEL 2007
WHI 2006 (12)
WHT Full-scale
WHT Vanguard 1991
WHTFSMP 2003
WINS 1993
Yadav 2016 (13)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.64; Chi² = 59.35, df = 12 (P < 0.00001); I² = 80%
Test for overall effect: Z = 5.43 (P < 0.00001)
3.8.5 Goal 10 to < 15%E from fat
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
3.8.6 Goal unclear
MSFAT 1995
Pilkington 1960
Subtotal (95% CI)
Heterogeneity: Tau² = 3.62; Chi² = 2.73, df = 1 (P = 0.10); I² = 63%
Test for overall effect: Z = 1.15 (P = 0.25)
Total (95% CI)
Reduced fat
Mean
-0.94
-2.7
-0.4
1.06
-0.18
-1.34
-1.27
-2.8
-4.2
-3.1
-2.7
-1.2
-0.8877
-0.8734
0.1
-0.4
-1.6
-0.65
59.6
62
67.3
63.4
-0.83
-1.6
74.1
-0.8
-1.9
-1.91
-1.8
-2.7
-7.4
0.4
66.7
SD
2.68
3.6
2.8
2.49
5.4225
6.3357
7.1294
3.5
4.2
3.7
3.5
4.7476
2.1451
2.6017
4.85
5.5
1.0131
5.22
7.3
9.1
13.8
11.1
3
5.4
19.53
10.1
4.2
4.9
4
15.3
7.9
2.36
5.9
Total
39
34
36
109
47
30
98
88
49
48
43
46
46
111
117
723
48
63
101
943
1155
76
388
47
34
15
48
1308
16297
176
159
1325
386
22
20281
0
117
12
129
22397
Usual or modified fat
Mean
0.06
-0.9
0.1
0.44
2.21
0.47
0.61
0.5
-0.6
-0.4
0.8
-1.1
-0.0402
0.1674
0.5
1.3
-1.0019
0.31
60.4
63.5
66.4
71.9
1.6
2.13
73.7
-0.1
-0.2
-0.08
-0.3
0
0.7
1.12
70.8
SD
1.86
3.5
2
2.68
6.0576
11.7962
7.8652
2.7
3.1
2.5
4.2
4.6433
0.213
1.8124
4.07
5.5
1.0262
5.22
8.4
9.4
12
11.7
1.8
5
19.2
10.1
3.7
4.3
4.2
15.3
5.4
2.36
5.2
Total
40
35
29
104
51
39
115
92
46
47
43
45
44
110
115
747
46
106
206
943
1301
78
401
50
38
15
51
1313
25056
188
102
883
998
27
29200
0
103
23
126
31478
Weight
3.9%
2.3%
3.5%
9.7%
3.9%
1.1%
1.3%
1.6%
3.2%
2.7%
3.0%
2.5%
1.9%
6.0%
5.4%
32.7%
2.1%
2.2%
6.4%
5.8%
16.5%
1.3%
3.1%
0.4%
0.3%
2.2%
1.7%
2.7%
6.5%
4.6%
3.6%
6.1%
2.1%
0.6%
35.2%
5.3%
0.6%
5.8%
100.0%
Mean Difference
IV, Random, 95% CI
-1.00 [-2.02 , 0.02]
-1.80 [-3.48 , -0.12]
-0.50 [-1.67 , 0.67]
-0.96 [-1.66 , -0.26]
0.62 [-0.40 , 1.64]
-2.39 [-5.11 , 0.33]
-1.81 [-4.30 , 0.68]
-1.88 [-4.07 , 0.31]
-3.30 [-4.55 , -2.05]
-3.60 [-5.08 , -2.12]
-2.70 [-4.03 , -1.37]
-3.50 [-5.09 , -1.91]
-0.10 [-2.04 , 1.84]
-0.85 [-1.25 , -0.45]
-1.04 [-1.62 , -0.46]
-1.77 [-2.56 , -0.99]
-0.40 [-2.21 , 1.41]
-1.70 [-3.41 , 0.01]
-0.60 [-0.84 , -0.36]
-0.96 [-1.43 , -0.49]
-0.71 [-0.96 , -0.46]
-0.80 [-3.28 , 1.68]
-1.50 [-2.79 , -0.21]
0.90 [-4.26 , 6.06]
-8.50 [-13.77 , -3.23]
-2.43 [-4.20 , -0.66]
-3.73 [-5.78 , -1.68]
0.40 [-1.08 , 1.88]
-0.70 [-0.90 , -0.50]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-2.70 [-4.50 , -0.90]
-8.10 [-11.98 , -4.22]
-1.73 [-2.35 , -1.10]
Not estimable
-0.72 [-1.34 , -0.10]
-4.10 [-8.06 , -0.14]
-1.82 [-4.93 , 1.28]
-1.42 [-1.73 , -1.10]
Mean Difference
IV, Random, 95% CI
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Total (95% CI)
Heterogeneity: Tau² = 0.39; Chi² = 128.06, df = 32 (P < 0.00001); I² = 75%
Test for overall effect: Z = 8.78 (P < 0.00001)
Test for subgroup differences: Chi² = 14.00, df = 4 (P = 0.007), I² = 71.4%
22397 31478 100.0% -1.42 [-1.73 , -1.10]
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) obese participants (BMI 28+)
(2) non-obese participants (BMI < 28)
(3) Non-preDM, change to 5 years
(4) preDM by IFT/IGT, change to 5 years
(5) pre-DM by HbA1c, change to 5 years
(6) Men, no exercise
(7) Men with exercise
(8) Women with exercise
(9) Women, no exercise
(10) High GI arms; Calculated from % change based on median baseline
(11) Low GI arms, Calculated from % change based on median baseline
(12) Change from baseline to 7.5 years
(13) Data for 22 of 26 intervention participants who were compliant with diet
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Analysis 3.9.   Comparison 3: Lower fat vs higher fat diet on body weight, subgrouping, Outcome 9: Weight, kg
Subgrouping by mean BMI at baseline
Study or Subgroup
3.9.1 BMI at baseline < 25
Anderson 1990
BDIT Pilot Studies 1996
Canadian DBCP 1997
De Bont 1981 (1)
De Bont 1981 (2)
MSFAT 1995
Nordevang 1990
ODMDC 2017
Pilkington 1960
Strychar 2009
Subtotal (95% CI)
Heterogeneity: Tau² = 0.23; Chi² = 17.93, df = 9 (P = 0.04); I² = 50%
Test for overall effect: Z = 3.44 (P = 0.0006)
3.9.2 BMI at baseline # 25 to 29.9
BRIDGES 2001
Bloemberg 1991
DEER 1998 (3)
DEER 1998 (4)
DEER 1998 (5)
DEER 1998 (6)
Ma 2016
Nutrition & Breast Health
Polyp Prevention 1996
RISCK 2010 (7)
RISCK 2010 (8)
Simon 1997
Swinburn 2001
WHEL 2007
WHI 2006 (9)
WHT Vanguard 1991
WHTFSMP 2003
WINS 1993
Yadav 2016 (10)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.53; Chi² = 95.59, df = 18 (P < 0.00001); I² = 81%
Test for overall effect: Z = 7.24 (P < 0.00001)
3.9.3 BMI at baseline # 30
CORDIOPREV 2016 (11)
CORDIOPREV 2016 (12)
CORDIOPREV 2016 (13)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.11, df = 2 (P = 0.95); I² = 0%
Test for overall effect: Z = 2.78 (P = 0.005)
3.9.4 BMI at baseline unclear
WHT Full-scale
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 4.09 (P < 0.0001)
Total (95% CI)
Heterogeneity: Tau² = 0.39; Chi² = 128.06, df = 32 (P < 0.00001); I² = 75%
Test for overall effect: Z = 8.78 (P < 0.00001)
Test for subgroup differences: Chi² = 7.25, df = 3 (P = 0.06), I² = 58.6%
Reduced fat
Mean
1.06
59.6
62
-2.7
-0.4
0.4
-0.4
-1.6
66.7
-0.83
0.1
-0.94
-4.2
-2.7
-2.8
-3.1
-1.2
67.3
-0.65
-0.8734
-0.8877
63.4
-1.6
74.1
-0.8
-1.91
-1.8
-2.7
-7.4
-1.34
-0.18
-1.27
-1.9
SD
2.49
7.3
9.1
3.6
2.8
2.36
5.5
1.0131
5.9
3
4.85
2.68
4.2
3.5
3.5
3.7
4.7476
13.8
5.22
2.6017
2.1451
11.1
5.4
19.53
10.1
4.9
4
15.3
7.9
6.3357
5.4225
7.1294
4.2
Total
47
76
388
34
36
117
63
101
12
15
889
48
39
48
46
49
43
46
47
943
117
111
34
48
1308
16297
159
1325
386
22
21116
98
30
88
216
176
176
22397
Usual or modified fat
Mean
0.44
60.4
63.5
-0.9
0.1
1.12
1.3
-1.0019
70.8
1.6
0.5
0.06
-0.6
0.8
0.5
-0.4
-1.1
66.4
0.31
0.1674
-0.0402
71.9
2.13
73.7
-0.1
-0.08
-0.3
0
0.7
0.47
2.21
0.61
-0.2
SD
2.68
8.4
9.4
3.5
2
2.36
5.5
1.0262
5.2
1.8
4.07
1.86
3.1
4.2
2.7
2.5
4.6433
12
5.22
1.8124
0.213
11.7
5
19.2
10.1
4.3
4.2
15.3
5.4
11.7962
6.0576
7.8652
3.7
Total
51
78
401
35
29
103
106
206
23
15
1047
46
40
47
45
46
43
44
50
943
115
110
38
51
1313
25056
102
883
998
27
29997
115
39
92
246
188
188
31478
Weight
3.9%
1.3%
3.1%
2.3%
3.5%
5.3%
2.2%
6.4%
0.6%
2.2%
30.8%
2.1%
3.9%
2.7%
2.5%
3.2%
3.0%
1.9%
0.4%
5.8%
5.4%
6.0%
0.3%
1.7%
2.7%
6.5%
3.6%
6.1%
2.1%
0.6%
60.6%
1.3%
1.1%
1.6%
4.0%
4.6%
4.6%
100.0%
Mean Difference
IV, Random, 95% CI
0.62 [-0.40 , 1.64]
-0.80 [-3.28 , 1.68]
-1.50 [-2.79 , -0.21]
-1.80 [-3.48 , -0.12]
-0.50 [-1.67 , 0.67]
-0.72 [-1.34 , -0.10]
-1.70 [-3.41 , 0.01]
-0.60 [-0.84 , -0.36]
-4.10 [-8.06 , -0.14]
-2.43 [-4.20 , -0.66]
-0.86 [-1.34 , -0.37]
-0.40 [-2.21 , 1.41]
-1.00 [-2.02 , 0.02]
-3.60 [-5.08 , -2.12]
-3.50 [-5.09 , -1.91]
-3.30 [-4.55 , -2.05]
-2.70 [-4.03 , -1.37]
-0.10 [-2.04 , 1.84]
0.90 [-4.26 , 6.06]
-0.96 [-1.43 , -0.49]
-1.04 [-1.62 , -0.46]
-0.85 [-1.25 , -0.45]
-8.50 [-13.77 , -3.23]
-3.73 [-5.78 , -1.68]
0.40 [-1.08 , 1.88]
-0.70 [-0.90 , -0.50]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-2.70 [-4.50 , -0.90]
-8.10 [-11.98 , -4.22]
-1.66 [-2.11 , -1.21]
-1.81 [-4.30 , 0.68]
-2.39 [-5.11 , 0.33]
-1.88 [-4.07 , 0.31]
-1.99 [-3.40 , -0.59]
-1.70 [-2.52 , -0.88]
-1.70 [-2.52 , -0.88]
-1.42 [-1.73 , -1.10]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) obese participants (BMI 28+)
(2) non-obese participants (BMI < 28)
(3) Men with exercise
(4) Women, no exercise
(5) Men, no exercise
 
Eects of total fat intake on body fatness in adults (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
155
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
 
Analysis 3.9.   (Continued)
(4) Women, no exercise
(5) Men, no exercise
(6) Women with exercise
(7) Low GI arms, Calculated from % change based on median baseline
(8) High GI arms; Calculated from % change based on median baseline
(9) Change from baseline to 7.5 years
(10) Data for 22 of 26 intervention participants who were compliant with diet
(11) preDM by IFT/IGT, change to 5 years
(12) Non-preDM, change to 5 years
(13) pre-DM by HbA1c, change to 5 years
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Analysis 3.10.   Comparison 3: Lower fat vs higher fat diet on body weight, subgrouping, Outcome 10: Weight, kg
Subgrouping by baseline health status
Study or Subgroup
3.10.1 Healthy people, not recruited on the basis of risk factors or illness
MSFAT 1995
ODMDC 2017
WHI 2006 (1)
WHTFSMP 2003
Subtotal (95% CI)
Heterogeneity: Tau² = 0.12; Chi² = 18.97, df = 3 (P = 0.0003); I² = 84%
Test for overall effect: Z = 4.45 (P < 0.00001)
3.10.2 People recruited on the basis of risk factors such as lipids, BMI, hormone levels, risk scores
Anderson 1990
BDIT Pilot Studies 1996
Bloemberg 1991
Canadian DBCP 1997
DEER 1998 (2)
DEER 1998 (3)
DEER 1998 (4)
DEER 1998 (5)
Nutrition & Breast Health
RISCK 2010 (6)
RISCK 2010 (7)
Simon 1997
Swinburn 2001
WHT Full-scale
WHT Vanguard 1991
Subtotal (95% CI)
Heterogeneity: Tau² = 1.01; Chi² = 65.40, df = 14 (P < 0.00001); I² = 79%
Test for overall effect: Z = 5.68 (P < 0.00001)
3.10.3 People with disease such as DM, MI, cancer, polypsp
BRIDGES 2001
CORDIOPREV 2016 (8)
CORDIOPREV 2016 (9)
CORDIOPREV 2016 (10)
De Bont 1981 (11)
De Bont 1981 (12)
Ma 2016
Nordevang 1990
Pilkington 1960
Polyp Prevention 1996
Strychar 2009
WHEL 2007
WINS 1993
Yadav 2016 (13)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.77; Chi² = 29.58, df = 13 (P = 0.005); I² = 56%
Test for overall effect: Z = 4.26 (P < 0.0001)
Total (95% CI)
Heterogeneity: Tau² = 0.39; Chi² = 128.06, df = 32 (P < 0.00001); I² = 75%
Test for overall effect: Z = 8.78 (P < 0.00001)
Test for subgroup differences: Chi² = 7.32, df = 2 (P = 0.03), I² = 72.7%
Reduced fat
Mean
0.4
-1.6
-0.8
-1.8
1.06
59.6
-0.94
62
-2.7
-4.2
-3.1
-2.8
67.3
-0.8877
-0.8734
63.4
-1.6
-1.9
-1.91
0.1
-0.18
-1.27
-1.34
-0.4
-2.7
-1.2
-0.4
66.7
-0.65
-0.83
74.1
-2.7
-7.4
SD
2.36
1.0131
10.1
4
2.49
7.3
2.68
9.1
3.5
4.2
3.7
3.5
13.8
2.1451
2.6017
11.1
5.4
4.2
4.9
4.85
5.4225
7.1294
6.3357
2.8
3.6
4.7476
5.5
5.9
5.22
3
19.53
15.3
7.9
Total
117
101
16297
1325
17840
47
76
39
388
46
48
43
49
47
111
117
34
48
176
159
1428
48
30
88
98
36
34
46
63
12
943
15
1308
386
22
3129
22397
Usual or modified fat
Mean
1.12
-1.0019
-0.1
-0.3
0.44
60.4
0.06
63.5
0.8
-0.6
-0.4
0.5
66.4
-0.0402
0.1674
71.9
2.13
-0.2
-0.08
0.5
2.21
0.61
0.47
0.1
-0.9
-1.1
1.3
70.8
0.31
1.6
73.7
0
0.7
SD
2.36
1.0262
10.1
4.2
2.68
8.4
1.86
9.4
4.2
3.1
2.5
2.7
12
0.213
1.8124
11.7
5
3.7
4.3
4.07
6.0576
7.8652
11.7962
2
3.5
4.6433
5.5
5.2
5.22
1.8
19.2
15.3
5.4
Total
103
206
25056
883
26248
51
78
40
401
45
47
43
46
50
110
115
38
51
188
102
1405
46
39
92
115
29
35
44
106
23
943
15
1313
998
27
3825
31478
Weight
5.3%
6.4%
6.5%
6.1%
24.3%
3.9%
1.3%
3.9%
3.1%
2.5%
2.7%
3.0%
3.2%
0.4%
6.0%
5.4%
0.3%
1.7%
4.6%
3.6%
45.8%
2.1%
1.1%
1.6%
1.3%
3.5%
2.3%
1.9%
2.2%
0.6%
5.8%
2.2%
2.7%
2.1%
0.6%
29.9%
100.0%
Mean Difference
IV, Random, 95% CI
-0.72 [-1.34 , -0.10]
-0.60 [-0.84 , -0.36]
-0.70 [-0.90 , -0.50]
-1.50 [-1.85 , -1.15]
-0.88 [-1.26 , -0.49]
0.62 [-0.40 , 1.64]
-0.80 [-3.28 , 1.68]
-1.00 [-2.02 , 0.02]
-1.50 [-2.79 , -0.21]
-3.50 [-5.09 , -1.91]
-3.60 [-5.08 , -2.12]
-2.70 [-4.03 , -1.37]
-3.30 [-4.55 , -2.05]
0.90 [-4.26 , 6.06]
-0.85 [-1.25 , -0.45]
-1.04 [-1.62 , -0.46]
-8.50 [-13.77 , -3.23]
-3.73 [-5.78 , -1.68]
-1.70 [-2.52 , -0.88]
-1.83 [-2.96 , -0.70]
-1.85 [-2.49 , -1.21]
-0.40 [-2.21 , 1.41]
-2.39 [-5.11 , 0.33]
-1.88 [-4.07 , 0.31]
-1.81 [-4.30 , 0.68]
-0.50 [-1.67 , 0.67]
-1.80 [-3.48 , -0.12]
-0.10 [-2.04 , 1.84]
-1.70 [-3.41 , 0.01]
-4.10 [-8.06 , -0.14]
-0.96 [-1.43 , -0.49]
-2.43 [-4.20 , -0.66]
0.40 [-1.08 , 1.88]
-2.70 [-4.50 , -0.90]
-8.10 [-11.98 , -4.22]
-1.48 [-2.16 , -0.80]
-1.42 [-1.73 , -1.10]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
(1) Change from baseline to 7.5 years
(2) Women, no exercise
(3) Men with exercise
(4) Women with exercise
(5) Men, no exercise
(6) High GI arms; Calculated from % change based on median baseline
(7) Low GI arms, Calculated from % change based on median baseline
(8) Non-preDM, change to 5 years
(9) pre-DM by HbA1c, change to 5 years
(10) preDM by IFT/IGT, change to 5 years
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(9) pre-DM by HbA1c, change to 5 years
(10) preDM by IFT/IGT, change to 5 years
(11) non-obese participants (BMI < 28)
(12) obese participants (BMI 28+)
(13) Data for 22 of 26 intervention participants who were compliant with diet
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Analysis 3.11.   Comparison 3: Lower fat vs higher fat diet on body weight, subgrouping, Outcome 11: Weight, kg
Subgrouping by assessed energy reduction
Study or Subgroup
3.11.1 E intake the same or greater in low fat group
De Bont 1981 (1)
De Bont 1981 (2)
Nutrition & Breast Health
ODMDC 2017
WHEL 2007
Subtotal (95% CI)
Heterogeneity: Tau² = 0.01; Chi² = 4.06, df = 4 (P = 0.40); I² = 2%
Test for overall effect: Z = 4.33 (P < 0.0001)
3.11.2 E intake 1 to 100kcal/d less in low fat group
BRIDGES 2001
Nordevang 1990
Polyp Prevention 1996
RISCK 2010 (3)
Simon 1997
Subtotal (95% CI)
Heterogeneity: Tau² = 0.22; Chi² = 9.21, df = 4 (P = 0.06); I² = 57%
Test for overall effect: Z = 3.23 (P = 0.001)
3.11.3 E intake 101 to 200 kcal/d less in low fat group
Anderson 1990
BDIT Pilot Studies 1996
RISCK 2010 (4)
WHI 2006 (5)
WINS 1993
Subtotal (95% CI)
Heterogeneity: Tau² = 0.28; Chi² = 12.47, df = 4 (P = 0.01); I² = 68%
Test for overall effect: Z = 2.27 (P = 0.02)
3.11.4 E intake > 201 kcal/d less in low fat group
CORDIOPREV 2016 (6)
CORDIOPREV 2016 (7)
CORDIOPREV 2016 (8)
Canadian DBCP 1997
DEER 1998 (9)
DEER 1998 (10)
DEER 1998 (11)
DEER 1998 (12)
MSFAT 1995
Swinburn 2001
WHT Vanguard 1991
WHTFSMP 2003
Subtotal (95% CI)
Heterogeneity: Tau² = 0.62; Chi² = 34.49, df = 11 (P = 0.0003); I² = 68%
Test for overall effect: Z = 7.14 (P < 0.00001)
3.11.5 E intake unclear
Bloemberg 1991
Ma 2016
Pilkington 1960
Strychar 2009
WHT Full-scale
Yadav 2016 (13)
Subtotal (95% CI)
Heterogeneity: Tau² = 1.45; Chi² = 16.85, df = 5 (P = 0.005); I² = 70%
Test for overall effect: Z = 3.21 (P = 0.001)
Total (95% CI)
Heterogeneity: Tau² = 0.39; Chi² = 128.06, df = 32 (P < 0.00001); I² = 75%
Test for overall effect: Z = 8.78 (P < 0.00001)
Test for subgroup differences: Chi² = 26.99, df = 4 (P < 0.0001), I² = 85.2%
Reduced fat
Mean
-2.7
-0.4
67.3
-1.6
74.1
0.1
-0.4
-0.65
-0.8877
63.4
1.06
59.6
-0.8734
-0.8
-2.7
-1.34
-1.27
-0.18
62
-2.8
-3.1
-4.2
-2.7
0.4
-1.6
-1.91
-1.8
-0.94
-1.2
66.7
-0.83
-1.9
-7.4
SD
3.6
2.8
13.8
1.0131
19.53
4.85
5.5
5.22
2.1451
11.1
2.49
7.3
2.6017
10.1
15.3
6.3357
7.1294
5.4225
9.1
3.5
3.7
4.2
3.5
2.36
5.4
4.9
4
2.68
4.7476
5.9
3
4.2
7.9
Total
34
36
47
101
1308
1526
48
63
943
111
34
1199
47
76
117
16297
386
16923
98
88
30
388
49
43
48
46
117
48
159
1325
2439
39
46
12
15
176
22
310
22397
Usual or modified fat
Mean
-0.9
0.1
66.4
-1.0019
73.7
0.5
1.3
0.31
-0.0402
71.9
0.44
60.4
0.1674
-0.1
0
0.47
0.61
2.21
63.5
0.5
-0.4
-0.6
0.8
1.12
2.13
-0.08
-0.3
0.06
-1.1
70.8
1.6
-0.2
0.7
SD
3.5
2
12
1.0262
19.2
4.07
5.5
5.22
0.213
11.7
2.68
8.4
1.8124
10.1
15.3
11.7962
7.8652
6.0576
9.4
2.7
2.5
3.1
4.2
2.36
5
4.3
4.2
1.86
4.6433
5.2
1.8
3.7
5.4
Total
35
29
50
206
1313
1633
46
106
943
110
38
1243
51
78
115
25056
998
26298
115
92
39
401
46
43
47
45
103
51
102
883
1967
40
44
23
15
188
27
337
31478
Weight
2.3%
3.5%
0.4%
6.4%
2.7%
15.2%
2.1%
2.2%
5.8%
6.0%
0.3%
16.5%
3.9%
1.3%
5.4%
6.5%
2.1%
19.2%
1.3%
1.6%
1.1%
3.1%
3.2%
3.0%
2.7%
2.5%
5.3%
1.7%
3.6%
6.1%
35.3%
3.9%
1.9%
0.6%
2.2%
4.6%
0.6%
13.8%
100.0%
Mean Difference
IV, Random, 95% CI
-1.80 [-3.48 , -0.12]
-0.50 [-1.67 , 0.67]
0.90 [-4.26 , 6.06]
-0.60 [-0.84 , -0.36]
0.40 [-1.08 , 1.88]
-0.59 [-0.85 , -0.32]
-0.40 [-2.21 , 1.41]
-1.70 [-3.41 , 0.01]
-0.96 [-1.43 , -0.49]
-0.85 [-1.25 , -0.45]
-8.50 [-13.77 , -3.23]
-1.04 [-1.68 , -0.41]
0.62 [-0.40 , 1.64]
-0.80 [-3.28 , 1.68]
-1.04 [-1.62 , -0.46]
-0.70 [-0.90 , -0.50]
-2.70 [-4.50 , -0.90]
-0.74 [-1.38 , -0.10]
-1.81 [-4.30 , 0.68]
-1.88 [-4.07 , 0.31]
-2.39 [-5.11 , 0.33]
-1.50 [-2.79 , -0.21]
-3.30 [-4.55 , -2.05]
-2.70 [-4.03 , -1.37]
-3.60 [-5.08 , -2.12]
-3.50 [-5.09 , -1.91]
-0.72 [-1.34 , -0.10]
-3.73 [-5.78 , -1.68]
-1.83 [-2.96 , -0.70]
-1.50 [-1.85 , -1.15]
-2.22 [-2.83 , -1.61]
-1.00 [-2.02 , 0.02]
-0.10 [-2.04 , 1.84]
-4.10 [-8.06 , -0.14]
-2.43 [-4.20 , -0.66]
-1.70 [-2.52 , -0.88]
-8.10 [-11.98 , -4.22]
-2.07 [-3.33 , -0.80]
-1.42 [-1.73 , -1.10]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
Footnotes
 
Eects of total fat intake on body fatness in adults (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
159
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
 
Analysis 3.11.   (Continued)
Footnotes
(1) obese participants (BMI 28+)
(2) non-obese participants (BMI < 28)
(3) High GI arms; Calculated from % change based on median baseline
(4) Low GI arms, Calculated from % change based on median baseline
(5) Change from baseline to 7.5 years
(6) preDM by IFT/IGT, change to 5 years
(7) pre-DM by HbA1c, change to 5 years
(8) Non-preDM, change to 5 years
(9) Men, no exercise
(10) Women with exercise
(11) Men with exercise
(12) Women, no exercise
(13) Data for 22 of 26 intervention participants who were compliant with diet
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Energy intake (SD), kcal Sugars
in-
take,
%E
CHO intake, %E Protein intake, %E Alcohol
intake,
%E
No. of
partici-
pants
Trial
Int. Cont Int. ContInt. Cont Int. Cont Int. Cont Int. Cont
Anderson 1990, 1 yr 1882 (521) 2010 (528) — — 53 (8.9) 50 (7.9) 17 (3.4) 18 (4.3) — — 47 51
AUSMED 2018, 6 mo 1800 (541) 2014 (461) 5.7
(4.1)
5.4
(4.4)
42.5 (7.1) 34.8 (7.2) 21.8 (5.8) 19.4 (4.2) 1.1
(2.4)
3.0
(4.1)
31 34
BDIT Pilot Studies 1996, 9 yrs 1460 (376) 1578 (365) — — 49.6 (7.5) 46.9 (6.2) 15.5 (2.4) 15.3 (2.6) 2.3
(3.3)
1.7
(2.4)
76 81
beFIT 1997 (data not reported in control groups)    
Black 1994, during trial 1995 (564) 2196 (615) — — 60.3 (6.3) 44.6 (6.9) 17.7 (2.2) 15.7 (2.4) 3.2
(3.4)
3.2
(3.9)
57? 58?
Bloemberg 1991, Δ to 6 mo — — — — 4.4 (6.5) 1.2 (6.1) 0.33 (2.9) 0.57 (1.7) — — 39 41
Boyd 1988, 6 mo 1491 (NR) 1676 (NR) — — 56.3 (NR) 48.1 (NR) 17.9 (NR) 15.8 (NR) 4.8
(NR)
4.2
(NR)
10 9
BRIDGES 2001, Δ to 6 mo -34 (79) + 22 (79) — — — — — — — — 48 46
Canadian DBCP 1997, 2 yrs 1540 (317) 1759 (437) — — 60.3 (8.3) 48.8 (8.1) 18.0 (3.2) 16.9 (2.8) — — 104 100
CORDIOPREV 2016, 5 yrs 1716 (363) 2024 (381) - - 45.6 (6.0) 38.5 (6.3) 18.9 (2.0) 17.3 (2.1) - - 406 447
De Bont 1981, Δ to 6 mo -98 (369) -120 (485) — — 7.9 (9.5) -0.1 (10.9) 2.4 (7.0) 1.7 (5.9) -0.2
(1.6)
-0.4
(2.6)
71 65
DEER 1998 (diet alone), Δ to 1 yr Women: -220
(356)
Men: -285 (541)
Women: -19
(367)
Men: -25 (482)
— — Women:
+5.5 (8.0)
Men: +8.0
(9.3)
Women: -0.2
(7.3)
Men: +1.1
(6.6)
— — — — 46,
49
45,
46
DEER 1998 (diet and ex), Δ to 1 yr Women:
-191 (343) Men:
Women:
-54 (410)
— — Women:
+7.8 (6.2)
Women:
-0.3 (7.9)
— — — — 43,
48
43,
47
Table 1.   Dietary intake of energy, sugars, carbohydrate and protein during trials 
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2
-167 (516) Men: +141 (437) Men:
+9.3 (8.3)
Men:
+1.4 (6.3)
Diet and Hormone Study 2003, 1 yr 1921 (386) 2063 (610) — — 64.3 (9.0) 54.6 (9.2) 14.5 (2.9) 14.1 (3.8) est:
1
(2)
est:
1
(2)
81 96
Ma 2016, 6 mo - - - - - - - - - - 46 44
MeDiet 2006, 6 mo 1676 (639) 1654 (498) 18.7
(6.9)
21.9
(9.2)
27.2 (17.0) 25.8 (11.0) 14.9 (4.7) 16.2 (5.1) 5.6
(11.1)
1.6
(2.2)
51? 55?
Moy 2001, 2 yrs 1825 (NR) 2092 (NR) — — — — — — — — 117 118
MSFAT 1995, 6 mo 2460 (NR) 2699 (NR) — — 47 (NR) 41 (NR) 16 (NR) 14 (NR) 3
(NR)
3
(NR)
117 103
NDHS Open 1st L&M 1968
6 mo
2154 (432) 2228 (456) — — 48.7 (12.3) 44.7 (11.7) 18.6 (3.4) 17.4 (3.1) 3.7
(3.7)
3.8
(4.0)
339 346
NDHS Open 2nd L&M 1968
6 mo
2249 (492) 2196 (427) — — 45.7 (12.7) 44.1 (11.1) 17.3 (3.5) 7.3 (3.0) 3.5
(4.2)
4.2
(4.0)
491 214
Nordevang 1990, Δ to 2 yrs -215 (P < 0.01) -143 (P < 0.01) +4.8
(P
<
0.01)
+1.4
(P
<
0.01)
+11.0 (P <
0.01)
+2.7 (P <
0.01)
+1.7 (P <
0.01)
+0.3 (P >
0.05)
+0.2
(P >
0.05)
+0.4
(P >
0.05)
63 106
Nutrition & Breast Health, 1 yr 1780 and 1960 1571 and 1687 — — — — — — — — 23
and
25
24
and
23
ODMDC 2017, during trial (by menu
analysis)
Male: 2094 (NR)
Female: 1697
(NR)
HF male: 2103
(NR)
HF female: 1704
(NR)
- - 66 (NR) HF 46 (NR)
MF 56 (NR)
14 (NR) HF 14
(NR)
MF 14
(NR)
- - 101 HF
101,
MF
105
Pilkington 1960, 1 yr NR NR — — — — — — — — 12 23
Polyp Prevention 1996, yr 4 1978 (471) 2030 (518) — — 58.3 (7.4) 47.1 (7.2) 17.3 (2.5) 16.5 (2.4) — — 605 581
Table 1.   Dietary intake of energy, sugars, carbohydrate and protein during trials  (Continued)
C
o
ch
ra
n
e
L
ib
ra
ry
T
ru
ste
d
 e
v
id
e
n
ce
.
In
fo
rm
e
d
 d
e
cisio
n
s.
B
e
tte
r h
e
a
lth
.
  
C
o
ch
ra
n
e D
a
ta
b
a
se o
f S
ystem
a
tic R
e
vie
w
s
E

e
cts o
f to
ta
l fa
t in
ta
k
e
 o
n
 b
o
d
y
 fa
tn
e
ss in
 a
d
u
lts (R
e
v
ie
w
)
C
o
p
yrig
h
t ©
 2020 T
h
e C
o
ch
ra
n
e C
o
lla
b
o
ra
tio
n
. P
u
b
lish
ed
 b
y Jo
h
n
 W
ile
y &
 S
o
n
s, Ltd
.
1
6
3
RISCK 2010 Δ to 6 mo
(LF/HGI vs HM/HGI
(95% CI)
-198.4
(-310.7,88.4)
-129.1 (-239,
-19.1)
3.8
(2.4,
5.3)
0.5
(-0.9,
1.9)
8.1 (6.3, 9.9) 1.9 (0.1, 3.7) -0.3
(-5.7,
5.1)
-2.2
(-7.5,
3.1)
    95 93
RISCK 2010 Δ to 6 mo
(LF/LGI vs HM/LGI
(95% CI)
-313.1
(-418.3, 210.3)
-74.1
(-181.6, 35.9)
3.5
(2.1,
4.8)
-0.5
(-1.9,
0.8)
8.5 (6.8,10.2) 1.6 (-0.2,
3.4)
-2.8
(-7.8,
2.2)
-3.4
(-1.9,
8.6)
    110 101
Rivellese 1994, 6 mo NR NR 14 10 55 48 18 16 — — 27 17
Sarkkinen Low Fat 1993; Sarkkinen
Low & Mod 1993, wks 14 to 28
AHA 1791 (382)
Mono 1887 (478)
Low fat 1648
(430)
1982 (406) — — AHA 48 (5)
Mono 47 (6)
Low fat 51
(5)
46 (6) AHA 17
(2)
Mono 17
(20)
Low fat
19 (3)
16 (2) — — AHA
41
Mono
41
Low
fat
40
37
Simon 1997, 1 yr 1570 (NR) 1594 (NR) — — — — — — — — 65 68
Strychar 2009, 6 mo NR NR — — — — — — — — 15 15
Swinburn 2001, 1 yr 1887 (672) 2269 (750) — — 54.2 (10.5) 45.8 (10.9) 18.4 (3.5) 16.6 (3.9) 3.6
(7.0)
5.7
(7.0)
49 61
WHEL 2007, 1 yr 1664 (345) 1635 (384) — — 65.3 (8.5) 57.1 (9.3) — — — — 197 196
WHI 2006, 7.5 yrs 1446 (510) 1564 (595) — — 52.7 (9.8) 44.7 (8.5) — — — — 14246 22083
WHT Full-scale, data only available af-
ter trial end
- - - - - - - - - - 448 457
WHT Vanguard 1991, 2 yrs 1356 (358) 1617 (391) — — 59.0 (8.8) 46.9 (8.9) 19.2 (3.9) 16.8 (3.8) — — 163 101
WHTFSMP 2003, Δ to 18 mo -488 (NR) -255 (NR) — — — — — — — — 285 194
WINS 1993, 5 yrs -167 (P < 0.0001
vs cont)
0 — — — — — — — — 380 648
Table 1.   Dietary intake of energy, sugars, carbohydrate and protein during trials  (Continued)
C
o
ch
ra
n
e
L
ib
ra
ry
T
ru
ste
d
 e
v
id
e
n
ce
.
In
fo
rm
e
d
 d
e
cisio
n
s.
B
e
tte
r h
e
a
lth
.
  
C
o
ch
ra
n
e D
a
ta
b
a
se o
f S
ystem
a
tic R
e
vie
w
s
E

e
cts o
f to
ta
l fa
t in
ta
k
e
 o
n
 b
o
d
y
 fa
tn
e
ss in
 a
d
u
lts (R
e
v
ie
w
)
C
o
p
yrig
h
t ©
 2020 T
h
e C
o
ch
ra
n
e C
o
lla
b
o
ra
tio
n
. P
u
b
lish
ed
 b
y Jo
h
n
 W
ile
y &
 S
o
n
s, Ltd
.
1
6
4
Yadav 2016 - - - - - - - - - - 26 27
Table 1.   Dietary intake of energy, sugars, carbohydrate and protein during trials  (Continued)
- Signifies that no data have been presented on this intake in this trial arm
AHA: American Heart Association
CHO: carbohydrate
CI: confidence interval
Cont: control arm
HF: high fat
HGI: high glycaemic index
HM: high monounsaturated fat diet
Int: intervention arm
LF: low fat
LGI: low glycaemic index
MF: moderate fat
Mono: monounsaturates
NR: not reported
SD: standard deviation
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Appendix 1. Searches run October 2019
The searches for this review were last run in November 2014 as part of a broader review (Hooper 2015a). As the review has now been split
and the previous search strategy was unsuitable, a new strategy has been run in October 2019, from database inception.
The RCT filter for MEDLINE is the Cochrane sensitivity and precision-maximising RCT filter (Lefebvre 2011), and for Embase, terms as
recommended in the Cochrane Handbook have been applied (Lefebvre 2011).
CENTRAL
#1 MeSH descriptor: [Weight Gain] explode all trees
#2 MeSH descriptor: [Weight Loss] explode all trees
#3 (obesity):ti,ab,kw
#4 (obese):ti,ab,kw
#5 (adipos*):ti,ab,kw
#6 ("weight gain"):ti,ab,kw
#7 ("weight loss"):ti,ab,kw
#8 (overweight):ti,ab,kw
#9 ("over weight"):ti,ab,kw
#10 (overeat*):ti,ab,kw
#11 (over NEXT eat*):ti,ab,kw
#12 (weight NEXT change*):ti,ab,kw
#13 (((bmi or "body mass index") NEAR/2 (gain or loss or change))):ti,ab,kw
#14 ("body fat"):ti,ab,kw
#15 ("body composition"):ti,ab,kw
#16 ("body constitution"):ti,ab,kw
#17 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16
#18 MeSH descriptor: [Dietary Fats] explode all trees
#19 MeSH descriptor: [Diet, Fat-Restricted] explode all trees
#20 ((fat* NEAR/2 (total or intake or consum* or ate or eat or reduce* or restrict* or low* or diet*))):ti,ab,kw
#21 #18 or #19 or #20
#22 #17 and #21
MEDLINE OVID
1 exp Weight Gain/
2 exp Weight Loss/
3 obesity.ab,ti.
4 obese.ab,ti.
5 adipos$.ab,ti.
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6 weight gain.ab,ti.
7 weight loss.ab,ti.
8 overweight.ab,ti.
9 over weight.ab,ti.
10 overeat$.ab,ti.
11 over eat$.ab,ti.
12 weight change$.ab,ti.
13 ((bmi or body mass index) adj2 (gain or loss or change)).ab,ti.
14 body fat$.ab,ti.
15 body composition.ab,ti.
16 body constitution.ab,ti.
17 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16
18 exp Dietary Fats/
19 exp Diet, Fat-Restricted/
20 (fat$ adj2 (total or intake or consum$ or ate or eat or reduce$ or restrict$ or low$ or diet$)).ab,ti.
21 18 or 19 or 20
22 17 and 21
23 randomized controlled trial.pt.
24 controlled clinical trial.pt.
25 randomized.ab.
26 placebo.ab.
27 clinical trials as topic.sh.
28 randomly.ab.
29 trial.ti.
30 23 or 24 or 25 or 26 or 27 or 28 or 29
31 exp animals/ not humans.sh.
32 30 not 31
33 22 and 32
Embase OVID
1 exp body weight gain/
2 exp body weight loss/
3 obesity.ab,ti.
4 obese.ab,ti.
5 adipos$.ab,ti.
6 weight gain.ab,ti.
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7 weight loss.ab,ti.
8 overweight.ab,ti.
9 over weight.ab,ti.
10 overeat$.ab,ti.
11 over eat$.ab,ti.
12 weight change$.ab,ti.
13 ((bmi or body mass index) adj2 (gain or loss or change)).ab,ti.
14 body fat$.ab,ti.
15 body composition.ab,ti.
16 body constitution.ab,ti.
17 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16
18 exp fat intake/
19 exp low fat diet/
20 (fat$ adj2 (total or intake or consum$ or ate or eat or reduce$ or restrict$ or low$ or diet$)).ab,ti.
21 18 or 19 or 20
22 17 and 21
23 random$.tw.
24 factorial$.tw.
25 crossover$.tw.
26 cross over$.tw.
27 cross-over$.tw.
28 placebo$.tw.
29 (doubl$ adj blind$).tw.
30 (singl$ adj blind$).tw.
31 assign$.tw.
32 allocat$.tw.
33 volunteer$.tw.
34 crossover procedure/
35 double blind procedure/
36 randomized controlled trial/
37 single blind procedure/
38 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37
39 (animal/ or nonhuman/) not human/
40 38 not 39
41 22 and 40
Eects of total fat intake on body fatness in adults (Review)
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42 limit 41 to embase
Clinicaltrials.gov
Condition or disease: weight loss OR weight gain OR body weight OR weight change OR obesity OR obese OR overweight
Intervention/treatment: Fat, Dietary OR fat
Study type: Interventional Studies (Clinical Trials)
ICTRP
Condition: weight loss OR weight gain OR body weight OR weight change OR obesity OR obese OR overweight
Intervention: Fat, Dietary OR fat
Appendix 2. Searches run in 2014
MEDLINE search run to collect adult and child RCTs and cohort studies 15 November 2014
Search adapted from that run in 2010, to search for both adult and child RCTs and cohort studies, but omitting dietary exposures other
than dietary fat.
Run 15 November 2014.
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) <1946 to Present>
Search Strategy:
--------------------------------------------------------------------------------
1 exp Weight Gain/ (24259)
2 exp Weight Loss/ (30933)
3 obesity.ab,ti. (152189)
4 obese.ab,ti. (86464)
5 adipos$.ab,ti. (71315)
6 weight gain.ab,ti. (44371)
7 weight loss.ab,ti. (59414)
8 overweight.ab,ti. (42626)
9 over weight.ab,ti. (349)
10 overeat$.ab,ti. (1934)
11 over eat$.ab,ti. (275)
12 weight change$.ab,ti. (8042)
13 ((bmi or body mass index) adj2 (gain or loss or change)).ab,ti. (2786)
14 body fat$.ab,ti. (24784)
15 body composition.ab,ti. (23804)
16 body constitution.ab,ti. (257)
17 exp Dietary Fats/ (73523)
18 exp Diet, Fat-Restricted/ (3040)
19 (fat$ adj2 (total or intake or consum$ or ate or eat or reduce$ or restrict$ or low$ or diet$)).ab,ti. (63037)
20 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 (366287)
21 17 or 18 or 19 (114331)
22 20 and 21 (28779)
23 randomized controlled trial.pt. (399992)
24 controlled clinical trial.pt. (90666)
25 Randomized controlled trials/ (99585)
26 random allocation.sh. (84070)
27 double blind method.sh. (132423)
28 single-blind method.sh. (20589)
29 23 or 24 or 25 or 26 or 27 or 28 (658672)
30 (animals not (human and animals)).sh. (5551801)
31 29 not 30 (590901)
32 clinical trial.pt. (501242)
33 exp Clinical trial/ (816129)
34 (clin$ adj25 trial$).ti,ab. (291641)
35 ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).ti,ab. (137043)
36 placebos.sh. (34004)
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37 placebo$.ti,ab. (169148)
38 random$.ti,ab. (764596)
39 research design.sh. (82260)
40 comparative study.sh. (1730651)
41 exp Evaluation studies/ (206135)
42 follow up studies.sh. (520109)
43 prospective studies.sh. (390949)
44 (control$ or prospectiv$ or volunteer$).ti,ab. (3243146)
45 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 (5767873)
46 45 not 30 (4293785)
47 31 or 46 (4323589)
48 exp Cohort Studies/ (1438154)
49 (cohort$ or quintile$ or quartile$ or quantile$ or tertile$).mp. (411555)
50 (follow-up$ or followup$).mp,tw. (970994)
51 longitud$.mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept word, unique identifier] (208935)
52 ((prospectiv$ or observation$) adj5 (research$ or data$ or stud$)).mp. (587538)
53 48 or 49 or 50 or 51 or 52 (2092058)
54 53 not 30 (1996509)
55 47 or 54 (4973664)
56 22 and 55 (9237)
57 limit 56 to (english language and yr="2010 - 2015") (3294)
58 exp Case-Control Studies/ (710182)
59 (case adj3 control$).tw. (93452)
60 (case adj3 series).tw. (42174)
61 case study/ (1736496)
62 letter.pt. (885169)
63 exp Drug Therapy/ (1125358)
64 exp Surgery/ (35422)
65 exp Biochemical Phenomena/ (3179065)
66 exp OBESITY/dt, ec, ra, ri, rt, su, ve [Drug Therapy, Economics, Radiography, Radionuclide Imaging, Radiotherapy, Surgery, Veterinary]
(21417)
67 exp HIV/ (89024)
68 exp HIV infections/ (246055)
69 cancer.ti. (653428)
70 (tumour or tumor).ti. (242371)
71 lung.ti. (197074)
72 asthma.ti. (66394)
73 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 (8021499)
74 57 not 73 (1961)
EMBASE search run to collect adult and child RCTs and cohort studies on 14th November 2014
Search adapted from that run in 2010, to search for both adult and child RCTs and cohort studies, but omitting dietary exposures other
than dietary fat.
Run 14 November 2014.
Database: EMBASE <1974 to 2014 November 14>
Search Strategy:
--------------------------------------------------------------------------------
1 exp Weight Gain/ (67847)
2 exp weight reduction/ (104267)
3 obesity.ab,ti. (197751)
4 obese.ab,ti. (114407)
5 overweight.ab,ti. (55916)
6 over weight.ab,ti. (671)
7 ((weight or bmi or body mass index) adj2 (gain or loss or change or reduc$)).ab,ti. (154396)
8 exp fat intake/ (42075)
9 exp low fat diet/ (6962)
10 (fat$ adj2 (total or intake or consum$ or ate or eat or reduce$ or restrict$ or low$ or diet$)).ab,ti. (76246)
11 1 or 2 or 3 or 4 or 5 or 6 or 7 (440097)
12 8 or 9 or 10 (102724)
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13 11 and 12 (27385)
14 controlled study/ (4458191)
15 randomized controlled trial/ (355956)
16 clinical trial/ (839688)
17 major clinical study/ (2275896)
18 (trial$ or control$).tw. (3805000)
19 (blind$ or placebo).tw. (383515)
20 placebo/ (260940)
21 14 or 15 or 16 or 17 or 18 or 19 or 20 (8434269)
22 exp human/ (15270878)
23 nonhuman/ (4404779)
24 23 not 22 (3499956)
25 21 not 24 (6542287)
26 exp Longitudinal Study/ (70712)
27 exp Prospective Study/ (266457)
28 (cohort$ or quintile$ or quartile$ or tertile$ or quantile$).mp. (498531)
29 (follow-up$ or followup$).mp,tw. (1184342)
30 longitud$.mp. (214152)
31 ((prospectiv$ or observation$) adj5 (research$ or data$ or stud$)).mp. (615851)
32 26 or 27 or 28 or 29 or 30 or 31 (2100044)
33 32 not 24 (2060027)
34 33 or 25 (7492226)
35 13 and 34 (12448)
36 limit 35 to (english language and yr="2010 - 2015") (6329)
37 exp Case-Control Studies/ (90210)
38 (case adj3 control$).tw. (107292)
39 (case adj3 series).tw. (51300)
40 case study/ (28823)
41 letter.pt. (860483)
42 exp Drug Therapy/ (1859698)
43 exp Surgery/ (3481521)
44 exp Biochemical Phenomena/ (81777)
45 exp obesity/cn, di, dr, dt, rt, su [Congenital Disorder, Diagnosis, Drug Resistance, Drug Therapy, Radiotherapy, Surgery] (33545)
46 exp HIV/ (138030)
47 exp HIV infections/ (303673)
48 cancer.ti. (812504)
49 (tumour or tumor).ti. (277200)
50 lung.ti. (240253)
51 asthma.ti. (82529)
52 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 (6915750)
53 36 not 52 (5003)
CINAHL search run to collect adult and child RCTs and cohort studies on 1st December 2014
Interface EBSCO host research databases, Advanced search, CINAHL Complete
 
# Query Limiters/Expanders Results
S1 (MH "weight gain+") Search modes - Boolean/Phrase 62,681
S2 (MH "weight loss+") Search modes - Boolean/Phrase 14,411
S3 TI obesity OR AB obesity Search modes - Boolean/Phrase 32,659
S4 TI obese OR AB obese Search modes - Boolean/Phrase 15,905
S5 TI adipos* OR AB adipos* Search modes - Boolean/Phrase 6,462
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S6 TI weight gain OR AB weight gain Search modes - Boolean/Phrase 6,645
S7 TI weight loss OR AB weight loss Search modes - Boolean/Phrase 11,452
S8 TI overweight OR AB overweight Search modes - Boolean/Phrase 12,405
S9 TI over weight OR AB over weight Search modes - Boolean/Phrase 1,157
S10 TI overeat* OR AB overeat* Search modes - Boolean/Phrase 418
S11 TI over eat* OR AB over eat* Search modes - Boolean/Phrase 321
S12 TI weight change* OR AB weight
change*
Search modes - Boolean/Phrase 3,689
S13 (TI ((bmi or body mass index) N2 (gain or
loss or change))) OR (AB ((bmi or body
mass index) N2 (gain or loss or change)))
Search modes - Boolean/Phrase 862
S14 TI body fat* OR AB body fat* Search modes - Boolean/Phrase 5,932
S15 TI body composition OR AB body com-
position
Search modes - Boolean/Phrase 5,353
S16 TI body constitution OR AB body consti-
tution
Search modes - Boolean/Phrase 26
S17 (MH "Dietary Fats+") Search modes - Boolean/Phrase 17,455
S18 (MM "Diet, Fat-Restricted") Search modes - Boolean/Phrase 901
S19 (TI (fat* N2 (total or intake or consum*
or ate or eat or reduc* or restrict* or
low* or diet*))) OR (AB (fat* N2 (total or
intake or consum* or ate or eat or re-
duc* or restrict* or low* or diet*)))
Search modes - Boolean/Phrase 11,074
S20 (S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR
S7 OR S8 OR S9 OR S10 OR S11 OR S12
OR S13 OR S14 OR S15 OR S16)
Search modes - Boolean/Phrase 99,408
S21 (S17 OR S18 OR S19) Search modes - Boolean/Phrase 25,122
S22 (S20 AND S21) Search modes - Boolean/Phrase 6,404
S23 PT randomized controlled trial Search modes - Boolean/Phrase 45,326
S24 TX "controlled clinical trial" Search modes - Boolean/Phrase 7,628
S25 MM "Randomized Controlled Trials" Search modes - Boolean/Phrase 668
S26 MM "Random Assignment" Search modes - Boolean/Phrase 147
S27 MM "Double-Blind Studies" Search modes - Boolean/Phrase 76
S28 MM "Single-Blind Studies" Search modes - Boolean/Phrase 26
  (Continued)
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S29 S23 OR S24 OR S25 OR S26 OR S27 OR
S28
Search modes - Boolean/Phrase 52,650
S30 SU (animals not (human and animals)) Search modes - Boolean/Phrase 53,619
S31 S29 NOT S30 Search modes - Boolean/Phrase 52,575
S32 PT clinical trial Search modes - Boolean/Phrase 77,533
S33 MH "Clinical Trials+" Search modes - Boolean/Phrase 184,793
S34 TI (clin* N25 trial*) OR AB (clin* N25 tri-
al*)
Search modes - Boolean/Phrase 53,327
S35 TI ((singl* or doubl* or trebl* or tripl*
or quad*) N (blind* or mask*)) OR AB
((singl* or doubl* or trebl* or tripl* or
quad*) N (blind* or mask*))
Search modes - Boolean/Phrase 300
S36 MM "Placebos" Search modes - Boolean/Phrase 828
S37 TI placebo* OR AB placebo* Search modes - Boolean/Phrase 27,852
S38 TI random* OR AB random* Search modes - Boolean/Phrase 144,733
S39 MM "study design" Search modes - Boolean/Phrase 5,275
S40 MM "comparative studies" Search modes - Boolean/Phrase 283
S41 MH "Evaluation Research+" Search modes - Boolean/Phrase 20,984
S42 MM "prospective studies" Search modes - Boolean/Phrase 800
S43 TI (control* or prospectiv* or volun-
teer*) OR AB (control* or prospectiv* or
volunteer*)
Search modes - Boolean/Phrase 357,450
S44 S32 OR S33 OR S34 OR S35 OR S36 OR
S37 OR S38 OR S39 OR S40 OR S41 OR
S42 OR S43
Search modes - Boolean/Phrase 542,974
S45 S44 NOT S30 Search modes - Boolean/Phrase 535,502
S46 S31 OR S45 Search modes - Boolean/Phrase 541,731
S47 MH "prospective studies+" Search modes - Boolean/Phrase 254,176
S48 TX cohort* or quintile* or quartile* or
quantile* or tertile*
Search modes - Boolean/Phrase 152,914
S49 TX follow-up* or followup* Search modes - Boolean/Phrase 249,854
S50 TX longitud* Search modes - Boolean/Phrase 103,954
S51 TX ((prospectiv* or observation*) N5 (re-
search* or data* or stud*))
Search modes - Boolean/Phrase 382,309
  (Continued)
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S52 S47 OR S48 OR S49 OR S50 OR S51 Search modes - Boolean/Phrase 613,040
S53 S52 NOT S30 Search modes - Boolean/Phrase 610,840
S54 S46 OR S53 Search modes - Boolean/Phrase 963,714
S55 S22 AND S54 Search modes - Boolean/Phrase 3,017
S56 S22 AND S54 Limiters - Published Date: 20100101-20151231; English
Language
Search modes - Boolean/Phrase
1,236
S57 MH "Case Control Studies+" Limiters - Published Date: 20100101-20151231; English
Language
Search modes - Boolean/Phrase
23,820
S58 TX case N3 control* Limiters - Published Date: 20100101-20151231; English
Language
Search modes - Boolean/Phrase
35,592
S59 TX case N3 series Limiters - Published Date: 20100101-20151231; English
Language
Search modes - Boolean/Phrase
10,407
S60 MM "Case Studies" Search modes - Boolean/Phrase 623
S61 PT letter Search modes - Boolean/Phrase 198,888
S62 MH "Drug Therapy+" Search modes - Boolean/Phrase 109,541
S63 MH "Surgery, Operative+" Search modes - Boolean/Phrase 385,583
S64 MH "Biochemical Phenomena+" Search modes - Boolean/Phrase 29,949
S65 MH "Obesity+/DT/EC/RA/RT/SU" Search modes - Boolean/Phrase 5,470
S66 MH "Human Immunodeficiency Virus+" Search modes - Boolean/Phrase 5,947
S67 MH "HIV Infections+" Search modes - Boolean/Phrase 62,282
S68 TI cancer Search modes - Boolean/Phrase 137,532
S69 TI tumor OR tumour Search modes - Boolean/Phrase 21,392
S70 TI lung Search modes - Boolean/Phrase 24,925
S71 TI asthma Search modes - Boolean/Phrase 15,732
S72 S57 OR S58 OR S59 OR S60 OR S61 OR
S62 OR S63 OR S64 OR S65 OR S66 OR
S67 OR S68 OR S69 OR S70 OR S71
Search modes - Boolean/Phrase 913,702
S73 S56 NOT S72 Search modes - Boolean/Phrase 765
  (Continued)
 
CENTRAL search run as part of the update in March 2014
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#1 lipid near (low* or reduc* or modifi*)
#2 cholesterol* near (low* or modifi* or reduc*)
#3 (#1 or #2)
#4 MeSH descriptor: [Nutrition Therapy] explode all trees
#5 diet* or food* or nutrition*
#6 (#4 or #5)
#7 (#3 and #6)
#8 fat* near (low* or reduc* or modifi* or animal* or saturat* or unsaturat*)
#9 MeSH descriptor: [Diet, Atherogenic] explode all trees
#10 MeSH descriptor: [Diet Therapy] explode all trees
#11 (#7 or #8 or #9 or #10)
#12 MeSH descriptor: [Cardiovascular Diseases] this term only
#13 MeSH descriptor: [Heart Diseases] explode all trees
#14 MeSH descriptor: [Vascular Diseases] explode all trees
#15 MeSH descriptor: [Cerebrovascular Disorders] this term only
#16 MeSH descriptor: [Brain Ischemia] explode all trees
#17 MeSH descriptor: [Carotid Artery Diseases] explode all trees
#18 MeSH descriptor: [Dementia, Vascular] explode all trees
#19 MeSH descriptor: [Intracranial Arterial Diseases] explode all trees
#20 MeSH descriptor: [Intracranial Embolism and Thrombosis] explode all trees
#21 MeSH descriptor: [Intracranial Hemorrhages] explode all trees
#22 MeSH descriptor: [Stroke] explode all trees
#23 coronar* near (bypas* or graK* or disease* or event*)
#24 cerebrovasc* or cardiovasc* or mortal* or angina* or stroke or strokes or tia or ischaem* or ischem*
#25 myocardi* near (infarct* or revascular* or ischaem* or ischem*)
#26 morbid* near (heart* or coronar* or ischaem* or ischem* or myocard*)
#27 vascular* near (peripheral* or disease* or complication*)
#28 heart* near (disease* or attack* or bypas*)
#29 (#12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28)
#30 (#11 and #29)
F E E D B A C K
Tobias 2016, July 2016
Summary
In their systematic review and meta-analysis of 32 randomized controlled trials, representing 54,000 participants, Hooper et al. reported
that a lower proportion of energy intake from total fat was associated with a small reduction in body weight (di$erence = 1.5 kg).1 The
authors’ conclusion, however, was contradicted by findings from their parallel meta-analysis of 25 observational cohort studies. The
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erroneous conclusion from the review of trials is a consequence of biased study selection criteria, inclusion of short-term follow-up (<12
months), and other methodologic flaws.
First, their criteria explicitly included only trials in which weight loss was not an objective of the intervention. This led to the exclusion of
several long-term, rigorously conducted RCTs designed specifically to test the hypothesis that the fat composition of the diet a$ects weight
change. The criteria used by Hooper et al. resulted in a heterogeneous subset of the of low-fat dietary intervention RCTs, which included
trials conducted to test the e$ects of low-fat diets on endpoints such as cancer incidence or lipids in higher risk study populations. In fact,
only three trials in their meta-analysis were among healthy participants, not recruited on the basis of risk factors or disease. The authors’
contend that including only studies not intending to alter weight would reduce potential publication bias. On the contrary, we believe this
would increase the likelihood of publication bias, since investigators of diet trials not explicitly conducted for weight loss would not be
motivated to publish null or contrary results. Since the point of this work is to advise generally healthy individuals as to how to maintain
or lose weight, it is bizarre to specifically exclude trials designed to answer that question.
Second, the authors’ included short-term trials (of as little as 6 months duration). Six months is typically when the e$ect of dietary
interventions on body weight wane and weight regain commences; thus short-term results do not reflect sustained e$ects at 1 year or
longer, which is of primary interest.2
Third, most of the studies included by Hooper et al. were seriously confounded by factors other than the fat content of the diet. Some of
the trials coupled a low-fat intervention with other advice, such as eating more fruits and vegetables, which obscures the interpretation
of the findings. The other key characteristic is the di$erences in intensity or attention between intervention groups (e.g., fewer or no in-
person visits, dietary counseling meetings, etc), because the control group was oKen simply assigned to maintain their usual diet. Aspects
related to the intensity of a dietary intervention, such as behavioral support, are modest predictors of weight loss success;3 thus, most
RCT’s designed to assess the e$ects of diet composition on weight intentionally balanced the intensity of interventions, but these were
the studies explicitly excluded by Hooper it al. In our previous meta-analysis of RCTs comparing low-fat vs. higher fat dietary interventions,
we conducted stratified analyses by these key trial characteristics.4 We observed that significant long-term weight loss favoring low-fat
interventions was observed only for trials in which the comparator group was “usual diet” or received less attention during the intervention
from study investigators. This was true regardless of whether the RCTs had a weight loss focus or not. Comparisons between low-fat and
higher fat interventions of similar intensity demonstrated no benefit of low-fat over higher fat diets, regardless of weight loss goal. Indeed,
the overall results of these trials favored a small but statistically significant greater weight loss with higher fat diets. Our findings clearly
demonstrated the biased impact of di$erential attention across treatment groups.
Only 4 RCTs in Hooper’s meta-analysis (419 total participants) remained aKer exclusion of trials in which control groups were asked simply
to maintain usual diet or received di$erentially less attention than the low-fat intervention arms. Three were 6 month trials, and the fourth
was published in 1960 among men with recent myocardial infarction to examine lipid changes aKer a 1 year intervention with either a low-
fat or a “unsaturated-fat” diet.5 These 4 RCTs also were judged by Hooper et al. to have relatively high “risk of bias” according to authors’
methodological quality criteria.
In summary, the results from the most recent Hooper et al. meta-analysis provide no convincing evidence for recommending a low-fat diet
for the prevention of weight gain and obesity in the general population. In fact, their strict exclusion criteria restricting the analysis only to
trials in which weight-loss was not intended led to biased results. Although the authors’ felt that limiting their analysis to non-weight loss
trials would enhance validity, this selectively excluded trials designed to avoid confounding by intensity of intervention and other factors.
Analysis of trials that include those specifically testing interventions for weight control, that exclude short-term trials, and account for key
trial characteristics yield consistent results that are consonant with observational studies. Would we derive recommendations for statin
use in the primary prevention of coronary heart disease solely from trials with a completely di$erent disease endpoint? Promoting low fat
diets for weight control can lead to increased consumption of refined carbohydrates, causing increased weight gain,4 an array of adverse
metabolic e$ects,6 and premature death.7 The overall body of scientific evidence clearly demonstrates that dietary recommendations
should focus not on lowering the total fat content of the diet but rather on specific types of fats and carbohydrates and, more importantly,
on specific foods and overall dietary patterns.8
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I do not have any a$iliation with or involvement in any organisation with a financial interest in the subject matter of my comment
Reply
Thank you for your interest in our systematic review (1). You are incorrect; we did not state anywhere in the review that “a lower proportion
of energy intake from total fat was associated with a small reduction in body weight (di$erence = 1.5 kg)”. We were not interested in
associations, we were interested in causality, so we included RCTs that reduced total fat in one randomised arm and not in the other. In
the abstract, we stated “There is consistent evidence from RCTs in adults of a small weight-reducing e$ect of eating a smaller proportion
of energy from fat; this was seen in almost all included studies and was highly resistant to sensitivity analyses. The e$ect of eating less
fat (compared with usual diet) is a mean weight reduction of 1.5 kg (95% confidence interval (CI) -2.0 to -1.1 kg), but greater weight loss
results from greater fat reductions.”
Yes, we only included studies where weight loss was NOT a goal (where fat reduction was assessed for its e$ect on cardiovascular disease,
cancer risk or other health issues). The reason for this was that we were interested not in weight-reducing diets for overweight people,
but in usual diets eaten day to day by generally healthy people all over the world. This issue was discussed in great detail by the World
Health Organization NUGAG committee before the review was commissioned and the committee was very clear that their instructions
were in setting goals for generally healthy populations and not therapeutic diets for those who were already overweight or obese.
Therapeutic weight-reducing diets are very di$erent and, whatever their macronutrient or food composition, cannot be disentangled from
the overriding and conscious requirement to eat less food (i.e. reduce energy intake). Indeed, and importantly, the participants in the
studies we reviewed were not recruited to studies that aimed to promote weight loss in participants, or where participants were aware
that one of the aims of the study was to promote a loss in their weight to achieve a healthy weight. This also meant that we did not include
studies where low fat diets were compared to other therapeutic diets (such as very low carbohydrate diets).
Our review assesses the e$ects on weight of encouraging normal populations to reduce their total fat intake over the long term. The studies
included durations of 6 months up to over 8 years. The e$ect in studies of between 6 and 12 months duration was a reduction of 1.74 kg in
the low fat group compared to control (95% CI -2.34 to -1.13), similar to that at 12 to 24 months (-2.00 kg, 95% CI -2.51 to -1.48) and at 24 to
60 months (-1.18 kg, 95% CI -1.65 to -0.70). The e$ect over more than 5 years was smaller (-0.68 kg, 95% CI -1.66 to 0.29) but two of the four
large RCTs still showed statistically significantly lower weight in the intervention groups (perhaps reflecting di$erences in the intensity of
the intervention delivery and support this far into the trials), and meta-regression did not suggest a significant e$ect of duration on the
extent of weight reduction in the low fat group compared to control. Dr Tobias’ own systematic review also clearly shows, in studies where
there was no intention to reduce weight “that low-fat interventions led to greater weight loss” compared to usual diets (abstract of (2)).
Strategies to help obese adults and children to lose weight are also clearly very important – but how to lose weight is a di$erent question
from how populations should eat day to day, year to year (there are a set of specific systematic reviews about weight reduction strategies
in di$erent populations on the Cochrane Library).
We used sensitivity analysis to assess the e$ect of “attention bias” (see Analysis 3.1). We removed studies where there appeared to have
been more attention and/or time spent on the intervention group than the control group. Five studies provided data for this meta-analysis,
finding that there was still a statistically significantly reduced weight in the low fat group (-1.25 kg, 95% CI -2.09 to -0.41). Three further
trials did not provide variance data so could not be included in the meta-analysis, but they all clearly showed greater weight reduction in
the low fat compared to usual fat arms, on average (though their statistical significance could not be assessed). This is a very consistent
e$ect, is not dependent on short duration, and does not rely on increased attention or behavioural strategies in the low fat arms.
We reiterate, “Trials where participants were randomised to a lower fat intake versus usual or moderate fat intake, but with no intention
to reduce weight, showed a consistent, stable but small e$ect of low fat intake on body fatness: slightly lower weight, BMI and waist
circumference compared with controls. Greater fat reduction and lower baseline fat intake were both associated with greater reductions
in weight.”
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W H A T ' S   N E W
 
Date Event Description
22 December 2019 New search has been performed Searches for RCTs updated to October 2019, omitted CINAHL
search, included searches of ClinicalTrials.gov and WHO ICTRP
trials registries.
22 December 2019 New citation required but conclusions
have not changed
Cohort data omitted.
Summary risk of bias assessed for all included trials, 'Risk of bias'
assessment updated across all included studies. Comparison of
fixed- and random-effects meta-analysis used in addition to fun-
nel plots and displaying missing data to understand small study
bias.
Seven new RCTs included in the review and meta-analyses (plus
three ongoing studies and six trials awaiting assessment). Data
updated for three of the 30 previously included trials.
All analyses and results updated, summary of findings updated.
No important changes in the bottom line of the review.
We have removed data on children from this review as effects of
total fat on body weight in children have now been assessed in a
separate review (Naude 2018).
 
H I S T O R Y
Review first published: Issue 6, 2020
 
Date Event Description
19 August 2016 Feedback has been incorporated Comment and authors' response added.
2 March 2016 Amended The description of data included in the main analysis for the WHI
study was incorrect, so the entry for the "Characteristics of In-
cluded Studies" table now reflects that the weight, BMI and waist
circumference data used in the main analyses were 7.5 year fol-
low up data (as is appropriate). The data in the forest plots were
already correct. Additionally the main reference for WHI is now
indicated as the paper that provides this 7.5 year follow up data.
The first paragraph of the text on "Associations between total
dietary fat in youth and measures of body fatness in children,
young people and adults (as seen in cohorts)" was unclear, so we
have tried to clarify these results. Table 2 is helpful to read in un-
derstanding this section.
21 July 2015 New search has been performed The searches were run on 12 November 2014.
11 July 2015 New citation required and conclusions
have changed
We split a previously published review (Reduced and mod-
ified dietary fat for preventing cardiovascular disease, DOI:
10.1002/14651858.CD002137.pub3) into six smaller review up-
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Date Event Description
dates. The conclusions are therefore now focused on the effects
of total fat intake on body weight instead of the effects of reduc-
ing or modifying fat intake overall on cardiovascular disease risk.
At the request of the World Health Organization (WHO) Nutrition
Guidance Expert Advisory Group (NUGAG) group we extended
this review to include cohort studies, and studies in children and
young people.
This split review update includes 32 randomised controlled trials
and also 30 sets of analyses of 25 cohorts.
11 June 2010 New citation required and conclusions
have changed
—
9 September 2008 Amended —
1 February 2000 New citation required and conclusions
have changed
Substantive amendment.
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